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ABSTRACT 
PrEP Use and Barriers to Use Among Adult and Young Sexual Minority Men in the United 
States 
By 
Thomas H.F. Whitfield 
Advisor: H. Jonathon Rendina 
Pre-exposure prophylaxis (PrEP) was approved for all individuals 13 years of age and 
older in May 2018. However, research pertaining to uptake has mostly focused on adult sexual 
minority men (SMM), leaving out many barriers and facilitators that may exist for those under 
18 years of age. Two of the most important precursors leading to PrEP uptake identified in prior 
research are the perception of self as a PrEP candidate and having intentions to begin PrEP. 
Developmental and dual processing theories suggest that individuals who are younger make 
behavioral decisions differently from those who are older. Developmental theories suggest that, 
compared to those who are older, those who are younger make decisions by placing more weight 
on social approval, as opposed to individual benefits. Dual processing theories suggest that, as 
individuals age, they utilize more ‘cold’ cognitive processing and conscious thought in their 
decision making; thus, those who are younger utilize more ‘hot’ affective processing. Taken 
together, theories of development and dual processing suggest that those who are younger may 
make decisions about PrEP use differently from those who are older. Current interventions 
aiming to increase PrEP uptake among adults may need to be altered to include the specific 
differences among decisions making in younger populations. As such, the aims of this 
dissertation were to: (1) examine PrEP use experience among both young sexual minority men 
(YSMM; ages 13-24) and SMM (25 years of age and up); (2a) investigate the role of age as a 
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moderator between affective and cognitive dimensions of HIV risk perception as associated with 
self-perception of PrEP candidacy and PrEP intentions among YSMM who are at-risk for HIV 
seroconversion; and (2b) investigate the role of age as a moderator between perceived benefits of 
PrEP use and PrEP stigma as associated with PrEP intentions among YSMM.   
 To achieve these aims, data were analyzed from a larger study of SMM living across the 
United States. As part of this project, participants first completed an online survey and then once 
enrolled, completed a baseline assessment. Utilizing data collected from the screener survey, in 
Study 1, I tested a series of hypotheses examining differences in PrEP use within an age-
stratified sample of YSMM and adult SMM. In bivariate analyses, I found that PrEP utilization 
was lowest among those 13-24 years of age. In regression analyses, stratified by age group and 
predicting PrEP use (i.e., former, and current), compared to never having used PrEP, I found that 
the odds of being a current PrEP user increased by 31% for each year of age for YSMM. 
Additionally, I found that while controlling for age, YSMM who were on their parent or 
guardian’s medical insurance had decreased odds of PrEP use compared to those on their own 
health insurance. There were also various demographic and behavioral differences that 
distinguished PrEP use history within the two age groups. These differences included sexual 
orientation, race, ethnicity, relationship status, region, medical insurance, and recent behavioral 
and sexual risk. Taken together, the findings from the first aim suggest there are many variables 
that need to be further investigated before PrEP uptake among YSMM is likely to increase.  
 Data for the second aim of this dissertation came from baseline data collected as part of 
the parent project, UNITE, a longitudinal cohort study examining the psychosocial and biological 
predictors of HIV seroconversion among SMM (UG3-AI133674). Utilizing these data, in Study 
2, I investigated a series of theoretically grounded hypotheses predicting the associations 
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between cognitive and affective dimensions of HIV risk and the two primary precursors to PrEP 
uptake (i.e., perceived PrEP candidacy, and PrEP intentions) among only YSMM (16-24 years of 
age, M = 21.2). I found that affective dimensions of HIV risk were significantly positively 
associated with PrEP candidacy and that this association was stronger among olderYSMM. 
Additionally, I found that cognitive dimensions of perceived HIV risk were significantly 
negatively associated with PrEP candidacy, and this association was weaker among older 
YSMM. Next, I tested affective and cognitive dimensions of HIV risk on PrEP intentions, 
mediated by perceived PrEP candidacy. I found support for perceived PrEP candidacy 
significantly mediating the associations between both affective and cognitive dimensions of 
perceived HIV risk and PrEP intentions. Lastly, I tested a model assessing whether age 
moderated the effects of perceived benefits of PrEP use and PrEP stigma on PrEP intentions. I 
found that perceived benefits of PrEP use were positively associated with PrEP intentions, and 
this association was stronger among older YSMM. In contrast, I found PrEP stigma was 
negatively associated with PrEP intentions, and this association was weaker among older 
YSMM. Findings from this dissertation highlight differences in factors that are known to change 
with increased age that significantly affects YSMM and may impede PrEP uptake.  
 There are many potential places for interventions to be made at different levels, including 
clinical, medical, and public health and policy. In order for the HIV epidemic to end in the 
United States, changes at all levels may be necessary, including interventions that focus on both 
young SMM and their caregivers. These intervention adaptations and future research ideas are 






ABSTRACT .................................................................................................................................... iv 
ACKNOWLEDGEMENTS ............................................................................................................ vi 
LIST OF TABLES ........................................................................................................................ viii 
LIST OF FIGURES ........................................................................................................................ ix 
CHAPTER 1 ................................................................................................................................... 1 
CHAPTER 2 ................................................................................................................................... 3 
CHAPTER 3 ................................................................................................................................. 19 
CHAPTER 4 ................................................................................................................................. 31 
CHAPTER 5 ................................................................................................................................. 53 
CHAPTER 6 ................................................................................................................................. 61 
CHAPTER 7 ................................................................................................................................. 77 
CHAPTER 8 ................................................................................................................................. 89 
CHAPTER 9 ................................................................................................................................. 98 
TABLES ..................................................................................................................................... 144 
FIGURES .................................................................................................................................... 156 








Table 1. History of PrEP use among a U.S. National Sample of Young and Adult SMM .......... 145 
Table 2. Demographic and Behavioral Predictors of PrEP Uptake among YSMM ................... 147 
Table 3. Demographic and Behavioral Predictors of PrEP Uptake among Adult SMM ........... 148 
Table 4 Demographics of YSMM at-risk for HIV and group differences in affective and cognitive 
dimensions of HIV risk scores (N=2,003)................................................................................... 149 
Table 5. Correlations of Variables of Interest ............................................................................ 151 
Table 6. Cognitive and Affective Perceived Risk of HIV, and Age, Associations with Perceived 
PrEP Candidcay and Intentions ................................................................................................. 152 
Table 7. Demographics of YSMM at-risk for HIV and group differences in perceived PrEP 
benefits and PrEP stigma (N=2,003) ......................................................................................... 153 






Figure 1. The Health Belief Model (HBM) ................................................................................ 157 
Figure 2. The Theory of Reasoned Action (TRA) ..................................................................... 158 
Figure 3. The Theory of Planned Behavior (TPB) ..................................................................... 159 
Figure 4. Hypothesized model to test affective and cognitive dimensions of HIV risk on 
perceived PrEP candidacy and PrEP intentions .......................................................................... 160 
Figure 5. Hypothesized model to test PrEP stigma and the benefits of PrEP use on PrEP 
intentions ..................................................................................................................................... 161 
Figure 6. Results of the first hypothesized model ...................................................................... 162 
Figure 7. Interaction plot of affective dimensions of HIV risk and age on perceived PrEP 
candidacy .................................................................................................................................... 163 
Figure 8. Results of the second hypothesized model ................................................................. 164 
Figure 9. Interaction plot of PrEP stigma and age on PrEP intentions....................................... 165 





Sexual minority men (SMM) are disproportionately affected by human 
immunodeficiency virus (HIV) in the United States (U.S.) and accounted for 83% of all new 
HIV diagnoses among men in 2016 (The Center for Disease Control and Prevention [CDC], 
2018a). Of particular concern are young sexual minority men (YSMM; ages 13-24) who, in 
2015, made up 92% of all new infections among men in their age group (CDC, 2018b).  
In 2012, the United States Food and Drug Administration (USFDA) approved pre-
exposure prophylaxis (PrEP), a once-daily pill that has been shown to be 92-99% effective in the 
prevention of HIV for individuals 18 years of age and older (CDC, 2012, 2015; Volk et al., 
2015). Since the approval of PrEP, research has focused mainly on examining group differences 
in uptake with samples consisting of SMM who are 18 years of age and older (Ayala et al., 2013; 
Bauermeister, Meanley, Pingel, Soler, & Harper, 2013; Galea et al., 2011; Gallagher et al., 2014; 
Golub et al., 2013; Grov et al., 2015; King et al., 2014; Mimiaga, Case, Johnson, Safren, & 
Mayer, 2009; Mustanski et al., 2013; Parsons et al., 2017; Rendina et al., 2017; Smith, Toledo, 
Smith, Adams, & Rothenberg, 2012). However, emerging research has demonstrated that PrEP is 
both safe and effective for individuals as young as 15 years of age (Hosek et al., 2017). On May 
15th, 2018, the USFDA approved PrEP for use by individuals under 18 years of age (National 
Institute of Child Health and Human Development [NICHD], 2018). With only limited research 
done to examine PrEP use among YSMM, it is impossible to know what other barriers exist that 
impede YSMM from beginning a PrEP regimen.  
 Addressing the unique barriers to PrEP uptake for YSMM is central to the successful 
implementation of PrEP use for this vulnerable population. In Chapter 2, I briefly review the 
safety and effectiveness of PrEP and the numerous factors that have already been shown to 
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increase and decrease PrEP uptake among adults. In Chapter 3, I discuss how the Theory of 
Planned Behavior (TPB) and Health Belief Model (HBM) further suggest there are various 
points along PrEP uptake models that may be intervened upon to increase uptake among YSMM. 
In Chapter 4, I examine different dual processing and developmental theories that suggest there 
may be different pathways to PrEP uptake among younger populations compared to adult SMM. 
In Chapter 5, I detail the proposed research, including both studies and theoretically grounded 
hypotheses. In Chapter 6, I provide details of the methods for both studies, including recruitment 
of the samples, data collection, measures, and the analytic plan. In Chapter 7, I provide the 
results of the first aim of this dissertation, along with a brief summary of the findings. In Chapter 
8, I provide the results of the second aim of this dissertation, along with a brief summary of the 
findings. Lastly, in Chapter 9, I discuss how these findings fit into other literature, their clinical 
implications, how these findings can be used to increase PrEP uptake, and limitations to this 
work.   
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CHAPTER TWO  
Pre-Exposure Prophylaxis for HIV Prevention 
 There are now more options than ever to prevent HIV transmission. The World Health 
Organization (WHO) suggests it is possible to stop new HIV transmission globally by the year 
2030 (WHO, 2016). They have stated that in order to achieve this goal, changes in both sexual 
risk behavior and medication utilization are necessary. Medication utilization includes adherence 
to antiretroviral therapy (ART) medication for individuals who are HIV-positive to achieve an 
undetectable viral load, and post-exposure prophylaxis (PEP) and PrEP use for HIV-negative 
individuals at risk for seroconversion (WHO, 2018). Understanding PrEP use among at-risk 
populations in the U.S. will help to identify factors that can be intervened upon to increase 
uptake, and thereby lower the number of new transmissions as 2030 moves closer. In the 
following chapter, I briefly discuss the current rates of HIV transmission for SMM before 
reviewing the current literature on PrEP uptake. This includes a review of the clinical trials and 
demonstration projects that show the efficacy and effectiveness of PrEP use for HIV prevention. 
I then discuss the importance and utilization of PrEP uptake models to increase uptake among 
SMM. Lastly, I argue there are additional unexplored developmental factors that may be 
additional barriers to PrEP use among YSMM. These additional barriers, along with those 
already identified for SMM, must be examined and intervened upon before uptake is likely to 
increase among HIV at-risk YSMM.  
HIV and Sexual Minority Men 
SMM are disproportionately affected by HIV in the U.S. and accounted for 83% of all 
new HIV diagnoses among men in 2016 (CDC, 2018a). As such, they remain a high priority in 
both psychological and public health research aimed at lowering rates of HIV in the U.S. Rates 
of new infections are particularly high among SMM of color, with recent estimations indicating 
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1 in 4 Latino and 1 in 2 Black SMM will be diagnosed with HIV in their lifetime (CDC, 2016). 
Additionally, age disparities also exist for SMM. Of particular concern, and the focus of this 
dissertation is YSMM, who made up 92% of all new infections among men in their age group in 
2015, and 21% of new diagnoses among all SMM (CDC, 2018b). As such, new developments in 
HIV prevention that target at-risk groups should include YSMM. However, not enough research 
has been conducted with this population to understand their specific needs in terms of PrEP 
utilization.   
PrEP - Clinical Trials, Effectiveness, and Recommendations 
 PrEP, in the form of a once-daily pill, is comprised of two antiretroviral medications 
(tenofovir disoproxil fumarate [TDF] and emtricitabine [FTC]), and optimal daily adherence can 
protect HIV-negative individuals from seroconverting in the event of HIV exposure (CDC, 2014; 
USFDA, 2012). Prior to approval by the USFDA, multiple randomized clinical trials (RCTs) 
were conducted to demonstrate both the safety and efficacy of PrEP use (Baeten et al., 2012; 
Choopanya et al., 2013; Grant et al., 2010; Sokal et al., 2013; Thigpen et al., 2012; Van Damme 
et al., 2012). Clinical trials consisted of a variety of populations, including SMM at high risk for 
HIV acquisition (Grant et al., 2010),  serodiscordant couples (Baeten et al., 2012), transgender 
individuals (Grant et al., 2010), heterosexuals (Baeten et al., 2012; Sokal et al., 2013; Thigpen et 
al., 2012; Van Damme et al., 2012), and injection drug users (Choopanya et al., 2013). RCTs 
examined multiple forms of PrEP, including oral TDF alone, oral TDF and FTC, and TDF 
vaginal gel. Equivocal results were reported for each form of PrEP across different populations. 
Overall, use of oral TDF alone resulted in an HIV reduction rate of 49-67% (Baeten et al., 2012; 
Choopanya et al., 2013), oral TDF and FTC resulted in an HIV reduction rate of 44-75% (Baeten 
et al., 2012; Grant et al., 2010; Thigpen et al., 2012), and use of TDF vaginal gel resulted in a 
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risk reduction of 39% (Sokal et al., 2013). Given the safety and efficacy across RCTs for all 
populations, and the focus of this dissertation, I herein only focus on those studies that were 
conducted using at least some SMM. 
Across RCTs, adherence was shown to be the most significant predictor of efficacy. For 
example, further statistical analysis of the iPrEx study sample demonstrated an increase from a 
44% risk reduction of seroconversion to 99% for those with drug levels that suggested daily 
adherence (Anderson et al., 2012). Non-adherence resulted in TDF/FTC being non-efficacious, 
and thus resulted in the discontinuation of two RCTs, the Vaginal and Oral Interventions to 
Control the Epidemic (VOICE) and the Preexposure Prophylaxis Trial for HIV Prevention 
among African Women (FEM-PrEP) (Marrazzo et al., 2015; Van Damme et al., 2012). Due to 
the findings from these RCTs, it is understood that in order for PrEP to have the highest efficacy, 
it is imperative that high drug levels be present at the time of exposure.  
 In 2012, the USFDA approved once-daily PrEP for use by individuals at risk of HIV 
acquisition (USFDA, 2012) and two years later, the CDC recommended that PrEP be used in 
concordance with other safe-sex practices by individuals 18 years of age and older, and at 
substantial risk for HIV (CDC, 2014) . The CDC defined substantial risk via sexual contact as 
one of the following criteria: having an HIV-positive sexual partner, a recent bacterial STI, a 
high number of sex partners, a recent history (3-6 months) of inconsistent or no condom use, or 
be a commercial sex worker in an area of high prevalence of HIV. In addition to meeting the 
behavioral eligibility to begin a PrEP regimen, clinical guidelines suggest potential users must 
also have a documented HIV-negative test result, no sign/symptoms of acute HIV infection, 
normal renal function, no contraindicated medications, and no hepatitis B virus infection and/or 
vaccination status. Additionally, guidelines also state that once all of the behavioral and clinical 
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eligibility for substantial risk is determined, providers can prescribe PrEP for daily dosing in less 
than or equal to a 90-day supply. These are only clinical guidelines, and there is currently no 
policy that enforces any or all of these steps.   
 Closely following the CDC Guidelines for recommended care may present potential PrEP 
users with barriers to acquiring and maintaining a prescription. Quarterly doctor’s visits include 
both HIV testing and prescription refills. Discussions between the provider and patient are also 
required and should cover sexual risk reduction behaviors, STI symptoms, side effect symptoms, 
and medication adherence. Additionally, STI testing is required every six months (CDC, 2014). 
For PrEP users, these appointments can be both costly and time-consuming, particularly for 
those without health insurance. Similarly, for providers, these guidelines may require more time 
and training to ensure users’ needs are met. Aside from these guidelines, there are social and 
psychological barriers to uptake that have appeared in the literature. Examples of these barriers 
include, potential users not viewing themselves as someone who should be on PrEP, 
experiencing stigma associated with PrEP use, and not having accurate information on where to 
obtain PrEP. The following section will further review the current literature on barriers and 
facilitators to PrEP uptake among SMM.  
Understanding Processes Leading to Uptake 
 PrEP uptake in the U.S. has increased since first approval in 2012. Since the release of 
PrEP, more than 140,000 individuals have begun a regimen, and there are an estimated 61,000 
current users as of the end of 2017 (Sullivan et al., 2018). This number is far below the estimated 
1.5 - 4.5 million SMM in the U.S. that may meet CDC criteria for uptake and could benefit from 
PrEP use (Rawlings, 2016; Sullivan et al., 2018). To increase uptake of PrEP among those at-
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risk for seroconversion, it is important we understand what psychological, social, and structural 
barriers impede the uptake process.  
One way to conceptualize processes that lead to PrEP uptake is through the use of a PrEP 
uptake model, often times framed in terms of a continuum or cascade. Multiple uptake models 
have been developed yet operationalized in different ways. The first came from Kelley and 
colleagues (2015), who based theirs on the HIV Care Continuum (Gardner, McLees, Steiner, Del 
Rio, & Burman, 2011; McNairy & El-Sadr, 2014). Their model proposed four steps: 
awareness/willingness; access to healthcare; likely to receive prescription; and adherence and 
efficacy. The first step includes awareness of PrEP, risk/benefit perceptions, and barriers to 
seeking PrEP. The second focuses on the individual having health insurance, access to a primary 
care doctor, being able to afford the medication, and having accessible transportation for care. 
The third includes focussing on the healthcare provider (i.e., awareness of PrEP, willingness to 
prescribe PrEP, and ability to determine a patient's eligibility) and the patient (i.e., accurately 
report risk behavior, and PrEP non-contraindicated). The fourth, and final, step includes 
medication tolerance, risk compensation, dosing schedules, long-term adherence, and PrEP care 
continuation. Following the development, these researchers projected their model onto a sample 
of 562 SMM living in Atlanta, Georgia. Of all sexually active SMM in the sample, 50% reported 
being aware and willing to begin PrEP, 43% reported access to healthcare, 30% were likely to 
receive a prescription based on their behavior, and 15% were projected to be adherent based on 
an estimate provided by the iPrEx open-label extension (Grant et al., 2014). Results for the use 
of this uptake model indicate the most significant drop off being at the beginning of the model, 
focused around PrEP awareness and acceptability. Thus theoretically, by increasing awareness 
and willingness to begin PrEP, percentages in the respective steps should also increase.  
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Building off of the Kelley and colleagues (2015) model, Nunn and colleagues (2017) 
expanded the model into nine stages among three steps. The first step, awareness, includes 
identifying individuals at highest HIV risk, enhancing self-perceived HIV risk awareness, and 
raising PrEP awareness. The second step, uptake, includes facilitating PrEP access, linkage to 
PrEP care, obtaining a prescription to PrEP, and initiating PrEP. The third, and final step, 
adherence, and retention, includes adherence to prep and retention in PrEP care. At the time of 
publication, this article did not project numbers into these stages to yet understand where it may 
catch people the Kelley and colleagues (2015) model did not. Both models suggest the high 
importance of early steps to increase uptake, including PrEP awareness and access.      
Parsons and colleagues (2017) created another PrEP uptake model, titled the Motivational 
PrEP Cascade. This model utilized the Transtheoretical Model of Change, which conceptualizes 
behavior change over time as a series of smaller decisions that lead to the larger behavioral 
change (Prochaska & Velicer, 1997; Velicer, Prochaska, Fava, Norman, & Redding, 1998). 
Beginning with objective identification for PrEP candidacy, the model theorizes there are an 
additional four stages individuals must pass through before resulting in maintenance and 
adherence. After meeting the CDC requirements for objective identification, the second stage is 
PrEP contemplation, which consists of men being both willing to take PrEP and self-identifying 
as a PrEP candidate. The third stage, PrEParation, describes individuals who must have a 
potential PrEP provider and also be intending to begin taking PrEP. The fourth stage, PrEP 
action and initiation, include those who have spoken to a medical provider about PrEP and are 
currently prescribed PrEP. The fifth stage, PrEP maintenance and adherence, includes 
participants maintaining at least four doses per week and continuing to return for quarterly 
testing. If an individual stops taking PrEP, they would move back to stage one, and if someone 
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seroconverts they would move to the HIV Care Continuum (CDC, 2011; Gardner, McLees, 
Steiner, Del Rio, & Burman, 2011). This model frames PrEP uptake as steps that include 
processes of behavior change via decision making and again, like other PrEP uptake models, 
emphasizes the importance of PrEP knowledge, acceptability, and intentions, for increasing 
uptake.  
In developing the Motivational PrEP Cascade, Parsons and Colleagues (2017) applied it 
to a sample of over 1,000 SMM from across the U.S. Their findings indicated that 63.9% (n = 
636) of their sample met CDC criteria for PrEP uptake. However, 52.7% (n = 301) of those were 
either unwilling or did not view themselves as a candidate for PrEP and were considered to be 
pre-contemplative. Among those that were willing and self-identified as a candidate, just over 
81% had a provider they believed would be willing to prescribe PrEP, and slightly more than 
half (57.5%) stated they planned to begin taking PrEP. Of those that had a provider and intended 
to begin (n = 152), 70.4% had spoken to a provider, and 53.9% had a current PrEP prescription 
(n = 82). Of those with a prescription, the majority (97.6%) reported taking at least four doses 
per week, and most (72.0%) attended the recommended quarterly doctors’ visits required to 
maintain a prescription. Overall, these numbers indicate that of the 636 SMM who met objective 
identification, only 58 (9.12%) were both adhering and maintaining their PrEP regimen. Like the 
other models, they reported their most massive drop off between acceptability and viewing 
oneself as a candidate. 
Across models, all researchers focused on PrEP knowledge, acceptability, and intentions 
as essential steps leading to PrEP uptake. SMM may be aware of PrEP and behaviorally eligible 
for PrEP, but not view themselves are someone who would benefit from PrEP. Gardner and 
colleagues (2011) and Parsons and colleagues (2017) showed this in both of their models. Self-
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identification as a PrEP candidate is the step along their models where the most significant drop 
off was reported. Intentions to begin a PrEP regimen were reported in the Motivational PrEP 
Cascade, but not the other models. This factor may be a key to getting SMM past awareness and 
acceptability to begin uptake, as intentions reflect real-world scenarios (Rendina, Whitfield, 
Grov, Starks, & Parsons, 2017). Additionally, the Motivational PrEP Cascade includes 
discontinuation of PrEP instead of ending at adherence. This additional step takes into account 
the “seasons of risk” hypothesis, which suggests that long-term PrEP use may not be a perfect 
solution for everyone and that some users are likely to use PrEP only during periods of increased 
sexual risk (Baeten, Haberer, Liu, & Sista, 2013; Haberer et al., 2015). With this model, when 
SMM discontinue use, they move back to the first step, meeting objective identification. This is 
an important step in the uptake model, as it suggests that PrEP use may not be a medication that 
is appropriate for everyone throughout time, or an individual may decide to stop using PrEP. 
Further, individuals may move in and out of meeting objective identification as a PrEP candidate 
based on current risk behaviors. In the following section, I examine barriers to PrEP uptake using 
the Motivational PrEP Cascade as a framework for conceptualizing the biopsychosocial variables 
associated with PrEP uptake. Primarily, I will focus on the two psychological precursors shown 
to be most predictive of actual PrEP uptake (i.e., PrEP acceptability and PrEP intentions).  
Using the Motivational PrEP Cascade as a Framework to Increase Uptake 
As indicated in The PrEP Motivational Cascade, knowledge of PrEP is imperative for an 
individual to consider beginning a regimen. The knowledge about the potential for taking ART 
medication while HIV-negative, to prevent seroconversion, began to spread before any RCTs 
examining PrEP use began. One of the earliest studies measuring knowledge of using such 
medications as prophylaxis comes from 2006. Kellerman and colleagues (2006) collected 
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responses from 1,041 individuals at gay pride events in five large cities in the U.S. Across all 
cities, a total of 248 (25%) of respondents reported having heard of ART use as PrEP, and 50 
(5%) reported having ever used ART as PrEP. Both use and awareness of ART as PrEP was 
associated with having received an HIV test within the prior twelve months. Shortly after, in 
2008, other researchers administered surveys on PEP and PrEP use to 1,819 SMM. These 
participants were recruited at three circuit parties and two city clinics in the San Francisco Bay 
Area counties. In total, 849 (47%) had previously heard of PEP, whereas 296 (16%) were aware 
of PrEP (Liu et al., 2008). Shortly after, some researchers began to investigate behavioral and 
social factors that may deter some individuals from starting a regimen of PrEP should it be 
shown to be effective (Golub, Kowalczyk, Weinberger, & Parsons, 2010). They anticipated that 
even if individuals were aware of PrEP, researchers would have to find ways to help individuals 
accurately process information pertaining to their risk behavior, frame the effects of the 
medication for the potential user, and address the role of HIV medication related stigma. These 
studies illustrate some awareness of PrEP as a potential for HIV prevention among SMM before 
the shown efficacy of the RCTs and that some researchers were already preparing for barriers to 
implementation. 
Awareness of PrEP increased quickly among SMM following its approval by the 
USFDA. One study assessed knowledge one month before the approval versus one month after 
and reported an increase of knowledge from 13% - 19% (Krakower et al., 2012). Another 
examined changes in knowledge from pre-approval in 2011 to post-approval in 2014 among 
SMM in Miami and D.C. Both cities exhibited an increase in knowledge over time. Miami went 
from 19.4% to 41.2%, and D.C. from 39.1% to 73.8% (Patrick et al., 2017). Significant 
differences were revealed between geographic locations, such that those in D.C. were more 
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likely to be aware of PrEP. This finding suggested that PrEP knowledge differed for SMM by 
location. Other researchers have reported similar findings (Elopre, Kudroff, Westfall, Overton, & 
Mugavero, 2017; Kuhns, Hotton, Schneider, Garofalo, & Fujimoto, 2017; Ojikutu et al., 2018; 
D. M. Santa Maria et al., 2018). Furthermore, disparities in geographic location are reflected in 
the finding that more than 50% of all PrEP prescriptions in the U.S. are located in only five 
states: California, Florida, Illinois, New York, and Texas (aidsvu.org, 2018; Siegler et al., 2018). 
Overall, awareness of PrEP has increased over time across the U.S., but to what end individuals 
outside of large metropolitan areas have accurate knowledge of PrEP has not been reported.  
 Another important factor associated with PrEP uptake is acceptability of PrEP. The 
literature on PrEP acceptability has reported varying results based on how questions are asked, as 
the acceptability of PrEP may not reflect real-world demands. For example, when asking about 
the acceptability of PrEP, differing dosing schedules are sometimes presented, and have included 
anywhere from intermittent dosing (Holt et al., 2012; Mustanski, Johnson, Garofalo, Ryan, & 
Birkett, 2013; Shrestha et al., 2018) to daily adherence (Aghaizu et al., 2013; Al-Tayyib, Thrun, 
Haukoos, & Walls, 2014; Barash & Golden, 2010; Galindo et al., 2012; Grov, Whitfield, 
Rendina, Ventuneac, & Parsons, 2015; Holt et al., 2012; Mustanski et al., 2013; Rendina et al., 
2017). Different levels of effectiveness have also been shown to influence acceptability, such 
that less effectiveness is associated with less acceptability (Al-Tayyib et al., 2014; Golub, 
Gamarel, Rendina, Surace, & Lelutiu-Weinberger, 2013; Golub, Kowalczyk, et al., 2010; Kahle, 
Sullivan, & Stephenson, 2018; Mustanski et al., 2013; Rendina et al., 2017). Acceptability has 
also been measured across studies under the assumption that the medication is free (Golub et al., 
2013; Golub, Kowalczyk, et al., 2010; Grov et al., 2015), which may not mirror real-world use, 
as in many locations PrEP can cost as much as $14,000 yearly without insurance coverage (San 
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Francisco AIDS Foundation, 2015). PrEP acceptability measures if an individual would begin 
taking PrEP in the best-case scenarios, meaning the easiest, fastest, and cheapest, as well as 
being the most effective.  
 Predictors of acceptability have primarily been confined to knowledge of PrEP and 
descriptive differences. Demographic variables predicting acceptability, such as age, income, 
education, race, and sexual identity, have resulted in conflicting evidence. Being younger has 
been shown to be a significant predictor of acceptability in some research (Aghaizu et al., 2013; 
Barash & Golden, 2010; Holt et al., 2012), but not others (Goedel, Halkitis, Greene, & Duncan, 
2016; Golub et al., 2013; Grov et al., 2015; Mustanski et al., 2013). Similarly, having lower 
income (Barash & Golden, 2010) has been predictive of being more willing to begin PrEP, 
whereas, in other studies, income was not predictive of acceptability (Goedel et al., 2016; Golub 
et al., 2013; Grov et al., 2015). Education has also resulted in conflicting findings, such that 
having more than a high school education has been associated with more acceptability 
(Mustanski et al., 2013), lower education associated with more acceptability (Grov et al., 2015), 
and in another study, education was not predictive of acceptability at all (Golub et al., 2013).  
Similarly, both Grov and colleagues (2015), and Mustanski and colleagues (2013) reported no 
difference regarding race, whereas Golub and colleagues (2010) reported Black participants were 
more than two times as likely to report acceptability, compared to White participants. Few 
differences in acceptability have been observed between men who identify as gay versus 
bisexual (Goedel et al., 2016; Holt et al., 2012; Mustanski et al., 2013). Unsurprisingly, those 
who are single are more likely to be accepting, versus those who are in relationships (Golub et 
al., 2013). Overall, there are very few consistent demographic predictors of PrEP acceptability 
across studies.  
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 In addition to demographic predictors, psychological and behavioral predictors of 
acceptability have also been studied. More PrEP acceptability has been associated with a higher 
perception of oneself as at risk for HIV (Biello, Edeza, Montgomery, Almonte, & Chan, 2019; 
Blumenthal et al., 2019; Bull et al., 2018; Golub, Fikslin, Goldberg, Peña, & Radix, 2019; Holt 
et al., 2012; Ojikutu et al., 2018; Rana et al., 2018; Underhill et al., 2018; Whitfield, John, 
Rendina, Grov, & Parsons, 2018b), fewer concerns about side effects (Goedel et al., 2016; 
Halkitis et al., 2018; Holt et al., 2012; Whitfield et al., 2018b), having previous experience with 
biomedical prevention such as PEP (Aghaizu et al., 2013; Holt et al., 2012), and having 
experience with a sexual health clinic (Aghaizu et al., 2013; Barash & Golden, 2010). In order 
for someone to be accepting of taking PrEP, it is crucial they view themselves as someone who 
would benefit from PrEP use. One study that assessed PrEP uptake reported that those who had 
higher HIV risk perception, greater actual risk in the past three months, and those in 
serodiscordant relationships had higher odds of actual uptake than those who did not engage in 
risk or viewed their behavior as risky (Golub et al., 2019). Additionally, having experience with 
sexual health clinics, which may include having previously used PEP, may provide potential 
users with either more knowledge of PrEP, the familiarity of sexual health services, or aid in the 
perception they are at risk- all leading to more PrEP acceptability.  
 Behavioral risk factors associated with PrEP uptake have also produced different 
findings. Before the release of PrEP, many providers and researchers expressed concern that 
behavior risk would increase for individuals who began taking PrEP (Eaton & Kalichman, 2007; 
Golub, Kowalczyk, et al., 2010; Guest et al., 2008; Marcus et al., 2013; Youle & Wainberg, 
2003). Research conducted with PrEP users has shown different results, with some showing an 
increase in risk behavior (Beymer et al., 2018; De Wit et al., 2015; Liu et al., 2013; Newcomb, 
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Moran, Feinstein, Forscher, & Mustanski, 2018; Oldenburg et al., 2018; Prestage et al., 2019) 
and some without (Guest et al., 2008; Koester et al., 2017; Liu et al., 2013; Marcus et al., 2013; 
Sagaon-Teyssier et al., 2016). One longitudinal study was even able to show that risk of 
condomless anal sex (CAS) increased while users were taking PrEP, but decreased when they 
stopped (Parsons, Whitfield, Rendina, & Grov, 2017).  
Specific to actual uptake, sexual risk is vital as the perception of being at risk for HIV 
acquisition has been shown to be associated with more acceptability and intentions to begin 
taking PrEP. However, results of objective behavioral risk have produced divergent findings with 
some showing more risk as predicting more acceptability (Aghaizu et al., 2013; Golub, 
Kowalczyk, et al., 2010; Holt et al., 2012), and no association between behavioral risk and PrEP 
acceptability among others (Barash & Golden, 2010; Blumenthal et al., 2019; Mustanski et al., 
2013). One study examined the perceived risk of HIV, PrEP eligibility, and actual PrEP use 
among YSMM (16-25 years of age) living in Washington, D.C. (Yellin et al., 2018). Just under 
10% of all 188 participants reported current PrEP use. Compared to those that perceived their 
risk as low, those who perceived their risk to be moderate or high had a higher likelihood of 
viewing them self as an eligible candidate and had more willingness to take PrEP.  
 One of the strongest predictors of future behavior is intentions (Albarracin, Johnson, 
Fishbein, & Muellerleile, 2001; Webb & Sheeran, 2006). However, an individual may have 
intentions to begin taking PrEP and come across provider-related barriers that inhibit use. A 
provider must first know about PrEP and be willing to prescribe the medication. Providers have 
voiced many concerns about prescribing PrEP, including the ability to accurately assess 
behavioral PrEP eligibility (Bacon et al., 2017), the cost of medication, cost of continued 
appointments, and cost of STI/HIV testing (Krakower, Ware, Mitty, Maloney, & Mayer, 2014). 
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Providers may also be concerned about the effects of the medication, including potential side 
effects associated with continued use (Bacon et al., 2017; Hakre et al., 2016; Krakower et al., 
2014), the ability to adhere to the medication (Hart-Cooper, Allen, Irwin Jr, & Scott, 2018; 
Krakower et al., 2014) and potential drug resistance to ARVs should the user seroconvert while 
taking PrEP (Karris, Beekmann, Mehta, Anderson, & Polgreen, 2013). Some providers have also 
stated concerns that users will engage in increased sex risk behavior that may lead to other STIs  
(Blackstock et al., 2017; Krakower et al., 2014; Morrison, Dortche, & Fadul, 2018; Petroll et al., 
2017). These concerns are demonstrated across studies that include both primary care providers 
(PCPs) and HIV care providers, suggesting that even if an individual is both willing and 
intending to begin PrEP, they may not have a doctor that is willing to prescribe the medication, 
and thus fewer intentions to actually begin taking PrEP. 
Potential PrEP users may also be unsure of where to go to access PrEP. Multiple studies 
have shown that HIV care providers are both more knowledgeable and more willing to prescribe 
PrEP compared to PCPs (Blackstock et al., 2017; Hakre et al., 2016; Krakower et al., 2015; 
Krakower et al., 2014; Petroll et al., 2017; Seidman, Carlson, Weber, Witt, & Kelly, 2016; 
Smith, Mendoza, Stryker, & Rose, 2016; Tripathi, Ogbuanu, Monger, Gibson, & Duffus, 2012; 
White, Mimiaga, Krakower, & Mayer, 2012). This may make it more difficult for some SMM to 
obtain PrEP, as they will likely not have an HIV care specialist because they are HIV-negative 
and may have to seek out new care. Fear of HIV-related stigma may also potentially impede 
some HIV-negative SMM from seeking treatment via an HIV specialist. Additionally, there are 
discrepancies among providers about who should be prescribing PrEP. To describe this barrier, 
researchers Krakower and colleagues (2014) coined the term “purview paradox,” which 
describes how neither PCPs nor HIV specialists consider PrEP care to fall within their domain. 
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Along with the various steps it takes to begin a PrEP regimen, continuing one requires quarterly 
doctor’s visits that are intended to include HIV testing, sexual risk assessment, STI symptoms 
assessment, and medication adherence counseling- a variety of things that not all PCPs have time 
for and experience doing.    
Together, these findings suggest many factors will impede movement along PrEP uptake 
models. In order for an individual to consider beginning PrEP, they must have a basic awareness 
of the medication, view themselves as someone who would benefit from its use, and have access 
to care (i.e., a doctor to prescribe, the ability to pay for the medication and quarterly 
appointments including STI/HIV testing). All of these have been shown to be predictive of PrEP 
uptake. Further, many of the above-reviewed studies highlighted age as a factor that 
differentiates many of these variables related to uptake, suggesting that developmental factors 
may play a role in why some individuals access PrEP whereas others do not.   
Summary 
 PrEP uptake includes many steps, which have been examined among adult SMM, and 
examined through the lens of PrEP uptake models aimed at increasing uptake. Across these 
models, it is consistently shown and theorized that for individuals to begin taking PrEP, and stay 
engaged in PrEP care; they must first view themselves as someone that would benefit from PrEP 
and then have intentions to begin a regimen. In order to develop interventions aimed at 
increasing uptake, it is imperative that focus is placed on understanding PrEP candidacy and 
PrEP intentions, the two primary precursors to PrEP uptake. Many SMM may be at risk for HIV, 
but they may not perceive themselves to be at risk. Understanding the processing that leads to the 
perception of self as a PrEP candidate may be a key area for intervention. Additionally, although 
viewing oneself as a candidate for PrEP may make someone more likely to begin a regimen, it 
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does not necessarily mean the individual has intentions to begin a regimen. As such, 
understanding what other factors lead to intentions is also imperative to increase uptake. Further, 
how these precursors to uptake apply to YSMM, or what additional barriers may exist, is yet 
unknown. Based on the findings of the studies reviewed in this chapter, it is also clear that age 
may be a determining factor, and as such, developmental factors for intervention may be 
appropriate. In the following chapter, I present two prominent theories of behavioral change that 
will help to illuminate decision-making processes that underlie SMM’s PrEP utilization and may 
be able to be intervened upon.  
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CHAPTER THREE  
Theories of Behavior Change 
 The Health Belief Model (HBM) and the Theory of Planned Behavior (TPB) are two 
widely accepted theoretical models used for predicting behavior change, both of which grew out 
of Social Cognitive Theory (Bandura, 1986). The HBM has been utilized to explain health-
related behaviors by examining an individual’s perceived threat of illness and the pros or cons of 
enacting health-related behavior. The TPB examines predictors for the intentions to enact a 
behavior including an individual’s attitudes, their social surroundings, and their perceived 
control over the behavior. In the following chapter, I describe each model, how they have been 
previously used to predict behavior, and how their use in PrEP interventions may lead to 
increased PrEP uptake.  
The Health-Belief Model 
 Godfrey Hochbaum, Stephen Kegels, and Irwin Rosenstock, three social psychologists 
working for the U.S. Public Health Service in the 1950s, developed the HBM (Figure 1) (Becker, 
1974). Up until the development of the HBM, predictors of health-related behaviors were 
primarily limited to demographic variables (e.g., socioeconomic status, gender, age, race, and 
ethnicity). The HBM aims to assess belief patterns or individual characteristics that shape 
behavior and are modifiable through socialization, as predictors of the likelihood of engaging in 
health-promoting behaviors. Since its inception, the HBM has evolved while keeping similar 
representations of health and health behavior. The model initially consisted of factors of only 
threat perception and behavioral evaluation, while future applications of the model included cues 
to action and self-efficacy (Conner & Norman, 2005).  
 Threat perception consists of two factors, perceived susceptibility and perceived severity 
of an illness or health problem. Perceived susceptibility refers to an individual’s perception of 
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their odds of acquiring a condition that negatively affects their health. Perceived severity refers 
to the concern an individual has about how a particular health condition may negatively affect 
them overall. Taken together, higher perceived susceptibility and severity of a condition suggests 
a higher threat, and therefore should lead to a higher likelihood of enacting a protective health-
related behavior.  In terms of PrEP use, perceived susceptibility of acquiring HIV should lead to 
higher PrEP uptake. However, perceived susceptibility is not the same as actual susceptibility, 
and as presented in the previous chapter, not all risk perception is in line with actual risk.  
 Similar to threat perception, behavioral evaluation also consists of two distinctly different 
constructs, perceived benefits and perceived barriers. Perceived benefits refer to the positive 
aspects an individual believes will be gained or experienced for enacting a specific health-related 
behavior. Perceived barriers refer to the costs of enacting the same behavior. These two 
constructs create a decisional balance for the individual where the more heavily weighted 
construct predicts the likelihood of behavior engagement. For example, someone who perceives 
more benefits to the behavior change is more likely to enact the behaviors, whereas someone 
who perceives more barriers is less likely to enact the behavior. Individuals who are 
contemplating PrEP use may find themselves having to weigh the options of the benefits of PrEP 
use versus the barriers. Depending on the age of the individual, these barriers are likely to 
change, with some becoming less important and others more important.  
 The two constructs later added to the HBM are cues to action and self-efficacy (Becker, 
Maiman, Kirscht, Haefner, & Drachman, 1977). Cues to action refer to internal or external 
stimuli presenting the individual with a cue leading to the behavior. The measurement used to 
assess factors associated with cues to action has varied greatly and included interpersonal 
communication (e.g., doctor, parent, and friend), mass media influences (e.g., advertisements in 
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magazines, tv, film, radio), and internal responses to threat stimuli (e.g., the perception of risk). 
For health-related behaviors, a cue to action may include a person, advertisement, or perceived 
threat suggesting that a change in behavior may lead to more positive outcomes. Self-efficacy is 
one’s belief in the individual’s ability to succeed in accomplishing a specific task. Higher levels 
of self-efficacy should be predictive of an individual being more likely to enact a behavior. 
Together, these two factors add constructs measuring if an individual has been alerted to a 
potential threat and if they believe themselves to have the power to enact the positive health 
behavior. For PrEP use, cues to action could include advertisements of the medication and who 
they are marketing the medication for, what their social circles say about the medication, and 
again, the perception of their own HIV risk. These cues to action could either be ignored by the 
individual, meaning they do not apply the cues to them self, or the cues could resonant with them 
and result in suggestions to use PrEP.    
 In short, these factors were theorized to influence an individual’s decisions around health 
behaviors, and by intervening on them, an individual would become more or less likely to enact a 
behavior change (Becker et al., 1977). This model was first utilized to examine decision making 
to obtain chest x-rays for early detection of tuberculosis (Hochbaum, 1958), and due to the 
flexibility of constructs within the model, it has since been used across a variety of health-related 
behaviors. Screening-related behavior utilizing the HBM have included hypertension (J. B. King, 
1983), cervical cancer (Orbell, Crombie, & Johnston, 1996), colorectal cancer (Hay et al., 2003), 
and mammography (Aiken, West, Woodward, Reno, & Reynolds, 1994). Risk behaviors have 
also been examined via the HBM and included smoking (Giannetti, Reynolds, & Rihn, 1985; 
Mullen, Hersey, & Iverson, 1987; Pederson, Baskerville, & Wanklin, 1982; Stacy & Loyd, 
1990), alcohol (K. H. Beck, 1981; Gottlieb & Baker, 1986; Portnoy, 1980), and changes in diet 
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(Aho, 1979; Langlie, 1977; Weitkunat et al., 2003). Other uses have included dental care (Chen 
& Land, 1986; Chen & Tatsuoka, 1984; Kegeles, 1963), medication adherence (Bradley et al., 
1987; Cummings, Becker, Kirscht, & Levin, 1982; Hershey, Morton, Davis, & Reichgott, 1980; 
Kirscht & Rosenstock, 1977; Nelson, Stason, Neutra, Solomon, & McArdle, 1978; Taylor, 
1979), and HIV risk (McCusker, Stoddard, Zapka, Zorn, & Mayer, 1989; Winfield & Whaley, 
2002; Wolcott, Sullivan, & Klein, 1990). All of these studies have provided evidence that not 
only is the HBM effective in understanding patient decision making but also that the different 
predictors within the models are better at predicting outcomes depending on the population and 
target health behavior.     
 Perceived susceptibility and seriousness are two critical factors associated with 
examining potential PrEP use among SMM and have been examined in some research. Perceived 
susceptibility refers to the individual's perception of their risk for HIV-acquisition, whereas 
perceived seriousness refers to an individual’s belief about how becoming HIV-positive may 
negatively affect their lives. Both more perceived susceptibility and seriousness have been 
shown to be highly associated with more intentions to begin taking PrEP (Aghaizu et al., 2013; 
Holt et al., 2012; Parsons, Rendina, et al., 2017). Together these findings across studies suggest, 
that to increase uptake of PrEP, it is imperative that those who are at-risk for HIV also view 
themselves as at-risk and perceive seroconversion would negatively impact their lives.    
 Other research on PrEP uptake and SMM has examined the benefits and barriers, or PrEP 
decisional balance, of beginning a PrEP regimen (Ayala et al., 2013; Galea et al., 2011; Golub et 
al., 2013; Holloway, Tan, et al., 2017; Young, Flowers, & McDaid, 2014). Benefits reported in 
research include feeling a sense of control over one’s sexual health, having more protection 
against HIV, and avoiding psychological distress should a condom break or not be used. Barriers 
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reported include high cost, not having health insurance, high PrEP related stigma, not having 
accurate knowledge of PrEP, and not knowing how to access PrEP. As the model suggests, 
individuals who perceive more benefits, compared to barriers, to beginning PrEP have a higher 
likelihood of engaging in PrEP use (Ayala et al., 2013; Golub et al., 2013; Grov et al., 2015). 
Further, self-efficacy for PrEP use is likely an important factor for men beginning a PrEP 
regimen. Beginning and continuing a PrEP regimen may be more difficult for some SMM 
because it is a process that includes regular doctors’ appointments, HIV/STI testing, and 
prescription refills, requiring a substantial amount of self-efficacy (CDC, 2017).Lastly, cue to 
action is defined as a construct in many different ways (Mattson, 1999; Schwarzer, 2014). 
Regarding PrEP research and SMM, perceived risk of HIV could be considered perceived 
susceptibility, as well as what those closest to the individual think of the medication. PrEP 
stigma, or a set of negative beliefs that a society or group of people have about PrEP use, may 
influence someone to not begin a PrEP regimen due to fear of negative social consequences of 
use (Calabrese & Underhill, 2015; Eaton & Kalichman, 2007; Haire, 2015; Liu, Cohen, et al., 
2014). As I will discuss later, social expectations are factors more closely related to adolescent 
behaviors than an adult.  
 With the HBM in mind, the perceived threat of an illness or condition is the first factor 
that must be examined in order to increase PrEP uptake among any population. It is unlikely that 
an individual will weigh the benefits and barriers to use, acknowledge their ability to begin 
enacting a behavior, or be swayed by a cue to action if they do not first perceive themselves to be 
at risk. This is mirrored in the Motivational PrEP Cascade, where the first stage is meeting 
objective identification as a PrEP candidate and the second includes self-identification as a PrEP 
candidate. Additionally, in stage two of the cascade, individuals are asked how likely they would 
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be to take PrEP if it were 90% effective and available for free. Both of these could be considered 
perceived benefits and barriers to uptake, two important factors in the HBM. An individual could 
perceive 90% to be very high, whereas another could believe this is too low. Further, “free” 
would be a benefit for almost all individuals, but may not reflect reality (e.g., accessibility, health 
insurance). Stage three and four of the cascade include finding a medical provider and actually 
discussing it with a provider. Discussing PrEP with a provider may be difficult for some SMM, 
and one study showed that SMM who are not out to their providers are less likely to ask about 
PrEP (Tan et al., 2019). To achieve these steps, self-efficacy is required, another factor in the 
HBM. Lastly, the HBM includes cues to actions, which may include knowing that PrEP exists 
and understanding your own risk behavior as pertaining to PrEP candidacy, again, part of the 
first step of the Motivational PrEP Cascade.  
 Although there are many ways the HBM and the Motivational PrEP Cascade overlap, 
they are not synonymous with each other. As presented in Figure 1, the HBM suggests that all of 
these factors influence the likelihood of a behavior change. However, they are presented as 
variables that may be equal to the effect of the behavior change. The Motivational PrEP Cascade 
utilizes many of the same concepts. However, they are presented as a series of steps where one 
must be accomplished before moving to the next. Further, the HBM stops at likelihood, and the 
cascade ends with the maintenance of the behavior change. In terms of HIV prevention, among 
both models, it is necessary that an individual views HIV as serious and themselves as 
susceptible for the other factors will become increasingly important in a decision around PrEP 
uptake.  
The Theory of Planned Behavior  
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 In addition to the HBM, the TPB (Ajzen, 1991) is another theoretical framework 
consistently used to predict behavior change, and often in health behavior research. The aim of 
both these frameworks is to understand the factors that lead to behavior change, however the 
HBM focuses on internal constructs (i.e., perceived benefits, barriers, seriousness, susceptibility, 
self-efficacy, and cues to action) whereas the TPB condenses these into an overall attitude about 
the behavior change and incorporates social constructs (subject norm) and perceived behavioral 
control. Additionally, the TPB extends the HBM by including intentions for the behavior change, 
and it’s association with the actual change. There are strengths and limitations to both models as 
HBM may provide a more nuanced look at internal constructs, but the TPB includes social 
constructs and belief in self. In the following section, I will discuss the TPB and how it suggests 
other factors outside of internal factors are equally important to PrEP uptake.   
 The TPB theory is an extension of the theory of reasoned action (TRA; Fishbein & 
Ajzen, 1975 ). Both theories aim to explain how unobservable factors (i.e., attitudes, subjective 
norms) lead to intentions for a behavioral change, and then ultimately the change itself. The TRA 
was developed for utilization with only easily amendable behaviors, whereas the TPB also takes 
into account the role of behavioral control or the ability one has to enact a behavioral change 
(Ajzen, 1987, 1991). In the following section, I briefly describe the TRA and the adjustments 
made for the TPB, how the TPB is used in research about health-prevention, and how it may be 
best used for understanding decisions leading to PrEP uptake.   
 The TRA aims to explain how two unobservable factors (i.e., attitudes and subjective 
norms) lead to volitional behavioral change via intentions (Figure 2). Fishbein and Ajzen (1975, 
p. 6) defined attitudes as “a learned disposition to respond in a consistently favorable or 
unfavorable manner with respect to a given object,” the object is representing the cue for 
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behavior change. If someone has more positive attitudes about the change, they should have 
higher intentions to enact the change. Conversely, more negative attitudes about the change 
should lead to lower intentions to enact the change. A subjective norm represents the perceived 
social pressure from significant others to either perform or not perform the behavior change. 
Important others could be individuals and groups whose opinions of the behavior are essential to 
the individual. As such, if someone perceives those significant to them to be supportive of the 
change, they are more likely to have intentions to enact the change. Further, subjective norms are 
also likely to influence the attitudes an individual has about the behavior change and vice-versa. 
Lastly, intentions represent the link between these unobservable cognitive processes and the 
behavior itself. Intentions and actual behavior are highly associated as individuals who have 
intentions for a behavior tend to engage in the behavior (Ajzen, 1987). Together, attitudes and 
subjective norm are predictive of intentions, which is then predictive of actual behavior. In terms 
of PrEP use, social norms are becoming more heavily researched in literature. Stigma to PrEP 
use has been reported by many PrEP users and has been shown to deter some from use 
(Calabrese & Underhill, 2015; Dubov, Galbo Jr, Altice, & Fraenkel, 2018; Franks et al., 2018; 
Golub, 2018; Grace, Jollimore, MacPherson, Strang, & Tan, 2018; Haire, 2015). 
 The TPB (Figure 3) builds upon the TRA by including the factor of perceived behavioral 
control and thus expanding the utility of the model to include behaviors that may not be within 
an individual’s volitional control. Behavioral control consists of the perception of the 
individual’s ability to perform a behavior is seen as easy or difficult. This factor is best viewed as 
a continuum where behaviors that are efficiently executed are on one end, and those more 
difficult on the other. For example, slowly walking across a flat football field will be more easily 
achieved than running a marathon and coming in the first place. The latter is more difficult and 
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requires training and specialized skills. Behavioral control is also theorized to be directly related 
to an actual enacted behavior and may or may not go through intentions. Similarly, self-efficacy 
is important in behavioral control as self-efficacy is the belief that one can accomplish their goals 
(Bandura, 2010). Self-efficacy is important for YSMM to engage in PrEP use, as it may be 
required to find a provider, attend regular appointments, and pay expense not covered by 
insurance. Together, this model places attitudes, subjective norms, perceived behavioral control, 
and self-efficacy as predictors of behavioral intentions.  
 Similar to the HBM, the TPB has also been examined among a variety of health-related 
behaviors. This has resulted in many reviews and meta-analyses focused on exercise (Blue, 
1995; Hagger, Chatzisarantis, & Biddle, 2002; Hausenblas, Carron, & Mack, 1997), substance 
use (Godin & Kok, 1996; Hausenblas et al., 1997; McEachan, Conner, & Lawton, 2005), and 
condom use (Albarracin et al., 2001; Godin & Kok, 1996; Sheeran & Taylor, 1999). Due to PrEP 
being an HIV-prevention method, I briefly review the two meta-analyses that examine HIV-
prevention.  
 The first was a meta-analysis conducted by Albarracin et al. (2001), which examined 
condom use among 96 studies that had utilized the TPB. Across studies, attitudes, subjective 
norms, and perceived behavioral control explained 50% of the variance in intentions for condom 
use. Attitudes explained the most variance (33.6%), followed by perceived behavioral control 
(20.3%) and subjective norm (15.2%). Another meta-analysis, examining condom use and safer-
sex behaviors among 17 studies, reported that 49% of the variance for intentions was explained 
across the same three domains (attitudes, subjective norm, and perceived behavioral control) 
(McEachan et al., 2005). Like the first meta-analysis, attitudes were the strongest predictor and 
explained 18.5% of the variance, but unlike the first, subjective norms was second (14.4%) and 
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lastly, perceived behavioral control (12.3%). Attitudes about condom use were the strongest 
predictor of condom use and safer sex behaviors across both studies. These findings suggest that 
more positive attitudes about the change are more likely to result in increasing both behaviors. 
However, according to the model, attitudes are also influenced by both subjective norms and 
perceived behavioral control. Given the results of these meta-analyses, the two factors that are 
most likely to influence PrEP intentions are the attitudes and subjective norm an individual has 
about PrEP.  
 The PrEP cascade views PrEP uptake as a progressive series of steps where an individual 
moves from acceptability to intentions and then eventual uptake. Acceptability as a construct is 
generally assessed via questions of if an individual would begin taking PrEP if they could get if 
for free (Golub et al., 2013; Golub, Kowalczyk, et al., 2010; Grov et al., 2015; Parsons, Rendina, 
et al., 2017; Rendina et al., 2017). Conceptually, this could also be a measurement of an 
individual’s attitudes towards their use of PrEP, and as the TPB suggests, a more positive 
attitude about the behavior leads to intentions. Additionally, social stigma for PrEP use is 
determined by the social norms of the people around the individual and has been shown to be a 
significant predictor of PrEP intentions (Calabrese & Underhill, 2015; Haire, 2015). Further, 
subjective norms for PrEP use may be of substantial importance for SMM as they are part of a 
sexual minority population and are more influenced by social norms of others who share the 
same sexual identity as them (Terry & Hogg, 1996). This may be especially important for PrEP 
use as more PrEP stigma is associated with less PrEP uptake (Calabrese & Underhill, 2015; 
Haire, 2015). Overall, the TPB suggests that those who have more positive attitudes about PrEP, 
have significant others who are supportive of PrEP and perceive themselves to have higher levels 
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of behavioral control to start taking PrEP, should have higher intentions, and therefore be more 
likely to begin taking PrEP.  
Summary    
 The HBM suggests that those who perceive themselves to be at higher risk of illness, and 
believe the illness would negatively impact their lives, are more likely to enact a behavioral 
change to avoid the illness. The TPB also examines similar constructs but includes subjective 
norms, which have been shown to be more impactful for individuals of minority populations 
(Terry & Hogg, 1996). Together these models suggest that to create interventions aiming to 
engage more HIV at-risk SMM in PrEP care, there are two critical areas that must first be better 
examined. One area includes examining how SMM perceive their sexual risk behavior, and how 
they believe they would be perceived by the significant relationships in their life for beginning a 
PrEP regimen. Multiple PrEP uptake models and research aiming at increasing uptake have 
stated those who view themselves as at-risk for HIV are more likely to be willing to use PrEP, 
have intentions for PrEP use, and begin taking PrEP (Kelley et al., 2015; Nunn et al., 2017; 
Parsons, Rendina, et al., 2017). Similarly, experiencing stigma associated with PrEP use has 
been shown to negatively influence potential PrEP use (Calabrese & Underhill, 2015; Golub, 
2018; Haire, 2015). 
 It is clear from the data presented by the various PrEP uptake models that beginning a 
PrEP regimen is a series of steps where not all variables are equal for all individuals. Based on 
the PrEP literature reviewed above, age likely also influences  many of these variables. For 
example, it is possible that those who are younger perceive their sexual risk and social influences 
differently. Further, those who are younger may have additional developmental barriers to 
uptake, for example, sexual identity development, outness to others, and access to health 
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insurance. If this is true, many of these factors may present areas that are able to be intervened 
upon. Not everyone who is at substantial risk for HIV begins taking PrEP. In order to increase 
uptake via new interventions, it is crucial that researchers examine how those at-risk for HIV 
come to the conclusion they are, or are not, at-risk and if PrEP is the right choice for them. In the 
following chapter, I discuss affective-cognitive processing, developmental theories, and 
developmental factors that I believe should be explored and utilized to expand current PrEP 
interventions to include the unique factors that may affect PrEP uptake among YSMM.   
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CHAPTER FOUR  
Decision Making and Development 
In the previous chapters, I discussed how different theoretical frameworks could and have 
been utilized in the literature pertaining to increasing PrEP uptake. These frameworks included 
the HBM, which focuses on internal constructs related to increasing the likelihood of a behavior 
change, and the TPB, which includes internal and social constructs leading to intentions for a 
behaviors change and eventual change. I also presented these frameworks as associated with the 
Motivational PrEP Cascade (Parsons, Rendina, et al., 2017), which presents stages of PrEP 
uptake as a series of steps, all of which include decision making. Lastly, I suggested that these 
decisions may be made differently for YSMM due to a number of developmental factors and 
milestones.  
According to the CDC’s most recent HIV surveillance data, SMM made up 82% of all 
new HIV diagnoses among men in the U.S. (CDC, 2018a). There are many disparities among 
this at-risk population, one of them being among individuals 13-24 years of age. The CDC 
estimates that those who are 13-24 years of age made up 21% of all new diagnoses in 2017 
(CDC, 2018a) and 93% of those were among sexual minority youth. Further, the CDC reported 
that this disparity in age has been stable over time, and those who are younger are least likely to 
have access to treatment and be virally suppressed. This is a group of individuals who are at 
high-risk for HIV infection, and yet least likely to access care once infected. PrEP use among 
this population is also extremely low. The Rollins School of Public Health at Emory University 
collected longitudinal data on PrEP use across the U.S., and their most recent report shows that 
those who are 24 years of age and younger are one of the two lowest PrEP using age groups 
(11%). Only those who are 55 years of age and older made up a smaller percentage of PrEP users 
(7%) (aidsvu.org, 2018; Siegler et al., 2018). The age group that made up the largest percentage 
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of users were those 25-34 years of age (39%). In order to increase PrEP use among those 24 
years of age and younger who are at-risk for HIV, it is imperative that researchers investigate 
differences that may exist for these YSMM.   
In the following chapter, I first briefly discuss the literature that led to the expansion of 
PrEP for younger populations. I then discuss dual-processing theories in decision making, which 
theorize those who are younger make decisions based on different information than those who 
are older (i.e., affect, cognition, social norms, and benefits). Next, I discuss different 
developmental theories, which suggest there are specific reasons that those who are younger may 
make decisions differently than those who are older. Lastly, I briefly examine developmental 
literature that is unique to the population focus of this project, YSMM. These factors include 
sexual orientation development, the coming out process, relationship importance, and substance 
use.  Together, these sections show there are substantial reasons to believe that younger versus 
older SMM view their sexual risk and PrEP candidacy differently and might, therefore, arrive atp 
different conclusions about their intentions to begin taking PrEP. Thus, in order to best 
implement PrEP use among those who are adolescents and emerging adults, interventions must 
be tailored to their specific developmental stage.  
PrEP Approval for YSMM Under 18 Years of Age 
On May 15th, 2018, the USFDA announced the approval of PrEP for use among anyone 
meeting behavioral criteria for uptake and weighing at least 77 pounds (NICHD, 2018). 
Approval for PrEP use in individuals under 18 years of age comes on the heels of a 
demonstration project by Hosek (2017). This study involved 67 HIV-negative males who were 
between 15 and 17 years of age. As part of participation, enrolled individuals were educated on 
what PrEP is and how it works. Additionally, they were provided an individual behavioral risk 
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reduction session and a once-daily PrEP prescription. Participants then completed visits monthly 
for the first three months and then quarterly until the completion of the study (48 weeks). At all 
visits, participants received an HIV prevention package that included HIV and sexually 
transmitted infection (STI) testing, counseling assessing sexual health and adherence promotion, 
and safety assessments for side effect symptoms. Additionally, participants completed computer-
assisted self-interviews that addressed their behaviors, received condoms, and were provided 
their next set of PrEP doses. Regarding safety, overall TDF/FTC was well tolerated aside from 
one participant who dropped out due to weight loss, potentially related to the medication. Other 
results showed no renal events, bone fractures, or heightened serum creatinine levels. Regarding 
sexual risk behaviors, there were no significant changes over time for the number of sexual 
partners, or CAS acts. STI rates overtime did increase from the first 24 weeks of treatment to the 
second, but not significantly (ARR = 1.93; 95% CI, 0.62-5.96; p = 0.25). Adherence was an issue 
and indicated that at the beginning of the study, 54% of participants were taking at least four 
doses per week, whereas, by week 48, only 22% were. Three participants seroconverted 
throughout the study follow-ups; however, all had levels of TDF/FTC consistent with less than 
two doses of medication per week. Overall, results from this project demonstrated that PrEP is 
both safe and effective for use among individuals under 18 years of age.   
The results of this study highlight that PrEP is effective for YSMM under 18 years of 
age. The HBM states that in order for someone to engage in health-promoting behavior (e.g., 
beginning a PrEP regimen), the individual must first have higher perceived benefits, more 
perceived threat, more self-efficacy, and more cues to action. Similarly, the TPB utilizes 
attitudes, subjective norm, and perceived behavioral control as precursors to intentions for a 
health behavior change. Further, previous cascades developed to increase PrEP uptake have 
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focused on adult SMM (Kelley et al., 2015; Nunn et al., 2017; Parsons, Rendina, et al., 2017), 
thus largely ignoring the differences in development that may differentiate YSMM from adult 
SMM.  Before interventions can be implemented that help YSMM access PrEP, we need more 
research on how younger populations of at-risk SMM make decisions about PrEP use. In the 
following section, I present theoretical frameworks that aim to explain decision making and how 
these processes change throughout development. Decision making pertaining to risk perception, 
susceptibility, and identity development may differently affect YSMM and therefore present 
unique areas for intervention.  
Decision Making 
According to the HBM, an individual who views illness as a threat is more likely to enact 
preventive health behaviors than someone who does not view the illness as a threat (Becker, 
1974). However, not everyone who is at risk for HIV acquisition views themselves as at-risk 
(Parsons, Rendina, et al., 2017). In order to increase uptake among these individuals, it is 
imperative that we understand how individuals perceive their risk. As discussed previously, 
research examining HIV risk perception and PrEP uptake has been limited mainly to samples 
consisting of all adult SMM. However, YSMM are at high risk for HIV and least likely to begin 
taking PrEP (CDC, 2018b). Expanding our understanding on how YSMM perceive their HIV 
risk will help to inform interventions aiming to increase PrEP use.  
Many theories have emerged that explain differences in decision making. The HBM and 
TPB are decision-making models that focus on health behaviors; however, others have focused 
on cognitive and developmental aspects of decision making. Some of these such theories have 
focused entirely on cognitive processing driving decision making (Frederick, 2005; Miller, 
2003), while others have focused on or incorporated affective processing (Baker, Piper, 
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McCarthy, Majeskie, & Fiore, 2004; De Houwer & Hermans, 2001; Zajonc, 1980). Theories that 
have focused on both are commonly called dual-process theories and, amongst many uses, have 
been used to explain differences in reasoning (Chaiken & Trope, 1999; James, 1884; Mischel & 
Shoda, 1995; Petty & Cacioppo, 2012). There are many different proposed theories of dual 
processing, and in the following section, I briefly review three frameworks that I think best apply 
to this dissertation focused on adolescent decision making and perception of risk.  
Affective and Cognitive processing in Decision Making 
Dual processing theories suggest that there are two forms of processing, affective and 
cognitive, that are independent features that also work together symbiotically in behavioral 
responses to stimuli. Affective processing in decision making, sometimes called ‘hot’ cognition, 
is implicit, quick, automatic, often the outcome of emotions or subjective feelings, and 
developed earliest in age (Mischel & Shoda, 1995; Zajonc, 1980). Subjective feelings are those 
that occur without conscious thought, for example, the automatic like or dislike of a smell, a 
person, or a place (Zajonc, 1980). These could also be considered gut reactions to stimuli. ‘Hot’ 
processing is developed first, considered to be more primal and might be the only form of 
processing among animals that may not have the brain functioning abilities for ‘cold’ cognitive 
processing (Zajonc, 1980). Cognitive processing in decision making, sometimes called ‘cold’ 
cognition, is explicit, controlled, independent of emotional involvement, includes conscious 
processing, and is developed over time (Metcalfe & Mischel, 1999; Mischel & Shoda, 1995). An 
example of completely ‘cold’ cognitive processing is solving a simple math problem requiring 
the order of operations. Different processing theories have commonly agreed that ‘hot’ 
processing is developed before ‘cold’ processing (Casey, Jones, & Hare, 2008; Ernst et al., 2005; 
 36 
Galvan et al., 2006; Hare et al., 2008; Steinberg, 2005; van Duijvenvoorde, Jansen, Visser, & 
Huizenga, 2010).  
Research on affective processing among humans has theorized its role in decision making 
differently over time. Some researchers have argued that affect in decision making only occurs 
after careful cognitive processing (James, 1884; Lange & James, 1922), and others that both 
affective and cognitive processes happen simultaneously (i.e., dual processing) (Metcalfe & 
Jacobs, 1996; Metcalfe & Mischel, 1999; Mischel & Shoda, 1995; Prencipe et al., 2011; 
Rendina, 2015; Zelazo & Carlson, 2012). Both theories agree that both cognitive and affective 
processing occurs during decision making. Theories of dual processing state affective and 
cognitive processing do not work entirely independently of each other, but rather ‘hot’ 
processing is a lower-order process developed at an earlier age and often leading to ‘cold’ 
cognition (Barrouillet, 2011; Chaiken & Trope, 1999; Metcalfe & Mischel, 1999; Sloman, 1996; 
Slovic, Finucane, Peters, & MacGregor, 2004).    
 James (1884) is often credited as being the first to consider affect and cognition as part of 
the decision making process. Later, Zajonc (1980) published “Feeling and Thinking: Preferences 
Need No Inferences,” which changed how many psychologists thought about decisions making. 
In this seminal piece, he argues there are eight “notions” that support the important role of affect 
in decision making. These include: affective reactions are primary; affect is basic; affect 
reactions are inescapable; affective judgment tends to be irrevocable; affective judges implicate 
the self; affective reactions are difficult to verbalize; affective reactions need not depend on 
cognition, and affective reasons may be separated from content. His review of the decision-
making literature examined the role of affect and the importance it plays in judgment and 
behavior. Ultimately, he concluded that affective processing develops earlier in life and happens 
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before cognitive processing can occur. This work directly influenced the development of modern 
dual processing models (Metcalfe & Mischel, 1999).  
 Metcalf and Mischel (1999) described a theoretical framework where ‘hot’ affective 
processing and ‘cold’ cognitive processing are two different functions that run parallel to each 
other, and connections develop over time that lead to a simultaneous function of behavioral 
decision. They suggested that each processing system is made up of either ‘cold’ or ‘hot’ nodes, 
which connect to each other and produce a reaction to stimuli. They argue that at the beginning 
of development, ‘hot’ processing is the default of mental processing; however, as an individual 
gains experience and learns, ‘cold’ processing emerges, functioning alongside ‘hot’ processing. 
Further, the nodes of each processing system begin to interact, and pathways are created from 
‘hot’ nodes to ‘cold’ nodes. As suggested by cognitive behavior theory, behavioral pathways 
become more salient over time based on the positive and negative outcomes of the behavior 
(Beck, 2011). Similarly, the pathways created via ‘hot’ and ‘cold’ processing are either 
strengthened or weakened over time depending on the outcomes of the individual’s behaviors 
(i.e., does this behavior lead the person closer toward or further from their goal).  
 In terms of PrEP use and development, the model presented by Metcalf and Mischel 
(1999) suggests that those who are younger may make decisions pertaining to PrEP use utilizing 
more affective ‘hot’ processing compared to cognitive ‘cold’ processing. As shown in the 
literature already reviewed for this project, one of the first decisions a potential PrEP user must 
make if they view themselves as someone who is at-risk for HIV. This processing theory 
suggests that it’s possible those who are younger may come to conclusions about their risk 
utilizing more ‘hot’ affective processing. An example of this is an individual who is at-risk for 
 38 
HIV focusing on if they affectively feel they are at risk as opposed to cognitively measuring and 
assessing their risk. 
The Elaboration Likelihood Model of Persuasion (ELM) (Petty & Cacioppo, 2012) is 
another dual-processing theory and examined attitude change along two paths or processes, 
central and peripheral. The central route is the ‘cold’ cognitive processing route, which occurs 
when someone has the ability and motivation to think critically about a particular message and is 
persuaded by the strength of that message. The peripheral route ‘hot’ affective processing occurs 
when someone has low ability or is unmotivated to think critically about a particular message. 
Persuasion can happen along both paths; however, the expected long-term change is different. 
Those who are persuaded via the central ‘cold’ cognition route, will have given critical thought 
to the message, and the effects will be enduring, resistant, and predictive of future behavior. 
Those who are persuaded  along the peripheral ‘hot’ affective route, will be due to byproducts of 
superficial cues outside of the relevance of the message and are less durable, or not integrated at 
all (Petty & Cacioppo, 2012). ELM explains why some individuals are presented with the same 
information multiple times; however, do not process and integrate it into their decision making 
the first time. Oppositely, an individual who perceives the information as pertinent to them in the 
current moment may begin to process and integrate the information immediately. Similarly, to 
Metcalf and Mischel (1999), these two routes run parallel to each other and interact to elicit 
decisions. However, information being passed along the peripheral ‘hot’ affective route may also 
be integrated by the person presented with the stimuli. As such, individuals may pick up 
information and integrate it into their central ‘cold’ cognitive route without consciousness.  
Not everyone who is aware of and eligible for PrEP use views themselves as eligible and 
the ELM (Petty & Cacioppo, 2012) suggests they may be perceiving information about the 
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medication or their risk level along the peripheral ’hot’ pathway as opposed to the central ’cold’ 
pathway. The individual may have the information, but has not internalized it or applied it to 
themselves, which requires ’cold’ cognitive central processing of the information. Specific to 
YSMM, and discussed further below, there are developmental variables that may also influence 
how a young person at-risk for HIV processes PrEP related information. For example, sexual 
identity develops over time, and some men who are engaging in sexual risk with other men may 
not self-identify as gay. PrEP is often marketed as a medication for SMM, and as such, if the 
individual does not identify as a sexual minority, the information may be utilized along the 
peripheral ’hot’ pathway, and not the central ‘cold’ pathway. As such, their interpretation could 
be, “I am not gay, and therefore, this medication is not for me,” regardless of if they meet the 
objective criteria for uptake. This may be opposite of a person who identifies as a sexual 
minority and interprets PrEP use as, “I am gay, and therefore, this medication is for me.”    
Lastly, the Prototype Willingness Model (Gerrard, Gibbons, Houlihan, Stock, & Pomery, 
2008) is a dual processing model aiming to explain differences in health risk behaviors among 
adolescents. Like other dual-processing theories, these researches theorized that decision making 
exists along two paths. However, they deemed these paths to be a reasoned and social reaction. 
The reasoned path is based on the theory of reasoned action and the social reaction path, a 
response perceived to be more socially desirable to the individual. Garrard et al., (2008) wanted 
to understand why adolescents make decisions that appear to result in negative outcome 
personally, but positive outcome socially, or vice-versa. This theory is the result of much of these 
researchers work that focused on smoking and drinking (Gerrard et al., 2002; Gerrard, Gibbons, 
Stock, Lune, & Cleveland, 2005; Gibbons & Gerrard, 1995), engaging in casual or unprotected 
sex (Gibbons, Gerrard, Blanton, & Russell, 1998; Gibbons, Helweg-Larsen, & Gerrard, 1995), 
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and driving under the influence of alcohol (Gibbons, Lane, Gerrard, Pomery, & Lautrup, 2002). 
Across studies, they found that adolescents who viewed others more favorably, who either 
engaged or didn’t engage in such behaviors, were more likely to engage or not engage in the 
behavior themselves. They theorized adolescent behaviors were not based in the positive and 
negative outcomes for themselves but based on how others might perceive them.   
In terms of PrEP use, the Prototype Willingness Model (Gerrard, Gibbons, Houlihan, 
Stock, & Pomery, 2008) suggests that how someone’s social network perceives PrEP use may 
move someone towards or away from PrEP use. If the individuals' social network is perceived as 
having negative views of PrEP use, the person considering using may fear experiencing the 
social consequences of use (i.e., stigma). Stigma can be experienced at any point in someone’s 
life, however, some developmental theories point to teenage years and early adulthood as times 
where stigma may have the most effect on a young person’s decision making. This 
developmental factor as a potential variable affecting PrEP uptake is expanded further in the 
following section.   
All of these theories state that dual processing coexists within decision making and that 
one path, process, or route interacts with the other to varying degrees, resulting in behaviors. 
They also suggest that these processes develop and change over time, and individuals eventually 
utilize both; however, ‘hot’ processing is developed at an earlier age. As such, developmental 
differences between childhood and adulthood must play a significant role in how information is 
processed and how decisions are made.  
Developmental Theory 
The HBM and TPB both stress the importance of an individual perceiving themselves as 
at-risk before either intending or taking a step towards enacting a health-promoting behavioral 
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change. Dual-processing theories suggest that decisions are made along pathways that include 
both affective and cognitive processing, however they function differently depending on various 
factors, including age. ‘Hot’ affective and ‘cold’ cognitive processes in decision making change 
over time and throughout development. As such, it is important to understand what and when 
developmental literature suggests are some of the pivotal moments and changes that occur 
throughout these processes. Specifically, in order to increase PrEP uptake among YSMM, the 
processes occurring during these periods of development are of increased significance. In the 
following section, I will briefly discuss some of the prominent theories of development and how 
they pertain to YSMM and PrEP use.  
Much psychological research aims to understand how the mind works and what 
differences exist within individuals who make different decisions at different times. For example, 
when the same individual under the same circumstances decides to go on PrEP versus when they 
decide not to. Dual-processes theories suggest some of these differences may be due to changes 
in the utilization of more cognitive versus affective processing. By understanding decision-
making processes, psychologists can treat individuals who have contradictory cognition and aid 
them in making decisions that have a higher potential of leading to more positive outcomes. 
Throughout the history of psychology, there have been many developmental theories aiming to 
understand individuals’ decision making. One of the most well-known and well-respected 
theories is Erikson’s eight-stage theory of personality (1959, 1993). This theory states that 
personality develops in a predetermined order of steps where the completion of one step builds 
onto the next, known as the epigenetic principle (Erikson, 1994). Non-completion of the previous 
step makes completion of the next more difficult and can result in a less functional personality 
type making adulthood more difficult. In the following section, I discuss differing developmental 
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theories that may all be useful in attempting to explain within-person differences in decision 
making, and ultimately how development affects an individual's perception of sexual risk and 
intentions of beginning a PrEP regimen.  
Erikson (1959) developed the eight stages of psychosocial development and included 
society and culture as important factors in development. Further, he argued that development 
does not conclude following puberty, but instead extends into adulthood. Erikson stated that 
every individual experience crisis at each stage, and the outcome is either positive or negative for 
personality development. Erikson theorized the crises come from conflicts between the 
individual’s psyche and the needs of society, the self-other relationship (Crain, 2015). Positive 
outcomes at each stage result in what’s known as virtues, or behaviors and beliefs indicative of 
showing high moral standards (Erikson, 1959). Due to the topic of this dissertation, I briefly 
provide background information on two of the middle stages of Erickson’s theory as they focus 
on changes from adolescence to adulthood.  
Adolescence begins during the fifth stage, identity versus role confusion (twelve to 
eighteen years of age) (Erikson, 1959). During this period the individual is asking themselves 
questions about who they are, where they are going in life, and wondering how they fit into their 
social groups (i.e., family, friends, and society) (Erikson, 1993). These questions are answered 
by the individual exploring their own beliefs, values, and goals for the future. This transition of 
exploring internal mechanisms mirrors the theories of dual-processing and suggest more 
integration of ‘cold’ cognitive processing. For an individual to assess and discover their own 
beliefs, values, and goals, they must be able to internally hold and manipulate different 
information and apply it to themselves (i.e., cognitive processing), which does not mean they 
will no longer be swayed by affective processing, but rather dueling mechanisms active in 
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decision making. Additionally, during this stage, Erikson (1959) theorized that if the parents 
push the child to take on a particular role or identity the result may be role-confusion and the 
child may try out many different roles. However, if the child is allowed to explore, they will 
consolidate at their identity. Part of the identity development includes examining the future for 
relationships, career, family, and learning about the role they wish to play in society. The role of 
society is vital during this stage; individuals generally want to fit into society and as such, may 
make decisions based on where they wish to fit in (Rice & Dolgin, 2005).  
According to Erikson, adolescence is a period of time where someone is attempting to 
discover their identity and questioning who they are in relation to these others. For those who are 
in this stage (approximately 12-18 years old according to Erikson), someone may not view the 
use of PrEP as being socially acceptable and therefore in order to avoid being othered, decide not 
to use the medication. Similarly, the Prototype Willingness Model of dual-processing suggests 
that during this period, an individual may be making decisions based more on social 
consequences to the behavior as opposed to individual internal benefits.   
This stage has also been closely examined in terms of sexual identity development. SMM 
may find themselves living a false identity to appear heterosexual while younger, and then 
developing a different identity as a gay man later in life (DuBay, 1987; Milton & MacDonald, 
1984; Peacock, 2000; Troiden, 1988). Successful completion of this stage should result in the 
individual having a strong sense of self and a distinct view of where they fit into society. For 
SMM, completion of this stage may be more complex than for heterosexual men.  
Erickson’s (1959) developmental theory has influenced many other theories of 
development, including Levinson’s Seasons of a Man’s Life (1978) and Arnett’s Theory of 
Emerging Adulthood (Arnett, 2000). Levinson’s (1978) theory spans the lifecycle, including four 
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eras, pre-adulthood (0-22 years old), early adulthood (17-45 years old), middle adulthood (40-65 
years of age), and late adulthood (60 years old to the end of life). In short, the earliest era of 
Levinson’s theory focuses on the individual making a distinction between “me” and “not me,” 
similar to Erickson’s (1959) theorized passing from adolescence to adulthood, and mirroring the 
Prototype Willingness Model of dual-processing. Levinson (1978) recognized the end of this 
first era as a period where an individual is deciding who they want to be and begins thinking in 
terms of who they are alone, as opposed to whom they are among society, suggesting again the 
integration of ‘cold’ cognitive processing in decision making. His eras overlap, and as such, 
early adulthood begins while pre-adulthood is ending. During pre-adulthood, Levinson argues 
that individuals experience the “greatest energy and abundance and greatest contradiction and 
stress” (Levinson, 1986, p. 5). Similar to Erickson’s identity versus role confusion (1959), 
Levinson sees this period as involving decisions about love, occupation, friendship, and values. 
In both Erickson’s and Levinson’s theories, it is suggested individuals pass quickly from child to 
adult, while Arnett (2000) theorized differently. 
 Arnett (2000) theorized there is a distinct stage between late teens and through the 
twenties that is unique to industrialized societies. This stage, emerging adulthood, primarily 
focuses on a period of time lasting from 18 years of age to 25 years of age. He defined this time 
as a period of exploration where individuals are continuing their education, dating, and living 
away from home for the first time. In more industrialized societies, the age of entering into 
marriage is increasing, and he argues that this is due to the freedom of self-exploration. He 
considered self-exploration to lead to the creation of identity without the pressure of marriage 
and family. Further, and similarly to Levinson (1986) and Erickson (1959), Arnett (2000) 
believes that this is a period where an individual develops more intimacy and asks the question 
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“given the kind of person I am, what kind of person do I wish to have as a partner through life?” 
(Arnett, 2000, p. 473). Again, moving away from attention on how society views an individual 
and towards how individuals view themselves, their own wants and needs (i.e., The Prototype 
Willingness Model).  
Development and Sexual Identity 
There have been many different models that have attempted to explain how individuals 
develop their sexual identities, specifically why some individuals are attracted to and have 
romantic feelings for individuals of the same-sex. One such model, and often credited as the first 
to discuss homosexual development as normative, came from Cass (1979) and is referred to as 
The Cass Identity Model. She theorizes that individuals who eventually identify as a non-
heterosexual pass through a series of stages, including identity confusion, identity comparison, 
identity tolerance, identity acceptance, identity pride, and identity synthesis. At each stage, an 
individual overcomes an obstacle that ultimately results in their sexual identity integration. Other 
stage models were also developed and varied in the number of stages, but ultimately ending in a 
similar place (Fassinger, 1991; Savin-Williams, 1990; Troiden, 1979, 1988). Later models 
integrated these stages into processes with society. One prominent model was developed by 
D’Augelli (1995) and suggested that, along with developing a personal identity, sexual minority 
individuals also develop a social identity in the LGBTQ community, develop a sexual minority 
intimacy status, identify as LGBTQ offspring (i.e., come out), and also enter the gay community. 
Along with the additional emphasis on the role of society, this model also states that’s these 
events can happen in an order, or occur concurrently, unlike the stage models. Sexual identity 
development is complex, and there is no one size fits all model that encompasses the many 
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different factors that may impact how a sexual minority individual comes to acceptance of their 
identity.   
There are multiple aspects of these stages and processes that could potentially impact 
how or when an individual considers accessing PrEP. According to the HBM (1974), if an 
individual perceives too many barriers to health-promoting behavior, they are less likely to 
engage in that behavior. In terms of sexual identity development, self-identity as a sexual 
minority could be a barrier to PrEP uptake as the medication is largely marketed towards sexual 
minorities, and HIV acquisition is commonly associated with SMM. Thus, even if a YSMM is 
engaging in sexual risk behaviors with other YSMM, they may not identify as a sexual minority 
and thereby not consider PrEP use or view themselves as an appropriate candidate for PrEP use. 
The ELM (Petty & Cacioppo, 2012) also suggests that an individual who is engaging in such 
risky behaviors but not identifying with the behaviors may be provided information about PrEP 
and process the information along the peripheral pathways as opposed to the central (i.e., not 
apply it to one's own behavior).  
Another barrier specific to those still in the processes of early sexual identification is 
coming out or telling others about your sexual identity. The period when an individual begins to 
disclose their sexual orientation has changed significantly over time, with people coming out 
younger each generation (Dunlap, 2016). For YSMM who do consider themselves to be good 
candidates for PrEP use, coming out may be a barrier to their beginning a regimen. In order to go 
on PrEP, an individual must take many risks that could potentially lead to being out about their 
sexual orientation to more or different people than they may prefer. For example, going on PrEP 
requires an individual to disclose their sexual behavior to their medical provider and feel 
comfortable picking up their medication from a pharmacy. Further, in the U.S. an individual can 
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be on their parent/caretakers’ health insurance until they are 26 years of age, and as such many 
may risk having to disclose their sexual orientation to their parent/caretaker in order to access 
their insurance. Additionally, even if an individual is open about their sexual orientation to their 
medical provider and parent/caretakers’, they may be uncomfortable engaging in a conversation 
about their sexual risk behavior with either. Coming out as a sexual minority is not required to 
gain access to PrEP. However, it is likely a barrier for many YSMM who may view themselves 
as an appropriate candidate for PrEP. A recent study of 156 young adults (18-25 years of age) 
were asked about being on their parent’s insurance and accessing PrEP (Moore Jr et al., 2019). 
Those who reported being on their parent’s insurance also reported lower willingness to begin 
taking PrEP compared to those that were on their own insurance. Engaging in a conversation 
about sexual risk and sexual orientation are likely to continue to be barriers to PrEP use among 
those on their parent’s insurance.  
Sexual identity development is often more complex for individuals with sexual minority 
status and may take longer. However, Erikson (1959) theorized that following this stage is the 
first stage of adulthood, intimacy versus isolation. He theorized this stage begins around eighteen 
years of age and continues through forty years of age. Here individuals are engaging in dating, 
marriage, starting families, and deepening relationships. The individual is consistently making 
choices that will either lead them towards or away from their goals, ultimately creating the future 
they view themselves as able to obtain. Intimacy becomes import in relationships, and those who 
can experience it are likely to feel cared for, safety, and a sense of commitment (Rosenthal, 
Gurney, & Moore, 1981). The inability to create intimate relationships may leave the adult 
feeling isolated and alone.  
 48 
For SMM, Erikson’s intimacy versus isolation stage may also be different complicated, 
and intimacy may be developed later in life compared to heterosexual men (Christian & Keefe, 
1997; Peacock, 2000). Associations between intimacy and HIV-prevention among SMM have 
also been established in the literature. One study consisting of over 300 highly sexual active 
SMM in NYC tested a model utilizing risk reduction benefits of condom use and beliefs that 
condoms reduce intimacy as predictors for the percentage of  CAS acts (Golub, Starks, Payton, 
& Parsons, 2012). They found that beliefs that condoms reduce intimacy explained three times 
the amount of variance in the model than perceived risk reduction benefits of condom use. 
Regarding PrEP use, another study examined intimacy motivations for CAS as associated with 
intentions to begin taking PrEP and found that higher intimacy motivations for CAS were 
associated with a higher likelihood of intentions to begin taking PrEP (Gamarel & Golub, 2015). 
Someone who is in the earlier parts of the intimacy versus isolation stage may be considering a 
multitude of factors to increase the possibility of longterm intimacy. For many at this stage, this 
may include PrEP use as an HIV-preventive technique to help increase the odds of ongoing 
health and also allowing for increased sexual intimacy via the decision to forego condom use.  
Although Erikson did not discuss the utilization of ‘cold’ or cognitive processing, it is 
clear from the dual processing theories discussed in this dissertation that in order for an 
individual to achieve many adult goals (e.g., college, occupation, family), some ‘cold’ cognitive 
processing is required (Gerrard et al., 2008; Metcalfe & Mischel, 1999; Mischel & Shoda, 1995; 
Petty & Cacioppo, 2012). These individuals moving into adulthood are more likely to focus on 
the behaviors they believe will lead to their long-term goals independent of what the social 
groups around them may argue (Arnett, 2000; Levinson, 1978, 1986; Zajonc, 1980).  
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Together, Erikson, Levinson, and Arnett align in their argument that across the lifespan, 
individuals focus on their decision-making changes from how others see them, to how they see 
themselves. The importance of an identity that is separate from society emerges, and individuals 
begin to make choices that will potentially impact their occupations, educational attainment, and 
intimate lives. These processes begin with first creating a self-identity, which requires the ability 
to utilize cognitive processing to guide their internalization of information into identity 
formation. However, this process of identity development is differently complicated for SMM 
and may continue into further stages than their heterosexual counterparts.  
Summary  
The period of time between childhood and adulthood has been theorized to contain 
different stages, steps, and eras. Across all three of the developmental models reviewed above, 
(Arnett, 2000; Erikson, 1959; Levinson, 1978), a common finding is that, between childhood and 
adulthood, an individual’s attention changes from how others see them, to how they see 
themselves. This is similarly reported in the dual processing literature reviewed for this 
dissertation (Gerrard et al., 2008; Metcalfe & Mischel, 1999; Mischel & Shoda, 1995; Petty & 
Cacioppo, 2012). Those who are at different periods of their life have different goals. A person’s 
focus might have previously including fitting in with those closest to them, slowly transitions 
into focus on individual accomplishments, goals, and plans for the future. These facts may have 
important implications in the implementation of PrEP for YSMM.  
To begin taking PrEP, individuals must first view themselves as those who would benefit 
from PrEP use (Parsons, Rendina, et al., 2017) and as those who PrEP is for. This may include 
identifying as a sexual minority, and also that the behavior they are engaging in includes HIV 
risk. Further, this may also include coming out to others about their sexual orientation (e.g., 
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parent/caretakers’, medical provider). Dual processing theories suggest that individuals could 
come to conclusions about their risk behavior by both a ‘cold’ cognitive and a ‘hot’ affective 
response to their risk behavior (Metcalfe & Jacobs, 1996; Metcalfe & Mischel, 1999; Mischel & 
Shoda, 1995; Prencipe et al., 2011; Rendina, 2015; Zelazo & Carlson, 2012). Further, much of 
the work by Gerrard and colleagues (1995, 1998, 2002, 2005) suggests that those who are 
younger do not necessarily view their own behavior as risky. As such, according to ELM (Petty 
& Cacioppo, 2012), risk perception may be happening along the peripheral path, resulting in an 
individual not completely integrating their own knowledge of risk to their own behaviors. 
Additionally, if an individual does not self-identify as a sexual minority, despite sexual behavior, 
information about PrEP may also happen along the peripheral path and result in the individual 
not applying the information to themselves.   
Gerrard’s (2008) model suggests that YSMMs’ behaviors are likely more swayed by how 
they believe those around them would perceive their behavior (i.e., social reaction) as opposed to 
a  path guided by pros of behavior that directly impact the individual. According to this theory, if 
the people around an individual are on PrEP, or supportive of PrEP use, the individual should be 
more likely to see PrEP use as positive. Oppositely, if those around the individual are against 
PrEP, the individual may perceive PrEP use to be negative and wish not to be associated with it. 
Similarly, Erickson (1959), described this period of life as identity versus role confusion. He also 
stated that individuals might come to conclusions about themselves via their perceptions of 
others. From Erikson’s perspective, at this stage, the individual is determining who they are 
based on others, and society becomes increasingly important. YSMM who are in this stage of 
development are likely looking to those closest to them for cues about the world, and thus may 
be more heavily influenced by perceived subjective norms. The TPB (Ajzen, 1991) suggests that 
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subjective norms are associated with intentions to enact a behavior; thus, more positive 
subjective norms should result in more intentions. At this time in an individual’s life, how social 
norms are developed and influence behavior becomes increasingly important and may sway an 
individual’s intentions to begin taking PrEP.   
In order to understand how to increase PrEP uptake among YSMM, particularly those 24 
years of age and younger who are disproportionately affected by HIV and least likely to engage 
in PrEP use (AIDSvu.org, 2018; CDC 2018a; Siegler et al., 2018), it is essential to address where 
they are regarding development. Different developmental and dual processing theories suggest 
that how younger individuals make behavioral decisions differs from those who are older. ‘Hot’ 
cognitive processing is primal and develops first. Although both processes affect decision 
making, ‘cold’ processing is developed over time. Health disparities in HIV transmission among 
men show that those who are YSMM are at elevated risk for acquisition (CDC, 2018a)    , and 
with the expansion of PrEP care to now include people under 18 years of age (NICHD, 2018), 
understanding how YSMM make decisions about PrEP use becomes increasingly important.  
In this chapter, I reviewed multiple developmental and dual processing theories that all 
suggest the period between childhood and adulthood is vastly different. Those who are younger 
may make more decisions based on how they believe other’s will perceive them, with less regard 
for their actual risk, and with the limited information they have gained in the peripheral. To 
engage YSMM 24 years of age and younger who are at-risk for HIV acquisition, it is imperative 
that we understand how they are making decisions about their risk behavior. If they are coming 
to conclusions based on PrEP via a quick affective ‘hot’ response, then targeting them with 
information that requires attention and conscious ‘cold’ cognition may be futile. Additionally, if 
they are making decisions about PrEP use based on how others may view them, more negative 
 52 
perception of use could deter intentions. Both have important clinical implications and potential 




Overview of the Proposed Research 
 The overall aim for this dissertation is to identify points for potential intervention to 
increase PrEP uptake among YSMM 24 years of age and younger who are at-risk for HIV. 
Research for this dissertation is guided by multiple theories, models, and health disparities 
among ages. These models include HBM (Becker, 1974), TPB (Ajzen, 1991), dual processing 
(Abelson & Rosenberg, 1958; Gerrard et al., 2008; Lazarus, 1982; Metcalfe & Mischel, 1999; 
Petty & Cacioppo, 2012), and theories of development (Arnett, 2000; Erikson, 1980; Levinson, 
1978). Epidemiological findings from the CDC show that YSMM who are 24 years of age and 
younger are at high risk for HIV, and make up one of the lowest PrEP using groups 
(AIDSvu.org, 2018l; CDC 2018a; Siegler et al., 2018). Together, these theories suggest that 
there are many developmental factors that differentiate decision making in YSMM from decision 
making in adult SMM, and thus conclusions about PrEP uptake. In the following chapter, I 
outline each of the studies, aims, and hypotheses of this research. 
The first study aims to establish that age disparities for PrEP use exist among a large U.S. 
national sample of SMM (YSMM who are less than 25 years of age, and SMM who are 25 years 
of age and up). Findings from this study will provide some of the first published evidence that 
there are distinct differences in trends of uptake among age groups. To do this, I will first 
identify group differences in uptake, and second, examine how these group differences influence 
PrEP uptake among YSMM and adult SMM. The second study aims to identify relevant 
developmental factors that may help to increase the two primary psychological precursors to 
PrEP uptake (i.e., PrEP acceptability, and PrEP intentions) among YSMM who are 24 years of 
age and younger and at risk for HIV. To do this, I will utilize a large national sample of YSMM 
for whom PrEP is already indicated. Results from both studies will provide evidence for 
 54 
potential intervention points that will help to increase PrEP uptake among YSMM at risk for 
HIV acquisition. As such, the project is designed to test several hypotheses detailed below.    
Study 1: Understanding Basic Trends in PrEP Uptake among YSMM in a large, diverse 
sample of SMM 
The first aim of this dissertation is to examine potential age disparities for PrEP use 
among SMM, specifically, that those who are under 25 years of age have less experience with 
PrEP than those who are older. To do this, I will examine fundamental trends in the prevalence 
of PrEP uptake and discontinuation in a large sample of sexually active YSMM and adult SMM, 
and second, examine how these group differences may influence PrEP uptake among these 
groups.  
As I describe in more detail in the following chapter, this is a very brief survey on a 
substantial number of YSMM and adult SMM. The data for the first aim provides one of the first 
epidemiological investigations of PrEP use among this vast age range. Though there are very few 
variables given the length of the survey, this allows a preliminary investigation of factors 
associated with PrEP use in a more generalizable sample. I will begin with the first set of 
analyses for aim 1 by examining group differences in the prevalence of PrEP use across the 
entire sample by age. In order to determine the appropriate age groupings for this research, I 
turned to PrEP use disparities as reported by the Rollings School of Public Health (AIDSvu.org, 
2018; Siegler et al., 2018) and the CDC (2018a). These age groups included the following, (13-
24, 25-34, 35-44, 45-54, 55+) with one change. I separated those 13-17 years of age and 18-24 
years of age based on the very recent inclusion of recommendations for those at-risk who are 
under 18 years of age.  
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The second set of analyses for aim 1 will explore group differences associated with PrEP 
use among those who are older verus younger SMM. To determine the appropriate age groups, I 
again turned to both the CDC and Rollins School of Public Health findings for HIV transmission 
rates and PrEP uptake, and developmental literature. There are significant changes that occur 
through these periods in development (Arnett, 2000; Erikson, 1959; Levinson, 1986). The theory 
of Emerging Adulthood (Arnett, 2000) suggests a higher ceiling for younger people (29 years of 
age), however in the U.S. an individual is able to access health care through their parent until the 
age of 26, which could directly impact YSMM’s access depending on a multitude of 
developmental and identity factors previously discussed. Taking into consideration the 
epidemiological research on HIV by the CDC and the developmental literature that does not 
suggest hard cutoffs for changes due to age, I chose to divide the sample at 13-24 and 25 years of 
age. This matches the CDC data while also not including those that can no longer legally be on 
their parent’s insurance in the younger group. Group differences among both age samples 
explored will be race, ethnicity, sexual orientation, health insurance, U.S. geographical location, 
relationship status, engagement in CAS with a casual HIV unknown partner, recent diagnosis of 
an STI, recent drug use, and recent heavy drinking.  
Hypotheses for aim 1. 
 Hypothesis 1a: Odds of both current and former PrEP use among individuals under the 
age of 24 will be lower compared to those 25 years of age and older.  
Hypothesis 1b: All of the below-mentioned variables have been shown to be associated 
with PrEP use among adult SMM and have not been examined in a larger population, including 
YSMM under 18 years of age.  
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Having shown that uptake is lower for those who are younger, I will examine those who 
are 13-24 years of age and those 25+ years of age for demographic and behavioral risk 
differences associated with PrEP use. The reasoning for these age groups has been explained 
above. Among both age groups, I anticipate differences in PrEP use will appear for race, sexual 
orientation, relationship status, sexual risk behavior, recent STI diagnosis, and recent substance 
use. I anticipate that those who are White (compared to all other races), identify as gay 
(compared to bisexual and queer), single (compared to in a relationship), those who have 
engaged in recent CAS with an HIV status unknown partner (compared to those who have not), 
those who have recently received an STI diagnosis (compared to those who have not received a 
recent STI diagnosis), and those who have recently used a drug (compared to those who have 
not) will be more likely to have current and former PrEP use compared to those that have never 
used PrEP.  
 Hypothesis 1c: In the age group of YSMM (13-24 years of age), I hypothesize there will 
be a difference in health insurance such that those who are on their parents’ health insurance will 
have lower odds of having experience with PrEP compared to those that are on their own 
insurance. This hypothesis has not been previously tested; however, YSMM who are on their 
parents’ health insurance may face additional barriers to uptake that may impede uptake, which 
has been discussed in the previous chapter. 
Together and if confirmed, these hypotheses will provide evidence that current PrEP use 
in the U.S. is lowest among YSMM, and that further research needs to be conducted to examine 
how the uptake of PrEP can be increased among those YSMM at-risk for HIV. Further, these 
findings are likely to indicate some disparities among YSMM that exist in terms of demographic 
and behavioral risk associations with use. Although I will not be statistically comparing the two 
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age groups (13-24 and 25 and up), these finding may highlight important trends in uptake among 
the two groups. The second aim of this dissertation examines developmental factors I believe 
will uncover potential intervention strategies for increasing uptake among YSMM.  
Study 2: Identify developmental factors as they pertain to PrEP uptake among a large 
national cohort of HIV at-risk YSMM 
Having identified the prevalence of, and factors associated with, PrEP uptake among a 
more generalizable and more extensive sample of YSMM in Study 1, the goal of Study 2 is to 
examine developmental factors that may impede YSMM from actual PrEP uptake. 
Understanding the unique psycholodevelopmental factors that influence decisions around PrEP 
intentions for YSMM will provide evidence for future interventions aiming to increase uptake 
among those at risk for HIV infection.    
Aim 2. I will examine and identify developmental differences that are associated with the 
primary psychological precursors to PrEP uptake that have been established in the literature to 
date—the perception of PrEP candidacy and having PrEP intentions. The models of health 
behavior and PrEP cascades reviewed in this project suggest that in order for an individual to 
have intentions to begin taking PrEP, they must first view themselves as someone who is a PrEP 
candidate (Ajzen, 1991; Fishbein & Ajzen, 1975; Kelley et al., 2015; Parsons, Rendina, et al., 
2017). Additionally, the dual processing theories reviewed for this dissertation also suggest those 
who are younger may make decisions differently than those who are older (Gerrard et al., 2008; 
Metcalfe & Mischel, 1999; Petty & Cacioppo, 2012). For younger individuals, ‘hot’ affective 
processing is often utilized more, compared to the use of ‘cold’ cognitive processing, and vice-
versa for older individuals (Metcalfe & Mischel, 1999). Further, those who are younger are more 
likely to be swayed in their decision making by perception of how others will view them, as 
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opposed to those who are older who are likely more concerned with their own perceived benefits 
of a behavior (Erikson, 1959; Gerrard et al., 2008; Levinson, 1978). Given these theories, I will 
examine the role of age in modifying the association between both cognitive and affective 
dimensions of HIV risk and viewing oneself as a PrEP candidate. I will also examine the 
mediating role of PrEP candidacy between affective and cognitive dimensions of HIV risk and 
PrEP intentions. Then, I will examine a scale that measures a social view of PrEP (PrEP stigma), 
and a scale measuring individual perceived benefits of PrEP use. Lastly, I will examine two 
different developmental factors that I believe will be differently associated with PrEP intentions 
by age. Taken together, these findings will provide evidence of how those who are younger may 
make decisions about PrEP, and highlight areas for potential intervention. As pictured in Figure 
4, I hypothesize the following:  
Hypothesis 2a: Affective dimensions of HIV risk will be positively associated with a 
perceived candidacy. 
Hypothesis 2b: Cognitive dimensions of HIV risk will be positively associated with a 
perceived candidacy.  
Hypothesis 2c: Age will moderate the association between affective dimensions of HIV 
risk and perceived PrEP candidacy such that as age increases, the association between affective 
dimensions of HIV risk and perceived PrEP candidacy weakens.  
Hypothesis 2d: Age will moderate the association between cognitive dimensions of HIV 
risk and perceived PrEP candidacy such that as age increases, the association between cognitive 
dimensions of HIV risk and perceived PrEP candidacy strengthens.  
These following hypotheses are guided by both the TPB (Ajzen, 1991), stating that the 
perception of candidacy for a health change or behavior should be directly related to enacting the 
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behavior, and the TRA (Fishbein & Ajzen, 1975), stating that the attitude of a behavior 
(perceived candidacy) and a behavioral change are mediated by intentions of the change. As 
such, I will next add PrEP intentions into the model, such that perception of self as a PrEP 
candidate will mediate the association between affective and cognitive dimensions of HIV risk 
and PrEP intentions. In other words, I believe I will find that in order for an individual to have 
intentions to begin taking PrEP, they must view themselves as someone who would be a good 
candidate for PrEP. These findings will demonstrate that affective dimensions of HIV risk will 
be more strongly associated with the perception of PrEP candidacy for those who are younger, 
whereas cognitive dimensions of HIV risk will be more strongly associated with the perception 
of PrEP candidacy for those who are older. These findings will provide evidence of how 
individuals come to a conclusion about their risk behavior is likely influenced by a differently 
developed and utilized processing response. As pictured in Figure 5, I hypothesize the following:  
Hypothesis 2e: There will be an indirect effect of affective dimensions of HIV risk on 
intentions through perceived candidacy, but no direct effect. 
Hypothesis 2f: There will be an indirect effect of the cognitive dimensions of HIV risk 
on intentions through perceived candidacy, but no direct effect. 
I will then explore other developmental factors that theoretically should differentiate 
those who are younger from those who are older in terms of their intentions to begin taking 
PrEP. As reviewed above in the developmental literature presented, as individuals move from 
adolescence into adulthood, their focus for decision making changes. Those who are younger are 
more likely to make decisions based on how they believe others will perceive them, and sexual 
identity may shape their perception of whether PrEP use is relevant for them or not. As they 
move into the next stage of development, their focus should change to their own independent 
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goals or perceived personal benefits of a behavior. They will begin moving away from decisions 
based on the perceived societal norms and into decisions where the outcome is more likely to be 
in favor of their independent goals, which could also include intimate relationship formation, or 
moving from “single” to “partnered” (Arnett, 2000; Erikson, 1959; Levinson, 1978). Similarly, 
the dual processing model theorized by Gerrard (2008) states that those who are younger are 
more likely to be focused on a social reaction in terms of decision making, instead of internally 
motivated decision making. In terms of PrEP use, I have selected a measure that targets how an 
individual perceives others who use PrEP (i.e., PrEP stigma), and a measure that focuses on the 
individuals’ perception of how PrEP might benefit them (i.e., benefits of PrEP use). As pictured 
in Figure 6, I hypothesize the following: 
Hypothesis 3a: PrEP stigma will be negatively associated with PrEP intentions. 
Hypothesis 3b: Perceived benefits of PrEP use will be positively associated with PrEP 
intentions.  
Hypothesis 3c: Age will moderate the association between PrEP stigma and PrEP 
intentions such that as age increases, the association between PrEP stigma and PrEP intentions 
weakens.  
Hypothesis 3d: Age will moderate the association between perceived benefits of PrEP 
use and PrEP intentions, such that as age increases, the association between perceived benefits of 
PrEP use and PrEP intentions strengthens. 
If confirmed, these two models will demonstrate there are significant differences in the 
ways those who are younger compared to older SMM conclude if they are a good candidate for 





Aim 1: Understanding Basic Trends in PrEP Uptake among YSMM in a large, diverse 
sample of SMM 
As previously stated in the Introduction, the goal of the first aim of this dissertation is to 
examine whether age disparities for PrEP use exist among SMM, specifically to examine if those 
who are 24 years of age and under have less experience with PrEP than those who are 25 years 
of age and older. 
 Data for this dissertation were collected with the support of a fellowship from the 
National Institute of Mental Health (F31-MH116874). The aims of this fellowship included 
secondary data analysis for this dissertation. The data for the first aim of this dissertation were 
drawn from the brief online survey used to assess preliminary eligibility for participation in 
UNITE, a longitudinal cohort study examining the psychosocial and biological predictors of HIV 
seroconversion among SMM (UG3-AI133674). This online screener data for the parent project 
and those specific to the first aim of this dissertation were collected as part of a single survey 
prior to participants’ enrollment in the parent project. Below I describe relevant data collection 
information for the first aim of this dissertation and then relevant information for the second aim 
in the following section of this chapter.  
Participants and Procedures 
The goal of recruitment for UNITE was to enroll 8,000 SMM who are at-risk for HIV 
acquisition. Between November 2017 and September 2018, targeted advertisements were placed 
on popular dating/sexual networking applications and social media websites (e.g., Scruff, Grindr, 
Adam4Adam, and FaceBook). When a potential participant clicked the ad, they were linked to a 
Qualitrics survey and asked if they would like to complete a survey to see if they are eligible for 
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a paid research study. Once the individual consented, they completed a short survey, lasting five-
ten minutes. Participants were not paid for completion of this survey; however, those that were 
preliminarily eligible for the parent project were provided a second link to an additional survey. 
Only data collected during this first survey was used for the analyses of the first aim of this 
dissertation. The subsequent survey and enrollment details for the parent project are described 
under the second aim.  
In total, 123,378 individuals completed the screener for eligibility into the study. As part 
of consent, IP addresses were collected, and contact information was submitted at the conclusion 
of the screener. IP addresses and contact information were cross-referenced, and duplicates were 
removed from the sample. In order to be included in the following analyses, individuals had to 
complete the full screener, be at least 13 years of age, currently identify as male, identify their 
sexual orientation as something other than heterosexual, reside in the U.S. or other U.S. territory, 
self-report an HIV-negative status, and indicated recent sexual behavior. This resulted in an 
analytic sample of 96,243 (78%) individuals. 
Measures. 
 Demographics. Individuals were asked a range of demographic questions. Participants 
were asked their age, which was collected as a continuous variable and in response to the 
question, “How old are you?” For bivariate analysis, ages were separated into the following 
groups: 13-17, 18-24, 25-34, 35-44, 45-54, and 55+. Age was utilized as a continuous variable in 
the age-stratified regression models, detailed below. Decisions around age groups were selected 
to reflect relevant literature from the CDC on the epidemiology of HIV in the U.S. (CDC, 2018a) 
and recent reports of PrEP use (AIDSvu.org, 2018; Siegler et al., 2018).  
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Participants were asked about sex and gender separately. Sex was asked via the item, 
“Which sex were you assigned at birth (as listed on your birth certificate)?” Response options 
included “male” and “female.” Participants were then asked, “What is your current gender 
identity?” Response options to this item included “male,” “female,” and “transgender.” Only 
those who reported being assigned the male gender at birth and currently identified as a male 
were included in the sample. This decision was made due to the various psychosocial factors that 
have been identified in the literature that differentiates transgender individuals from cis-gender 
individuals (Dowers, White, Kingsley, & Swenson, 2019). Participants responded to one 
question about their sexual identity, “What do you consider your sexual identity?” Response 
options included “gay,” “straight,” “queer,” “bisexual,” and “lesbian.” In an effort to control for 
different HIV-risk processing that may exist between those who identify as SMM, only those 
who reported a sexual identity as gay, queer, and bisexual were included in the final sample and 
coded as 0 (gay), 1 (queer), and 2 (bisexual). 
Participants were asked, “What is your race?” and provided the options, “Black/African 
American/Afro Caribbean,” “White,” “Asian or other Pacific Islander,” “Native American or 
Alaskan Native,” “Multiracial,” and “Other (please specify).” Race was coded as 0 (White), 1 
(Black/African American/Afro Caribbean), 2 (Asian or other Pacific Islander), 3 (Native 
American or Alaskan Native), 4 (Multiracial), and 5 (Other, please specify). Additionally, 
participants were asked “Do you consider yourself to be Hispanic or Latino?” with response 
options “yes” and “no,” and coded as 0 (no) and 1 (yes).  
Participants were also asked about their HIV status, “What is your HIV status?” 
Response choices included “Negative,” “Positive,” and “I don’t know.” Due to this study being 
about PrEP use, those who reported being “Positive” were not included in the analyses. Location 
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of the participant was asked via two questions. The first being, “Where do you currently live?” 
Their response options included, “United States (including D.C.),” “Puerto Rico,” “Another U.S. 
territory (e.g., Guan, U.S. Virgin Islands),” and “Other (Outside the U.S.) – Please specify:” 
Those who reported living outside of the U.S. were not included in the analyses, and all others 
were asked for their five-digit ZIP code, “What is your ZIP code?” The U.S. Census Bureau 
(United States Census Bureau, 2016) has divided the U.S. into four geographic regions based on 
U.S. zip codes (i.e., West, Midwest, South, and Northeast). Participant’s zip codes were matched 
to their geographic region as determined by the U.S. Census Bureau. Those who are currently in 
the military or reside in another U.S. territory have a geographic region coded as “U.S. 
Territory/Military.” Responses were coded as 0 (South), 1 (Northeast), 2 (Midwest), 3 (West), 
and 4 (U.S. territory/military). All other questions and measures assessed are detailed below. 
Medical insurance. Participants were asked “Do you currently have medical insurance?” 
and provided the response options, “No, I am currently uninsured,” “Yes, a private insurance 
plan through my employer,” “Yes, a private insurance plan through my parent’s employer,” 
“Yes, a private insurance plan through my partner’s employer,” “Yes, a private insurance plan I 
pay for through the health insurance marketplace (e.g., through ObamaCare),” and “Yes, a public 
insurance plan such as Medicaid”. Those who reported “Yes, a private insurance plan through 
my parent’s employer” were coded as 0 (yes, parent’s), those who reported “Yes, a private 
insurance plan through my partner’s employer” were coded as 1 (yes, partner’s), those who 
reported “Yes, a private insurance plan through my employer,” “Yes, a private insurance plan I 
pay for through the health insurance marketplace (e.g., through ObamaCare,” and “Yes, a public 
insurance plan such as Medicaid” were coded as 2 (yes, own).  Those who responded, “No, I am 
currently uninsured” were coded as 4 (no).  
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Sexual behavior. Participants were asked multiple questions about sexual behavior, in 
similar ways that have previously been published (Golub, Rosenthal, Cohen, & Mayer, 2008; 
Golub, Tomassilli, et al., 2010; Grov, 2012; Parsons, Grov, & Golub, 2012; Rendina et al., 
2016). Although we did not ask participants if they had reached their sexual debut, we asked 
them about recent sexual behavior in the last six months. To first determine if they had recently 
engaged in sexual behavior, those who reported being in a relationship were asked, “Within the 
past 6 months, have you had anal sex with your main partner?” Response options included “yes” 
and “no.” All participants were presented with the text, “For the next set of questions we want to 
know about any male partners you had sex within the past 6 months. Please do not count your 
main partner when answering these questions.” They were then asked, “How many male sex 
partners have you had sex within the past 6 months? (We define sex as any physical contact that 
could lead to orgasm.)” Participants were able to enter any number. Responses to the first 
question were coded as 0 (no) and 1 (yes). Responses to the second question were could as 0 (no) 
and 1 and up (yes). Participants that were coded as “yes” for either question were included in the 
analysis. Participants were also asked questions about recent sexual risk behavior. All 
participants were asked, “How many of your male partners in the past 6 months did not tell you 
their HIV status OR told you there was a different HIV status than you?” Responses were open 
and coded as “CAS with HIV status different or unknown partner” 0 (no) 1 or more (yes).  
Recent STI diagnosis. Participants reported if they had received a positive STI diagnosis 
in the last six months via a series of  questions beginning with “In the past 6 months, have you 
been diagnosed with any of the following,” and then separately queried for chlamydia, 
gonorrhea, syphilis, hepatitis B, hepatitis C, herpes, or HPV/genital warts. Responses options 
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included “yes” and “no” for each STI. Positive STI results for any of these presented were coded 
as 0 (no) and 1 (yes).  
Substance use. Participants reported on recent substance use, including recreational 
drugs and alcohol. They responded to the following, “For the next section, we are interested in 
knowing about your recent substance use. Please indicate how many days you’ve used each of 
the following drugs within the past 3 months (90 days).” They were then provided ordinal 
number options for the following substances “marijuana,” “cocaine,” “crack,” “crystal meth,” 
“GHB/GBL,” “heroin/opiates,” “ketamine (K),” “MDMA (Ecstacy, Molly),” “Poppers,” 
“Prescription drugs for fun or to get high,” and “Viagara/Levitra/Cialis”. If the participant 
indicated one or more for any of these options, they were coded as 1 (yes), if not, they were 
coded as 0 (no). Marijuana was included, as its use is not legal in all of the United States 
(Dragone, Prarolo, Vanin, & Zanella, 2019), and poppers as their legal/intended use are not 
sexual and have been linked to more sexual risk behavior (Mayer, Colfax, & Guzman, 2006). 
Additionally, participants were asked about recent alcohol use. They responded to the question, 
“How many days in the past 3 months have you had five (5) or more drinks on one occasion?” 
Participants were able to write-in a numbered response. Those who indicated having at least five 
drinks on one occasion were coded as “heavy drinking” 0 (no) and 1 (yes).  
PrEP use. Participants were provided a brief description of PrEP and then asked about 
past and current use (Holloway, Dougherty, et al., 2017; Morgan, Ryan, Newcomb, & 
Mustanski, 2018; Parsons, Rendina, et al., 2017; Whitfield, John, Rendina, Grov, & Parsons, 
2018a). The introduction read “PrEP (pre-exposure prophylaxis) is a biomedical strategy to 
prevent HIV infection. PrEP involves HIV-negative guys taking anti-HIV medications (for 
example, Truvada) once a day, every day to reduce the likelihood of HIV infection they were 
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exposed to the virus.” Participants were then asked “Have you ever been prescribed HIV 
medication (e.g., Truvada) for use as PrEP (pre-exposure prophylaxis)” Response options were, 
“Yes, I am currently prescribed PrEP,” “Yes, but I am no longer prescribed PrEP,” and “No, I’ve 
never been prescribed PrEP.” These responses were coded as 0 (never), 1 (former), and 2 
(current).  
Analytic Plan 
 All hypotheses for the first aim were conducted with SPSS version 25. To explore 
differences in individual characteristics associated with the dependent PrEP use variable (i.e., 
never, former, current), group differences were explored and included age (13-17, 18-24, 25-34, 
35-44, 45-54, 55 and up), relationship status (partnered versus single), sexual orientation (gay, 
queer, bisexual), race (White, Black/African American/Afro Caribbean, Asian or other Pacific 
Islander, Native American or Alaskan Native, Multiracial, Other), Hispanic/Latino (yes/no), 
region (South, Northeast, West, Midwest, Other U.S. Territory/Military), health insurance status 
(none, own, partner’s, parent/guardian), recent STI diagnosis (yes/no), CAS with an HIV status 
unknown partner (yes/no) recent drug use (yes/no), and heavy drinking (yes/no). I utilized two-
tailed t-tests to examine differences in Hispanic/Latino ethnicity, relationship status, recent STI 
diagnosis, CAS with an HIV status unknown partner, recent drug use, and heavy drinking. 
Analyses of variances (ANOVA) were used to examine differences in age, race, sexual 
orientation, region, and health insurance. 
To test hypothesis 1a, that the percentage of current and former PrEP use is lowest among 
individuals 24 years of age and younger, I first ran descriptive statistics to assess the number of 
participants that fall into each of the three groups of PrEP use (i.e., never on PrEP, previously on 
PrEP, and currently on PrEP) by age (13-17, 18-24, 25-34, 35-44, 45-54, 55 and up). Having 
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shown that PrEP use is lowest among those 24 years of age and younger, I then split the sample 
to examine those who are 13-24 years of age and those who are 25 years of age and older. These 
age groupings were selected to match CDC age group categorizations for HIV risk (CDC, 2018a) 
and the Rollins School of Public Health (AIDSvu.org, 2018; Siegler et al., 2018) groupings for 
PrEP uptake across the use. Further rationale surrounding this decision can be found in the 
previous chapter (CDC, 2018a).  
To examine hypotheses 1b, that demographic and behavioral risk differences exist for 
PrEP use among those 24 years of age and younger, and those 25 years of age and older, I 
conducted two multinomial logistic regressions stratified by age, predicting PrEP use with all 
variables of interest included in the models. These variables included age (continuous within 
each age group), race (White, Black, Asian or other Pacific Islander, American Indian or Alaskan 
Native, Multiracial, and Other), Hispanic/Latino Ethnicity (yes/no) sexual identity (gay, 
bisexual, queer), relationship status (yes/no), geographic region determined by US Census data 
(South, Northeast, Midwest, West, U.S. Territory/Military), recent CAS with an partner of 
different or unknown HIV status (yes/no), recent STI diagnosis (yes/no), recent drug use 
(yes/no), and recent heavy drinking (yes/no). All variables were dummy coded before being 
entered into the model, as 0 (no) and 1 (yes). 
Lastly, to test hypothesis 1c, that those who are under 24 years of age and on their 
parent’s insurance will have lower odds of experience with PrEP compared to those who are on 
their own insurance, I conducted a multinomial logistic regressions predicting PrEP use for the 
stratified sample of YSMM with health insurance included in the model while controlling for all 
other demographic and behavioral variables.   
 69 
Due to the large sample size of aim 1 (N = 96,243), and in effort to avoid Type I errors, 
only analyses outside of the specific hypotheses of this aim that resulted in a p-value of 0.001 or 
less will be presented in the results section and discussion of the findings. However, all 
significant p-values of 0.05 and below are marked in their associated tables and figures. This 
decision was made in order to reduce the chances of reporting an association among variables 
that may be statistically significant yet not clinically meaningful.       
Aim 2: Identify individual developmental factors as they pertain to PrEP uptake among a 
large national cohort of at-risk YSMM. 
  As stated above, data for this dissertation were collected with the support from a 
fellowship from the National Institute of Mental Health (F31-MH116874). The aims of this 
fellowship included secondary data analyses of data collected as part of UNITE, a longitudinal 
cohort study examining the psychosocial and biological predictors of HIV seroconversion among 
SMM (UG3-AI133674). Participants of the parent project may be followed for as long as three 
years; however, data for the second aim were primarily drawn from the baseline data collected 
during the enrollment process for the longitudinal cohort. The only data from a different survey 
comes from demographic characteristics that were collected via the online screener, which were 
linked to this baseline data pool via identification numbers provided to the participants. These 
analyses focus on the participants that are officially enrolled in the parent project, and as such, 
relevant procedures for enrollment are described below.  
Procedures and Participants 
 Relevant procedures from the parent project. 
 Data for the second aim came from the UNITE cohort, consisting of 7,952 HIV-negative 
SMM (16 years old and up). Between November 2017 and September 2018, 123,378 individuals 
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fully completed the screening survey, detailed above in methods of the first aim. Once 
individuals were deemed preliminarily eligible, they were linked to a second survey. Before 
completing the second survey, participants were presented with a brief video introducing the 
research team, the purpose of the study, study procedures, and critical information for informed 
consent. Participants were then asked to review the consent form and completed a brief consent 
comprehension quiz. After consenting, participants proceed to the baseline assessment, which 
took approximately 30-40 minutes to complete. After completion of the baseline survey, 
individuals were sent an at-home HIV/STI testing kit and were required to send the specimen to 
the lab before being officially enrolled in the cohort. Participants were paid $25 for completion 
of the enrollment procedures. 
Enrollment into the final UNITE cohort included: (1) reporting an HIV-negative or 
unknown status; (2) being at least 16 years old; (3) currently identifying as male; (4) having sex 
with another male in the past three months; (5) not currently prescribed PrEP and adhering to the 
medication; (6) report sexual HIV transmission risk in the past six months, which has been 
defined as meeting at least one of the following three criteria: (a) a self-reported STI diagnosis; 
(b) CAS with a casual male sex partner; or (c) CAS with an HIV-positive/unknown main partner; 
(7) able and willing to provide informed consent; (8) able and willing to complete the baseline 
procedures, including the online survey and at-home resting procedures; and (9) living in the US, 
including Puerto Rico or another U.S. territory. In total, 7,952 individuals completed the online 
screener, completed the baselines assessment, HIV/STI testing, consented to be in the study, and 
were enrolled in the final longitudinal cohort. The following analyses were conducted utilizing 
participants that were enrolled in the longitudinal cohort, reported being 16-24 years of age 
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during the completion of the screener survey, and not currently prescribed PrEP. This resulted in 
an analytic sample of 2,003 (25.2%).   
Measures.  
Demographics. During the online screener, individuals reported on a range of 
demographic features, including sex assigned at birth, gender identity, race, ethnicity, sexual 
identity, age, relationship status, zip code, and medical insurance status. Collection of these 
variables and coding is detailed above in the first aim and consistent throughout the second aim. 
These descriptive variables from the online screener were merged with the data collected during 
the baseline survey. Additional demographic characteristics collected during the baseline survey 
included educational attainment and employment status. Educational attainment was asked with 
the question, “What’s the highest grade of school you have completed?” and response options 
provided included, “Some high school,” “High School Diploma or GED,” “Some College or 
Associates Degree,” “Currently enrolled in college,” “4-Year College Degree (BA, BS, BFA),” 
and “Graduate School”. Those who responded “Some high school” or “High School Diploma or 
GED” were coded as 0 (Some High School/GED or less), “Some College or Associates Degree” 
or “Currently enrolled in college” as 1 (Some College), and 4-Year College Degree (BA, BS, 
BFA)” or “Graduate School” as 2 (4-Year College or More). Employment status was asked with 
the question, “Which of the following best describes your current employment status?” Response 
options included, “Full-time,” “Part-time,” “Part-time work – full time student,” “Permanent or 
temporary disabled and NOT working,” “Permanent or temporary disabled BUT working ‘off 
the books’ (or ‘under the table’),” “Unemployed – Student,” and “Unemployed – Other”. Those 
who reported “Permanent or temporary disabled and NOT working,” “Unemployed – Student,” 
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and “Unemployed – Other” were coded as, 0 (unemployed), “Part-time,” “Part-time work – full 
time student,” 1 (part-time), and “Full-time” as 2 (full-time). 
Dimensions of Risk Perception. Participants completed the Perceived Risk of HIV Scale 
(Napper, Fisher, & Reynolds, 2012). This scale consists of three subscales that measure 
affective, cognitive and salience dimensions of perceived HIV risk. Only the affective and 
cognitive subscales were utilized for this study. The affective dimensions of perceived HIV risk 
subscale included the items, “What is your gut feeling about how likely you are to get infected 
with HIV?,” “I worry about getting infected with HIV,” “Getting HIV is something I am 
concerned about,” “I feel I am unlikely to get infected with HIV,” and “I feel vulnerable to HIV 
infection.” All questions were asked on 5-point Likert type scales were higher scores indicated 
more feelings of HIV acquisition. The cognitive dimensions of perceived HIV risk subscale 
included the items “I am sure I will not get infected with HIV,” and “There is a chance, no 
matter how small, I could get HIV.” Responses for the cognitive dimension subscale were 
collected on a 5-point Likert type scale, 0 (strongly disagree) to 5 (strongly agree). The first item 
was reverse coded, such that a higher score indicated more cognitive dimensions of perceived 
HIV risk. A mean total on each subscale was calculated for each participant. With this sample, 
the internal consistency of the subscale was good for both affective dimensions of HIV risk 
(Cronbach's α = 0.72) and cognitive dimensions of HIV risk (Cronbach's α = 0.71). 
PrEP Measures. Before completing all PrEP measures, participants were provided with 
the following statement “PrEP (pre-exposure prophylaxis) is a biomedical strategy to prevent 
HIV infection. PrEP involved HIV-negative guys taking anti-HIV medications (for example, 
Truvada) once a day, every day to reduce the likelihood of HIV infection if they were exposed to 
the virus. Please note that PrEP is not the same as taking HIV medications for a brief period of 
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time (i.e., 28 days) after a high-risk exposure to HIV through encounters such as having sex 
without a condom. PrEP is intended for regular, long-term use.”  
PrEP stigma. To better understand how participants view others who use PrEP we asked 
eleven questions about PrEP stigma, a scale that was adapted from a scale measuring HIV stigma 
(Berger, Ferrans, & Lashley, 2001). Example items include “I think people should take PrEP,” 
“People who are on PrEP are irresponsible,” and “Many people on PrEP lie about whether or not 
they take it every day.” Response options were provided on a 5-point Likert scale 0 (strongly 
disagree) to 4 (strongly agree). Items that indicated positive views of PrEP were reverse coded, 
such that higher scores on this scale indicated more PrEP-related stigma. With this sample, the 
internal consistency of the scale was good (Cronbach's α = 0.79). 
Benefits of PrEP use. Participants were asked 12 questions about the importance of 
different factors in their decision making for PrEP use, which was recently published (John, 
Rendina, Starks, Grov, & Parsons, 2019), however created from multiple researchers previous 
work (Auerbach, Kinsky, Brown, & Charles, 2015; Ayala et al., 2013; Brooks, Landovitz, 
Regan, Lee, & Allen, 2015; Carlo Hojilla et al., 2015; Cohen et al., 2015; Flash et al., 2014; 
Gamarel & Golub, 2015; Grov et al., 2015; John, Whitfield, Rendina, Parsons, & Grov, 2018; H. 
L. King et al., 2014; Kubicek, Arauz-Cuadra, & Kipke, 2015; Liu, Hessol, et al., 2014; Mantell 
et al., 2014; Pérez-Figueroa, Kapadia, Barton, Eddy, & Halkitis, 2015; Underhill et al., 2015). 
Examples of questions include “Taking PrEP would mean I have more freedom to decide when 
to use and not use condoms,” “Taking PrEP would help me to feel less inhibited and ‘let go,’” 
and “Taking prep seems like the responsible thing to do.”  Response options were provided on a 
5-point Linkert scale ranging from 0 (not at all important) to 4 (extremely important). Possible 
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total scores range from 0-48, where higher scores indicating more perceived benefits to PrEP 
use. With this sample, the internal consistency of the scale was good (Cronbach's α = 0.85). 
Perceived PrEP candidacy. Participants were asked about their own perception of 
themselves as PrEP candidates (Gallagher et al., 2014; Parsons, Rendina, et al., 2017; Rendina et 
al., 2017). Participants were asked “Do you believe you are currently an appropriate candidate 
for PrEP?” with response options, “Yes, I am definitely an appropriate candidate for PrEP,” 
“Yes, I think I am an appropriate candidate for PrEP,” “I’m not sure if I am an appropriate 
candidate for PrEP,” “No, I don’t think I am an appropriate candidate for PrEP,” “No, I am 
definitely not an appropriate candidate for PrEP”. Responses were coded as a dichotomous 
variable where “Yes, I am definitely an appropriate candidate for PrEP” and “Yes, I think I am 
an appropriate candidate for PrEP” were coded as 1 (yes) and all other responses were be coded 
as 0 (no).      
PrEP intentions. In order to assess intentions to begin PrEP participants, were provided 
with a statement informing the participant that doctors are currently able to prescribe PrEP and 
asked if they begin to start taking PrEP. This statement and question have been used to assess 
intentions in previous research (Parsons, Rendina, et al., 2017; Rendina et al., 2017). 
Specifically, participants were provided the statement “PrEP is currently available with a 
prescription from your doctor, and research has shown that a majority of insurance companies 
cover most or all of the costs of PrEP,” followed by the question “Do you plan to begin PrEP?” 
Response options included “Yes, I will definitely begin taking PrEP,” “Yes, I will probably 
begin taking PrEP,” “I’m not sure – I might begin taking PrEP,” “No, I probably will not begin 
taking PrEP,” and “No, I definitely will not begin taking PrEP.” The variable was not distributed 
normally and therefore coded as an ordinal variable, 1 (No, I definitely will not begin taking 
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PrEP), 2 (No, I probably will not begin taking PrEP), 3 (I’m not sure – I might not begin taking 
PrEP), 4 (yes, I will probably being taking PrEP), and 5 (yes, I will definitely begin taking 
PrEP). 
Analytic Plan  
 I began by utilizing SPSS version 25 to explore differences in individual characteristics 
associated with the primary independent variables (i.e., affective dimensions of HIV risk, 
cognitive dimensions of HIV risk, perceived PrEP benefits, PrEP stigma). I first examined group 
differences between those who are 13-17 years of age and those 18-24 years of age. Although I 
did not expect there to be a difference between these two groups, I sought to understand how 
many individuals were under the age of 18 in the final sample. Other group differences explored 
included relationship status (partnered versus single), sexual orientation (gay, queer, bisexual), 
race (White, Black/African American/Afro Caribbean, Asian or other Pacific Islander, Native 
American or Alaskan Native, Multiracial, Other), ethnicity (Hispanic/Latino, yes/no), region 
(South, Northeast, West, Midwest, Other U.S. Territory/Military), recent STI diagnosis (yes/no), 
and recent drug use (yes/no). I utilized two-tailed t-tests to examine differences in ethnicity, 
relationship status, recent STI diagnosis, and recent drug use. Analyses of variances (ANOVA) 
were used to examine differences in race, sexual orientation, education, and employment. 
 To test all hypotheses in the second aim of this dissertation project, I utilized MPlus 7. 
Beginning with hypotheses 2a – 2d, path analysis was conducted to assess if age moderates the 
relationship between both affective and cognitive dimensions of HIV risk and perceived PrEP 
candidacy. The independent variables of the regression are affective and cognitive dimensions of 
HIV risk, age, and the interaction between both affective and cognitive dimensions of HIV risk 
and age.  All variables were centered on their grand mean, producing analytic variables with a 
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mean of 0. The interaction was created by multiplying the affective dimensions of HIV risk and 
age together after both variables had been mean-centered.  The dependent variable of the 
regression is the dichotomous variable PrEP candidacy.  All demographic variables were dummy 
coded and entered into the model simultaneously. If the interactions were significant, then 
moderation was supported. For all path analyses, I utilized the default maximum likelihood 
estimation with bootstrapped standard errors estimated from 10,000 draws.   
For hypothesis 2e and 2f, a path analysis utilizing MPlus 7 was run with both affective 
and cognitive dimensions of HIV risk as the independent variables, PrEP intentions as ordinal 
the dependent variable, and PrEP candidacy as the mediator. All other variables of interest were 
dummy coded and entered into the model simultaneously. I examined the direct effects of 
affective and cognitive dimensions of HIV risk on PrEP intentions, as well as the indirect effects 
of affective and cognitive dimensions of HIV risk on PrEP intentions, through PrEP Candidacy.  
Similarly, hypotheses 3a-3d were tested with the same moderation analysis technique as 
hypotheses 2a-2d, utilizing MPlus 7. For this model, the independent variables included benefits 
of PrEP use, PrEP stigma, age, and the interaction between both benefits of PrEP use and PrEP 
stigma with age. PrEP intentions was the dependent variable of the model. Additionally, all other 
variables of interest were dummy coded and entered into the model simultaneously. 
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CHAPTER SEVEN  
Results of the First Aim 
The first aim of this dissertation project was to examine whether age disparities for PrEP 
use exist among SMM, specifically to examine rather those who are under 24 years of age have 
less experience with PrEP than those who are 25 years of age and older. Further, I explored 
group differences between those who had experience with PrEP and those who did not for 
YSMM (13-24 years of age) and SMM (25 years of age and up). One such variable of focus is 
health insurance status, as I hypothesized those who are under 24 years of age and on their parent 
or guardian’s health insurance would have lower odds of having used PrEP compared to those 
who have their own insurance. Bivariate analyses were conducted first, and then two 
multinomial regression analyses predicting PrEP use (i.e., current, former, never) were run while 
controlling for all covariates. The first multinomial regression analyses examined these variables 
among only those 13-24 year of age, while the second examined the same set of variables among 
those 25 years of age and up.  
Demographic and Behavioral Characteristics 
 Table 1 presents the demographic and behavioral characteristic of the SMM included in 
the sample (N = 96,243). As can be seen in the table, the majority of the sample was White 
(63%). However, other races were well represented, with almost 40% identifying as people of 
color. A large majority of the sample was gay-identified (78.9%) as opposed to bisexual (18.7%) 
and queer (2.4%). Almost 70% of the sample reported being single. The geographic distribution 
of participants spanned across all regions of the U.S., with a larger proportion in both the South 
(34.4) and West (26.7%) compared to Northeast (19.7%) and Midwest (18.1%). Additionally, 
more than 1,000 participants (1.1%) were located in a U.S. territory or the military. 
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 The bivariate analysis presented in Table 1 resulted in statistically significant within-
group differences for PrEP uptake among all demographics and behavioral variables at the p < 
0.001 level. Among race, those who were American Indian or Alaskan Native, made up the 
smallest percentage of those who had never used PrEP (1.8%), those who were White made up 
the largest percentage of those who were current PrEP users (68.2%) and former PrEP users 
(60.6%).In terms of ethnicity, those who reported being Hispanic or Latino made up the smallest 
percentage of  never (25.1%), former (21.2%), and current PrEP users (27.2%). In terms of 
sexual orientation, those who identified as queer made up the smallest percentage of never 
(2.1%), current (3.2%), and former (4.5%) PrEP users, while those who identified as gay made 
up the largest percentage of never (76.3%), current (88.2%), and former (85.1%) PrEP users. 
Relationship differences in PrEP use also emerged, and those who reported being in a 
relationship made up the smallest percentage of those that never (29.5%) used PrEP, while those 
who reported being single made up the largest percentage of those that were current (64.6%) and 
former (68.6%) PrEP users. Regional differences showed that those who resided in the South 
made up the largest percentage of those who have never used PrEP (36.2%) and those in the 
West made up the largest percentage of both current (29.6%) and former (31.3%) PrEP users. 
Those who reported being on their partner’s insurance made up the smallest percentage of those 
that had never (2.0%) and formerly (2.3%) used PrEP, while those on their own insurance made 
up the largest percentage of those that are current PrEP users (82.7%). In terms of behavioral 
risk, those who had engaged in CAS with an HIV status unknown partner made up the largest 
percentages of never (80.3%), current (84.8%), and former (81.5%) PrEP users. Those had been 
diagnosed with an STI in the last 6 months made up the smallest percentage of never (8.4%), 
current (27.5%), and former (20.5%) PrEP users. In terms of substance use, those who used any 
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drug in the last 3 months made up the largest percentages of  never (59.0%), current (75.8%), 
and former (72.9%) PrEP use. Alcohol use was differently associated with PrEP use such that 
those who had 5 or more drinks in the past 3 months made up a larger percentage of never 
(61.5%), current, (64.8%), and former (65.7%) PrEP users.  
Hypothesis 1a 
 Table 1 displays the results of analyses for Hypothesis 1a, where I proposed that the 
percentage of those 24 years of age and under would have less experience using PrEP compared 
to the percentage of those 25 years of age and older. This hypothesis was supported. Bivariate 
analyses showed significant differences between age groups for those that reported never, 
current, and former PrEP use, (χ2 (10) = 3,086.34, p <0.001). The age group reporting the least 
current use were those 13-17 years of age (1.2%), followed by those 18-24 years of age (7.8%). 
Current PrEP use increased to 18.1% for those 25-34 years of age, continued to increase for 
those 35-44 years of age (23.0%), and then decreased to 21.5% for those 45-54 years of age, and 
18.5% for those 55 years of age and up. Former PrEP use followed a similar pattern with the 
lowest at 1.0% for those 13-17 years of age and highest at former use for those 25-34 years of 
age (7.6%). Both current and former PrEP use statistics result in a curvilinear trend where PrEP 
use increases with age, peaks, and then declines with age. The peak period is slightly different 
for the two PrEP use outcomes, such that the peak age for current use is higher than the peak age 
for former use. The relevance of this finding is discussed further in the discussion.  
Hypothesis 1b 
  Table 2 displays the results of analyses for Hypothesis 1b among YSMM, whereas Table 
3 displays the results of analyses Hypothesis 1b among adult SMM. There were many 
demographic factors I wanted to investigate among the two age groups. As such, for ease of 
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reading and comparison, I break the following findings into sections pertaining to each age 
group, and demographic variables explored. Due to the focus of this project, I first present the 
variables most closely associated with the developmental literature reviewed. 
Demographic associations of PrEP use among YSMM  
Beginning with sexual orientation, I hypothesized that those who identified as gay 
(compared to bisexual and queer) would be more likely to have current and former PrEP use, 
compared to never having used PrEP. I found partial support for this hypothesis. Those who 
identified as bisexual versus gay had lower odds of being a former (AOR = 0.45, p < 0.001) and 
current (AOR = 0.39, p < 0.001) PrEP user compared to never having used PrEP. Identifying as 
queer, compared to gay, was associated with higher odds of being a former PrEP user compared 
to never PrEP user (AOR = 1.45, p < 0.01). The differences between those who identify as gay 
and bisexual are significant at the 0.001 level. However, the difference between those who 
identify as gay compared to queer is only significant at the 0.01 level and therefore at risk of a 
Type 1 error with a sample size this large.  
I hypothesized that relationship status would also be associated with PrEP use history, 
such that those who were single (compared to in a relationship), would be more likely to have 
current and former PrEP use, compared to never having used PrEP. This hypothesis was partially 
supported. Among YSMM, those who were single, compared to in a relationship, had higher 
odds of being a former PrEP user compared to having never used PrEP (AOR = 1.26, p < 0.01). 
However, YSMM may stop using when they enter a relationship or are simply more likely to 
stop using PrEP due to other factors that impede continued use. Neither can be supported with 
this cross-sectional data. Further, this association is significant at the 0.01 level, but not at 0.001 
level, and as such, there is a risk of a Type I error with a sample size this large.  
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I then examined factors associated with behavioral risk. Beginning with recent 
engagement in CAS with an HIV status unknown partner, I hypothesized that those who had 
recent engagement in CAS with an HIV status unknown partner (compared to those who had 
not) would be more likely to have current and former PrEP use, compared to never having used 
PrEP. This hypothesis was not supported. Among YSMM, there were no significant differences 
in either former or current PrEP use for those who had engaged in CAS with an HIV status 
unknown partner compared to those who had not.  
 In terms of having had a recent STI diagnosis, I hypothesized that those who had 
received an STI diagnosis (compared to those who had not) would be more likely to have current 
and former PrEP use, compared to never having used PrEP. This hypothesis was supported. 
Among YSMM, those who had recently been diagnosed had higher odds of being both a former 
(AOR = 3.57, p < 0.001) and current (AOR = 4.77, p < 0.001) PrEP user compared to never 
having used PrEP.  
In terms of recent drug use, I hypothesized that those who had recent use of a recreational 
drug (compared to those who had not) would be more likely to have current and former PrEP 
use, compared to never having used PrEP. This hypothesis was supported. Having recently used 
a recreational drug was associated with higher odds of being both a former (AOR = 1.55, p 
<0.001) and current (AOR = 1.50, p < 0.001) PrEP use.  
Last, I examined the difference in PrEP use among YSMM of different races. I 
hypothesized that those who were White (compared to all other racial groups) would be more 
likely to have current and former PrEP use, compared to never having used PrEP. There was 
only one significant difference by race. Those who were categorized as “other” due to not 
identifying as any of the race options provided, had decreased odds (AOR = 0.61, p < 0.001) of 
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being a current PrEP user compared to those who were White. The remaining hypotheses 
regarding other men of color having lower experience with PrEP were not confirmed among 
YSMM. 
Demographic associations of PrEP use among SMM  
Beginning with sexual orientation, I hypothesized that those who identified as gay 
(compared to bisexual and queer) would be more likely to have current and former PrEP use, 
compared to never having used PrEP. This hypothesis was partially supported. SMM who 
identify as bisexual versus gay had lower odds of being either a former (AOR = 0.46, p < 0.001) 
or current (AOR = 0.36, p < 0.001) PrEP user compared to never having used PrEP. Identifying 
as queer compared to gay was associated with higher odds of being a former (AOR = 1.85, p < 
0.001) or current PrEP user (AOR = 1.37, p < 0.001) compared to never PrEP user.  
I hypothesized that relationship status would also be associated with PrEP use history, 
such that those who were single (compared to in a relationship), would be more likely to have 
current and former PrEP use, compared to never having used PrEP. This hypothesis was partially 
supported. Among SMM, those who were single, compared to in a relationship, had higher odds 
of being a current PrEP user (AOR = 1.08, p < 0.001). This finding suggests that once SMM 
begin a PrEP regimen, they may be less likely to stop using PrEP depending on relationship 
status (i.e., they may not stop using when they enter a relationship). 
Next, I examined behavior risk associations with PrEP use among SMM. Those who had 
engaged in recent CAS had higher odds of being a current (AOR = 1.48, p < 0.001) or former 
(AOR = 1.11, p < 0.01) PrEP user compared to never having used PrEP. Due to the sample size 
of this group, it is possible that at the 0.01 level a Type I error is being made and as such, the 
statistically significant differences between recent engagement in CAS and former versus never 
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having used PrEP should be interpreted with caution. Those who had recently been diagnosed 
had higher odds of being both a former (AOR = 2.36, p < 0.001) and current (AOR = 3.95, p < 
0.001) PrEP user compared to never having used PrEP. And SMM having recently used a 
recreational drug was associated with higher odds of being both a former (AOR = 1.78, p 
<0.001) and current (AOR = 2.11, p < 0.001) PrEP user compared to never having used PrEP.  
Last, I examined race among SMM and  hypothesized that those who were White 
(compared to all other racial groups) would be more likely to have current and former PrEP use, 
compared to never having used PrEP. I found partial support for this hypothesis. In terms of race 
difference among adult SMM and former PrEP use, compared to those who were White, only 
those who identified as Multiracial (AOR = 1.19, p < 0.001) had a statistically significant 
difference in PrEP use at the 0.001 level or below, such that they have increased odds of being a 
former user PrEP user compared to never having used PrEP. Compared to those who were 
White, those who identified as American Indian or Alaskan Native (AOR = 0.64, p < 0.001), and 
something other than the majority (AOR = 0.77, p < 0.001) had lower odds of being a current 
PrEP user compared to those that never used PrEP.  
Hypothesis 1c 
 Table 2 displays the results of analyses for Hypothesis 1c that YSMM on their parent’s 
insurance would have lower odds of being a former and current PrEP user compared to those on 
their own insurance. This hypothesis was supported. Individuals who had their own health 
insurance versus their parent or guardian’s had higher odds of being both a former (AOR = 1.26, 
p < 0.001) and current (AOR = 1.20, p <0.001) PrEP user.  
Other Significant Findings 
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 Although the above covers all of the hypothesized findings of the first aim of this 
dissertation, there are other findings that I think are important and should be noted. I stated in 
Hypothesis1a that those under 25 years of age would have less experience with PrEP use. This 
was supported by the findings and is presented in Table 1. However, age was entered in the age-
stratified regression models as a continuous variable. Results are displayed for YSMM in Table 
2. In the regression model for YSMM, age was positively associated with being a former PrEP 
user compared to never PrEP user (AOR = 1.23, p < 0.001), such that every increase of one year 
of age was associated with a 23% increase in the odds of being a former PrEP user. Similarly, for 
YSMM, age was positively associated with being a current PrEP user compared to never PrEP 
user (AOR = 1.31, p < 0.001), such that every increase of one year of age was associated with a 
31% increase in the odds of being a current PrEP user.  
In the regression model for adult SMM (Table 3), age was negatively associated with 
being a former PrEP user compared to never PrEP user (AOR = 0.99, p < 0.001), such that every 
increase of one year of age was associated with a 1% decrease in the odds of being a former 
PrEP user. The association between age and current PrEP use compared to never having used 
PrEP was not statistically significant for adult SMM (AOR = 1.00, ns).  
These differences in findings among the two stratified age groups are in line with the 
findings for PrEP use from the Rollins School of Public Health (AIDSvu.org, 2018; Siegler et 
al., 2018) and provide more evidence that there are different barriers to PrEP use for those that 
are younger. In order to increase uptake among YSMM , it is important to identify what those 
factors are impeding uptake and clearly diminish with age.  
Additionally, I did not have a hypothesis for the geographic location of the participants, 
however significant difference where reported. Among the regression model with YSMM, 
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compared to those living in the South, those living in the Northeast (AOR = 1.85, p < 0.001), and 
West (AOR = 1.49, p <0001) had higher odds of being a former PrEP user compared to having 
never used PrEP. Compared to those living in the South, those living in the Northeast (AOR = 
2.01, p < 0.001), and the West (AOR = 1.42, p <0.001) has higher odds of being a current PrEP 
user compared to a never PrEP user. Overall, there are significant regional differences across the 
U.S. for PrEP use among YSMM. This suggests that either access to PrEP or knowledge about 
PrEP is not evenly distributed across the country. Of particular concern are those who live in the 
South.  
Aim 1 Discussion 
 The first aim of this dissertation was to examine if age disparities for PrEP use exist 
among SMM, specifically to examine it those under 25 years of age have less experience with 
PrEP than adult SMM 25 years of age and older. These findings support that there were 
significant differences in PrEP use by age groups. Those under 25 years of age had the lowest 
percentage of current users, while the highest percentage was those 35-44 years of age. In the 
two multinomial regression models stratified by age, age was also associated with use, such that 
for YSMM, there was an increase of 31%in the odds of being a current PrEP user for each year 
of age. This magnitude of change was not anticipated and highlighted the extreme barriers to 
PrEP use that likely diminish with increases in age. Further, this highlights the need to fully 
explore and examine the differences in barriers that exist for those who are younger and at-risk 
for HIV seroconversion. These barriers are likely complex in nature and include biological, 
psychological, and social factors.  
I was also interested in examining how health insurance may be associated with 
beginning PrEP. YSMM who had their own insurance had higher odds of being both a current 
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and former PrEP user compared to those on their parent or guardian’s insurance. This suggests 
that access to insurance alone is not likely to increase uptake among this population if that access 
is through their parent or guardian. This could be due to sexual identity development and how 
open about their sexuality an individual is to their parents. If the individual is not open about 
their sexuality, they may not be comfortable utilizing the shared insurance to access a medication 
that is associated with sexual orientation. Helping YSMM to obtain PrEP without insurance, 
including those who do have insurance via their parent or guardian may be a key to increasing 
uptake.  
In terms of sexual orientation, those who identified as bisexual compared gay were less 
likely to be both current and former PrEP users among both the samples of YSMM and SMM. I 
had also hypothesized that those who identified as queer would have less experience with PrEP 
use than those who identified as gay. Among the sample of YSMM, this was incorrect and those 
who identified as queer had significantly higher odds of being a former PrEP user compared to 
those who identified as gay. In the sample of SMM, those who identified as queer have higher 
odds of both former and current PrEP use compared to those that identified as gay.  
The term queer is defined by the Merriam-Webster dictionary in multiple ways, 
“sometimes disparaging and offensive, of relating to, or characterized by sexual or romantic 
attraction to member’s of one’s own sex,” “of relating to, or characterized by sexual or romantic 
attraction that is not limited to people of a particular gender identity or sexual orientation,” “or, 
relating to, or being a person whose sexual orientation is not heterosexual and/or whose gender 
identity is not cisgender” (Merriam-Webster, 2019). In earlier LGBTQ history, queer was 
perceived as a negative term whereas more recent literature has shown that many younger people 
are reclaiming the term and proudly announcing their queer identity (Morandini, Blaszczynski, & 
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Dar-Nimrod, 2017). Some research has also shown that many people choose to identify as queer 
versus gay because identifying as queer is seen as a spectrum that could include sexual attraction, 
sexual behavior, gender identity, and gender presentation (Morandini et al., 2017). According to 
developmental literature (Erikson, 1959), identity development is extremely important and 
carried out over a period of time. Due to the more nuanced nature and political purposes of 
identifying as queer, it’s possible that those who identify as queer are more open to potential 
information that may be ignored by someone who identifies as gay and assumes information may 
not apply to them. Based on the ELM, those who identify as queer may be receiving a broader 
spectrum of information along the central path as opposed to the peripheral, thereby closely 
analyzing if that information pertains to them or not. As such, it may be possible that information 
on PrEP may enter the central processing pathways for those with more complex identities like 
queer. It’s also possible that those who identify as queer as coming out earlier than those who are 
gay and therefore able to access PrEP with fewer barriers. Further research would need to be 
done to confirm these theories, however understanding how those who identify as queer are 
gaining knowledge and access to PrEP differently than those who identify as bisexual and gay 
may inform interventions aiming to engage those at-risk for HIV and not taking PrEP.    
For both YSMM and adult SMM, a recent STI diagnosis was associated with higher odds 
of being a current and former PrEP user. These AORs are large within the stratified age groups 
and suggest that testing positive for an STI can actually be a protective factor to HIV acquisition 
by increasing PrEP uptake among those vulnerable. It is also possible that receiving an STI 
positive result leads to PCPs recommending PrEP to their patients, or a patient is more interested 
in PrEP use for prevention due to the increased risk perception.     
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Recent CAS with an HIV unknown status partner was not significantly associated with 
PrEP use for YSMM but was associated with current use for adult SMM. This difference 
between age groups may have to do with risk perception. As presented in the HBM, perceived 
susceptibility should be positively associated with health-promoting behavior. Engagement in 
CAS with unknown partners may be perceived as increasing susceptibility for adult SMM, but 
not for YSMM. In the second aim, I will examine how developmental factors may explain some 
differences in YSMM perception of oneself as a PrEP candidate. Specifically, I will examine the 
role of affective and cognitive dimensions of HIV risk as associated with perceived PrEP 
candidacy, and moderated by age, among YSMM at risk for HIV acquisition. Additionally, in the 
second aim, I will examine social factors associated with development and intentions to begin 
taking PrEP. Specifically, the role of individual perceived benefits of PrEP use and perceived 
PrEP stigma as associated with intentions to begin taking PrEP and moderated by age.    
Together, these findings from the first aim suggest that PrEP use may be less likely for 
YSMM, men of color, those on their parent or guardian’s insurance, and those who identify as 
bisexual. Further, testing positive for an STI may actually be protective against HIV for some, as 
it increases the odds of beginning a PrEP regimen. The results from this aim and the following 
will help us to understand better what the strongest barriers may be that impede YSMM from 
beginning PrEP, and inform future interventions aimed at increasing uptake among those at-risk.  
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CHAPTER EIGHT  
Results of the Second Aim 
The second aim of this dissertation was to identify relevant developmental factors that 
may help to increase two primary hypothesized precursors to PrEP uptake (i.e., PrEP 
acceptability, and PrEP intentions) among HIV at-risk YSMM (16-24 years of age). Unlike the 
first aim of this project, the second only consists of participants that were enrolled in the final 
cohort of the longitudinal study, and as such, 16 is the lowest age available in this sample for 
inclusion in the analyses. These hypotheses were developed to understand better how decisions 
around PrEP uptake are made for this HIV at-risk and non-PrEP utilizing population. Further, 
these hypotheses were designed to investigate how specific psychological constructs pertaining 
to ‘hot’ and ‘cold’ processing may differently affect the perception of HIV risk and PrEP 
intentions. As mentioned previously, all models were adjusted for the impact of demographic 
and behavioral variables associated with PrEP use, which were previously explored in the first 
aim.  
Demographic Characteristics 
 Table 4 presents the demographic characteristics of the 2,003 HIV at-risk YSMM who 
were enrolled in the final UNITE cohort. As can be seen in the table, the majority of the sample 
was between 18 and 24 years of age (96.1%), white (57.5%), identified as gay (79.7%), and 
single (81.9%). Both employment and geographic region were relatively evenly distributed 
among the different categories. This sample was utilized for all analyses pertaining to hypotheses 
2a-2f and hypotheses 3a-3d.   
Correlations and Bivariate Analyses among Variables of Interest for Hypotheses 2a-2f 
The variables of interest for the first set of hypotheses include age, affective dimensions 
of HIV risk, cognitive dimensions of HIV risk, perceived PrEP candidacy, and PrEP intentions. 
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The bivariate analyses in Table 4 and correlations presented in Table 5 should be interpreted 
with caution as the sample size is large and many of these correlations may be statistically 
significant yet not meaningful in their amount of variance accounted for. As such, a Bonferroni 
correction was conducted post-hoc, and regardless of statistical significance, only those that have 
at least a small effect size of 0.2 are presented here and discussed elsewhere (Bonferroni, 1936).  
In Table 5, Affective dimensions of HIV risk was positively correlated with cognitive 
dimensions of HIV risk (r = 0.58, p < 0.001) and perceived PrEP candidacy was positively 
correlated with PrEP intentions (r = 0.37, p < 0.001).  All results of the bivariate analyses for the 
independent variables of interest for hypotheses 2a-2f are presented in Table 4, Significant 
differences in mean scores for affective dimensions of HIV risk were observed such that those 
who were single (M = 3.24, SD = 0.72) compared to partnered (M = 3.06, SD = 0.80) also 
reported higher affective dimensions of HIV risk, t = 4.05, p < 0.000; d = 0.24. Lastly, compared 
to those who had not recently been diagnosed with an STI (M = 3.18, SD = 0.73), those who had 
been recently diagnosed (M = 3.37, SD = 0.76) reported higher affective dimensions of HIV risk, 
t (2001) = 4.14, p < 0.001; d = 0.25.  
Hypothesis 2a 
 Results for this hypothesis are displayed in Table 6 and Figure 6. Hypothesis 2a was that 
affective dimensions of HIV risk would be positively associated with perceived PrEP candidacy. 
I found support for this hypothesis in the fully adjusted model. The fully adjusted model showed 
a conditional main effect of affective dimensions of HIV risk on perceptions of PrEP candidacy 
(AOR = 1.44, p < 0.001), such that for every increase of one unit of affective dimensions of HIV 
risk, there was an increase of the odds of self-identifying as a PrEP candidate by 44%. 
Hypothesis 2b 
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 In Hypothesis 2b, I stated that cognitive dimensions of HIV risk would be positively 
associated with perceived PrEP candidacy. I did not find support for this hypothesis in the fully 
adjusted model (AOR = 0.92, p = ns).  
Hypothesis 2c 
 In Hypothesis 2c I stated that age would moderate the association between affective 
dimensions of  HIV risk and perceived PrEP candidacy such that for every one-year unit increase 
in age, the association between affective dimensions of HIV risk and perceived PrEP candidacy 
weakened. This hypothesis was not supported. Results indicated the association between 
affective dimensions of HIV risk and PrEP candidacy was stronger at higher levels of age (AOR 
= 1.10, p < 0.05), as displayed in Figure 6, Table 6, and the interaction plot Figure 7. It is worth 
noting this interaction was conditional upon a main effect of age in predicting perceiving PrEP 
candidacy (AOR = 1.11, p < 0.001) such that for every increase in one year of age there is an 
increase of 11% in the odds of perceiving oneself as a PrEP candidate.  
Hypothesis 2d 
In Hypothesis 2d I stated that age would moderate the association between cognitive 
dimensions of HIV risk and perceived PrEP candidacy such that as age increased, the association 
between cognitive dimensions of HIV risk and perceived PrEP candidacy strengthened. This 
hypothesis was not supported. The interaction of cognitive dimensions of HIV risk and age was 
not significant (AOR = 0.97, p = ns).  
Hypothesis 2e 
 In Hypothesis 2e, I stated that there would be an indirect effect of the affective 
dimensions of HIV risk on intentions through perceived PrEP candidacy, but no direct effect. 
There was a direct effect of perceived PrEP candidacy on PrEP intentions (AOR = 3.56, p < 
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0.001). There was also a direct effect of the affective dimensions of HIV risk on intentions (AOR 
= 1.35, p < 0.001), and a statistically significant indirect effect of affective dimensions of HIV 
risk on intentions via PrEP candidacy (AOR = 0.46, 95% CI = 0.24, 0.68). As such, mediation 
was supported, as displayed in Figure 6.  
Hypothesis 2f 
In Hypothesis 2f, I stated that there would be an indirect effect of the cognitive 
dimensions of HIV risk on PrEP intentions through perceived PrEP candidacy, but no direct 
effect. There was also a direct effect of the cognitive dimensions of HIV risk on intentions (AOR 
= -0.20, p <0.05), and a statistically significant indirect effect of cognitive dimensions of HIV 
risk on PrEP intentions (AOR = -0.01, 95% CI = -0.33, 0.10). As such, mediation was supported, 
as displayed in Figure 6.   
Correlations among Variables of Interest for Hypotheses 3a-3d 
 Analogous to the correlations and bivariate analyses for presented for hypotheses 2a-2f, a 
Bonferroni correction was conducted post-hoc, and regardless of statistical significance, only 
those that have at least a small effect size of 0.2 are presented here and discussed elsewhere 
(Bonferroni, 1936). Table 5 displays the correlations among variables of interest for this set of 
hypotheses; however, none met the above-stated effect size. These variables include age, 
perceived benefits of PrEP use, and PrEP stigma.   
Results of the bivariate analyses for the independent variables of interest for hypotheses 
3a-3d are presented in Table 7. Beginning with perceived benefits of PrEP use, only those who 
had recently been diagnosed with an STI (M = 3.67, SD = 0.68) compared to those who hadn’t 
(M = 3.51, SD = 0.70) reported more benefits to PrEP use, t (2001) = 3.83, p < 0.01; d = 0.23.  
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In terms of PrEP stigma,  individuals who reported their race as White (M = 2.19, SD = 
0.53) reported lower PrEP stigma compared to all other groups, including American Indian or 
Alaskan Native (M = 2.23, SD = 0.50), multiracial (M = 2.26, SD = 0.57), Asian and other 
Pacific Islander (M = 2.31, SD = 0.53), and those who reported the highest, Black (M = 2.35, SD 
= 0.55) men and individuals who were of another race outside of the options provided  (M = 
2.38, SD = 0.56; F [5,1997] = 6.79, p < 0.000; d = 0.28). Those who reported their sexual 
orientation as bisexual (M = 2.34, SD = 0.55), compared to both gay (M = 2.22, SD = 0.54) and 
queer (M = 2.13, SD 0.54), also reported more PrEP stigma, F (2, 2000) = 8.14, p < 0.001; d = 
0.23. Compared to those with some college (M = 2.21, SD = 0.54) and a 4-year college degree or 
more (M = 2.22, SD = 0.53), those with some high school/GED or less (M = 2.32, SD = 0.57) 
reported more PrEP stigma, F (2, 2000) = 7.13, p < 0.001; d = 0.20. Lastly, those on their 
parents’/guardians’ insurance (M = 2.18, SD = 0.52) reported lower PrEP stigma than those on 
their own (M = 2.26, SD = 0.55), without insurance (M = 2.31, SD = 0.58), and those who are on 
their partner’s (M = 2.41, SD = 0.55) reporting more than all others, F (3, 1999) = 6.46, p <0.01; 
d = 0.32.   
Hypothesis 3a  
 Table 8 displays the full results of analyses, while Figure 8 displays the significant 
associations between the variables. In Hypothesis 3a, I stated that PrEP stigma would be 
negatively associated with PrEP intentions. I found support for this hypothesis. The fully 
adjusted model showed a direct effect of PrEP stigma on PrEP intentions (AOR = 0.81, p < 
0.05), such that for every increase of one unit of PrEP stigma, there was a 19% decrease of the 
odds of a one-unit increase in PrEP intentions.  
Hypothesis 3b  
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In Hypothesis 3b, I stated that the perceived benefits of PrEP use would be positively 
associated with PrEP intentions. I found support for this hypothesis. The fully adjusted model 
showed a conditional main effect of perceived benefits of PrEP use on PrEP intentions (AOR = 
2.15, p < 0.000), such that for everyone one unit increase in perceived benefits of PrEP resulted 
in a 115% increase in the odds of a one-unit increase in PrEP intentions.  
Hypothesis 3c  
 In Hypothesis 3c, I stated that age would moderate the association between PrEP stigma 
and PrEP intentions such that as age increases, the association between PrEP stigma and PrEP 
intentions weakens. There was no conditional main effect of age on PrEP intentions (AOR = 
0.02, ns). However, there was an interaction effect (Figure 9) between age and PrEP stigma, such 
that as age increased, the effect of PrEP stigma on PrEP intentions weakened (AOR = 0.93, p < 
0.05). Additionally, this resulted in AOR = 0.74, a 26% decrease in the odds of being highest on 
PrEP intentions versus lowest.  
Hypothesis 3d  
 In Hypothesis 3d I stated that age would moderate the association between PrEP 
perceived benefits of PrEP use and PrEP intentions, such that as age increases, the association 
between perceived benefits of PrEP use and PrEP intentions strengthens. There was no 
conditional direct effect of age on PrEP intentions (AOR = 0.02, ns). However, there was an 
interaction effect (Figure 10) between age and perceived benefits of PrEP use. As age increased, 
the effect of perceived benefits of PrEP use on PrEP intentions strengthened (AOR = 0.07, p < 
0.05).     
Aim 2 Discussion 
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 The second aim of this dissertation project was to test developmental differences among 
YSMM that may help to explain disparities in PrEP use that were presented in the outcomes of 
the first aim. Specifically, I sought to understand the role of development in psychological 
processes that may impact the perception of self as a PrEP candidate and intentions of PrEP use.  
 I first tested my hypotheses that affective dimensions of HIV risk and cognitive 
dimensions of HIV risk would be differently associated with the perception of PrEP candidacy 
by age. I expected that affective dimensions of HIV risk would be positively associated with 
PrEP candidacy, and this association would weaken at higher ages. I also expected that cognitive 
dimensions of risk would be positively associated with PrEP candidacy, but that this association 
would strengthen at higher ages. These hypotheses were constructed based on dual-processing 
and developmental literature that suggests those who are younger would be utilizing more 
affective processing compared to those who are older and integrating more cognitive processing. 
Based on Erikson’s theory (1959), this sample contains individuals in the identity versus role 
confusion and intimacy versus isolation stages of development. With that in mind, I expected 
that as individuals age, they begin utilizing more cognitive processing and making decisions that 
could potentially result in more identity solidification and intimacy. Results indicated that 
affective dimensions of HIV risk were positively associated with the perception of PrEP 
candidacy. However, the cognitive dimensions of HIV risk were not significantly associated with 
the perception of PrEP candidacy. The interaction between affective dimensions of HIV risk and 
PrEP candidacy was opposite of my hypothesis and became stronger at higher ages.  
For many SMM, fear of HIV may contribute to a form of cognitive dissonance where 
they do not view their sexual behaviors as risky but are rather moved to the perception of 
potential HIV transmission based on affective fear of HIV. As such, they may not be accurately 
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assessing their own risk behaviors, but rather relying on their instinct or emotion (i.e., affective 
response). Additionally, during this period of development, individuals may be struggling with 
obtaining intimacy, and there for the drive for intimacy may override their cognitive thought 
processes that suggest their behavior is risky. For example, if an individual has fears that 
changing their sexual risk behavior will lead to a lesser likelihood of obtaining intimacy, the 
affective yearning for intimacy may be increasingly impactful in their self-perception of risk and 
lead to a decrease in risk perception.      
 Next, I tested my hypotheses that perceived PrEP candidacy would mediate the 
associations between the affective and cognitive dimensions of HIV risk and intentions to begin 
a PrEP regimen. As expected, PrEP candidacy was significantly positively associated with PrEP 
intentions, suggesting that individuals have increased odds of intentions to begin PrEP when they 
first see themselves as candidates for PrEP. However, mediation was neither supported for the 
affective nor cognitive dimensions of HIV risk. Affective dimensions of HIV risk were till 
significantly positively associated with PrEP intentions through PrEP candidacy, and cognitive 
dimensions of risk was significantly negatively associated with PrEP intentions through 
perceived PrEP candidacy. These results indicate that the affective decision making may actually 
lead to more PrEP uptake, whereas cognitive decision making around risk may lead to decreased 
PrEP uptake. This suggests that interventions, which use cognitive-based evidence of risk to 
increase uptake, may not be as effective as interventions that target affect for at-risk individuals. 
One explanation for these findings is potentially stigma around PrEP use. This will be discussed 
further in the conclusions.   
 The final set of analyses included examining the association between two variables 
believed to change during development, and PrEP intentions. These variables were PrEP stigma 
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and perceived benefits of PrEP use. Developmental literature suggests that as individuals age, 
their decision making is more strongly associated with individual perceived benefits of the 
outcome, whereas decision making when an individual is younger is more strongly associated 
with avoiding potential negative outcome from peers (e.g., stigma) (Arnett, 2000; Erikson, 1959; 
Gerrard et al., 2008). As such, I hypothesized that as age increases, the association between PrEP 
stigma and PrEP intentions would weaken, whereas the association between perceived benefits 
of PrEP use and PrEP intentions would strengthen by increases in age. These hypotheses were 
supported by the findings from these analyses. In the fully adjusted model, age alone was not 
associated with PrEP intentions; however, PrEP stigma and the interaction between PrEP stigma 
and age were both significantly negatively associated with PrEP intentions. I had expected that 
as age increased, PrEP stigma would be less associated with PrEP intentions, and this association 
did weaken. Further, as expected, both benefits of PrEP use and the interaction between the 
benefits of PrEP use and age were significantly positively associated with PrEP intentions. This 
suggests that as age increases, an individual who is at risk for HIV may perceive more benefits to 
PrEP use, and thereby have higher intentions to begin taking PrEP. To increase PrEP uptake 
among at-risk YSMM, it may be important for providers to explore the benefits of PrEP use with 
the patient, while simultaneously attempting to destigmatize the use of the medication.  
 Together, these two studies provide valuable insight into the psychological mechanisms 
that impact YSMM’s decision to begin taking PrEP. Many of these findings were unexpected 
(e.g., affective risk being more strongly associated with intentions); however, they shine a light 
on the importance of developmental stage, and emotion and decision making for this at-risk 
population. Similarly, PrEP stigma may affect decision making around an individual’s health 
more when younger, but also continue into adulthood.        
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CHAPTER NINE  
Discussion 
In the following chapter, I provide a brief overview of the relevance of this research area, 
the theoretical framework for the hypotheses of this dissertation, and key findings. I then closely 
examine findings within each of the two studies and explain why I believe some of my 
hypotheses were supported, while others were unsupported. Additionally, I present mental 
health, medical, and social implications of this work and how these findings can be used to 
inform future interventions aiming to increase PrEP use among YSMM at-risk for HIV 
seroconversion. Lastly, although there are many strengths to this work, the limitations cannot be 
ignored, and are briefly discussed.  
Background, Hypotheses, and Key Findings   
YSMM are at high risk for HIV seroconversion and make up 92% of all new HIV 
infections among men in their age group (CDC, 2018b). PrEP was approved by the USFDA in 
2012 (CDC, 2012), and much research has focused on how to increase uptake among adult SMM 
(Ayala et al., 2013; Bauermeister, Meanley, Pingel, Soler, & Harper, 2013; Galea et al., 2011; 
Gallagher et al., 2014; Golub et al., 2013; Grov et al., 2015; King et al., 2014; Mimiaga, Case, 
Johnson, Safren, & Mayer, 2009; Mustanski et al., 2013; Parsons et al., 2017; Rendina et al., 
2017; Smith, Toledo, Smith, Adams, & Rothenberg, 2012). However, more recently, PrEP has 
been approved for all individuals at-risk and meeting the bodyweight requirement (NICHD, 
2018), and little research has focused on the unique barriers YSMM may face when attempting 
to begin a PrEP regimen. Past research models predicting PrEP uptake have identified self-
perception as a PrEP candidate and having PrEP intentions as important precursors to PrEP 
uptake (Kelley et al., 2015; Nunn et al., 2017; Parsons, Rendina, et al., 2017). These models are 
supported by both the HBM (Becker, 1974) and TPB (Ajzen, 1991), such that an individual must 
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view oneself as at-risk for a negative health outcome (i.e., perception of themselves as a PrEP 
candidate), and have intentions to change a behavior, before steps are taken to enact a behavior 
change.  
Affective ‘hot’ processing and ‘cold’ cognitive processing are two components of 
decision making, and may play different roles in how younger versus older individuals make 
decisions (Barrouillet, 2011a; Chaiken & Trope, 1999; Metcalfe & Mischel, 1999; Sloman, 
1996; Slovic, Finucane, Peters, & MacGregor, 2004). Affective ‘hot’ processing is automatic and 
often an outcome of emotions or feelings, whereas ‘cold’ processing is more controlled and 
includes conscious processing. Although these processing systems theoretically exist 
independently from each other, they work simultaneously and together in decision making. ‘Hot’ 
processing is considered to be more primal, whereas ‘cold’ processing is strengthened during 
development over time (Metcalfe & Mischel, 1999). As such, these two processes are likely 
differently associated with decisions pertaining to PrEP use for YSMM compared to adult SMM. 
 The developmental literature reviewed for this dissertation suggests there are many 
different stages and eras of the lifespan.  However, much of this literature agrees that when an 
individual is younger, they are more likely to be swayed by societal pressures and fears of 
negative societal consequences, whereas they become more concerned with individual benefits 
as they age (Arnett, 2000; Erikson, 1959, 1980; Levinson, 1978, 1986). For YSMM, the 
decreasing stigma associated with PrEP use may be an important key in understanding how to 
increase PrEP use among HIV at-risk YSMM, whereas examining individual benefits may be 
less helpful.  
The primary aims of this dissertation were to examine age disparities in PrEP uptake 
among SMM, test a model of ‘hot’ and ‘cold’ processing in risk perception and the primary 
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precursors to PrEP uptake (i.e., perception of PrEP candidacy and PrEP intentions), and test a 
model of individual benefits and social risks associated with PrEP intentions.  
 In order to accomplish these aims, I utilized data collected as part of a larger study (i.e., 
parent project, UNITE). The first aim was accomplished using data collected during recruitment 
into the parent project via an online survey. I conducted a series of multinomial regression 
models with PrEP uptake (i.e., never, former, current) as the primary outcome, while stratified by 
age and adjusting for potential covariates. To accomplish the second aim, I used data collected 
during the baseline assessment of the parent project. In the second aim, I conducted two path 
analyses. In the first model, I tested the associations between affective and cognitive dimensions 
of HIV risk and perceived PrEP candidacy, moderated by age, and then I tested the association 
between affective and cognitive dimensions of HIV risk on PrEP intentions, through PrEP 
candidacy. In the last model, I tested the associations between perceived benefits of PrEP use 
and PrEP stigma on PrEP intentions, moderated by age.  
Results from these analyses supported eight of my thirteen hypotheses. In the first aim, I 
examined PrEP use among two age groups of sexual minority individuals, YSMM (13-24 years 
of age) and SMM (25 years of age and older). I first utilized a regression model for YSMM and 
found that age was positively associated with former and current PrEP use, such that every 
increase of one year of age was associated with an increase of 31% in the odds of being a current 
PrEP user compared to never having used PrEP. In the second regression model for SMM, age 
was negatively associated with former PrEP use compared to never have used PrEP, and age was 
not significantly associated with current PrEP use compared to never having used PrEP. This 
difference in the association of age and PrEP use suggests that there are many barriers to use that 
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dissolve with increases in age and in order to intervene on these barriers, it is imperative that 
these barriers are explored further.  
Along with age, I also examined many other demographic and behavioral variables 
predictors in the two age-stratified models. Lastly, I found support for my hypothesis that even 
while adjusting for age, YSMM who are on their parent guardian’s health insurance had lower 
odds of having experience using PrEP, compared to those that are on their own insurance. These 
findings pertaining to health insurance suggest that for YSMM, just having health insurance may 
not mean more access to PrEP. This is likely a prime area for clinical, medical, and public health 
interventions aiming to increase uptake, all of which are discussed in detail below. 
The findings for the second aim varied most from my hypotheses. Perception of affective 
and cognitive dimensions of HIV risk were significantly associated with the perception of PrEP 
candidacy. However, the age interaction was statistically significant, but in the opposite direction 
of what I hypothesized for affective dimensions of HIV risk, and not statistically significant in 
the cognitive risk association. As age increased, the association between affective dimensions of 
HIV risk and the perception of self as a PrEP candidate strengthened. Further, in these models, 
perception of PrEP candidacy only partially mediated the associations between affective and 
cognitive dimensions of HIV risk and PrEP intentions. These findings were the most surprising 
and are not consistent with the literature reviewed for this dissertation project. According to 
Metcalfe and Mischel (1999), an affective ‘hot’ response to stimuli should weaken as an 
individual develops, and ‘cold’ cognition becomes more consciously accessed. Similarly, the 
ELM (Petty & Cacioppo, 2012) states that as an individual develops, they begin more frequently 
accessing a more central route to processing for important decision making. Although I 
anticipated that both affective and cognitive dimensions of HIV risk would be associated with 
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the perception of oneself as a PrEP candidate, applying these dual-processing theories to these 
new areas, I hypothesized that affective dimensions of HIV risk should have weakened as age 
increased, and cognitive dimensions of HIV risk should have strengthened as age increased. The 
data suggest that having a higher affective perception of HIV risk may lead to higher perceived 
PrEP candidacy and intentions to begin PrEP. I theorize an explanation for these findings and the 
many clinical implications below.   
Unlike the first part of my second aim, I found support for almost all of my hypotheses in 
the second. I found conditional main effects for both benefits of PrEP use and PrEP stigma on 
PrEP intentions in the fully adjusted model, including the interaction variables. As expected, 
perceived benefits of PrEP use were positively associated with PrEP intentions, and that 
association became stronger with increased age. These findings suggest that as YSMM age, their 
intentions to begin taking PrEP are guided by both their perceived benefits of use and also by 
perception of stigma associated with use. PrEP stigma was negatively associated with PrEP 
intentions, and this association became weaker with increased age.   
Taken together, the findings of these studies suggest that in order to increase PrEP uptake 
among HIV at-risk YSMM, there are access and developmental barriers that must be overcome. 
These barriers are likely different for adult SMM, making current intervention models targeting 
adult populations potentially ineffective in increasing uptake among YSMM.  
One such barrier is access to PrEP without health insurance, or without having to use the 
health insurance of a parent or guardian. In terms of identity development, even if an individual 
has accepted their sexual identity, they may not have yet reached a point to where they are 
willing or able to inform others of their sexual orientation. The process of coming out can be a 
long and difficult one, and some YSMM may view this as a barrier they are unwilling or unable 
 103 
to overcome. Allowing such individuals to access the medication either for free or without the 
use of their parent/caregiver's health insurance, may lessen this barrier and thereby increase 
uptake.   
Another potential barrier for YSMM is ‘hot’ and ‘cold’ processing of HIV risk. My 
findings suggest that affective ‘hot’ processing may be more highly associated with PrEP 
intentions through PrEP candidacy than cognitive ‘cold’ processing. This could be a barrier to 
uptake as many YSMM may rely on how they are feeling in the moment, as opposed to critically 
assessing their sexual risk behavior. Dimensions of HIV risk associated with PrEP use may also 
be subconsciously connected with HIV acquisition, and therefore, responses triggered 
affectively. The stigma of PrEP use may also affect dimensions of risk, which is discussed 
further below. One other potential explanation for my findings is that my model did not test a 
moderation term of age, affective, and cognitive dimensions of risk as a predictor. The addition 
of this term in the model may explain more of the associations.   
Lastly, perceived individual benefits and social costs were associated differently with 
PrEP intentions. These findings suggest that individual benefits increased as age increased, while 
PrEP stigma decreased as age increased. The stigma associated with PrEP use is discussed in 
more detail below. In order to increase PrEP use among YSMM, it may be helpful to guide them 
towards viewing more perceived benefits while simultaneously extinguishing stigma around use. 
These findings and themes are discussed in further detail in the following sections.   
Study 1: PrEP Use among YSMM 
 The first aim of this dissertation was to examine if age disparities in PrEP use exist 
among SMM. Specifically, I aimed to examine if those who are 24 years of age and younger 
have less experience with PrEP than those who are older. I tested a series of hypotheses that, if 
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true, would support the idea that current interventions used to increase uptake among adult SMM 
may need modification to incorporate the unique barriers YSMM face. In my first hypothesis, I 
stated that those who are under 25 years of age would have lower odds of PrEP use experience 
compared to those who are older. I also made several hypotheses about demographic and 
behavioral risk differences that would be associated with PrEP use among both age groups. Last, 
I hypothesized that those who were under 25 years of age and on their parent or guardian’s 
health insurance would have lower odds of PrEP use. Results from these analyses largely 
supported these hypotheses.  
 PrEP use among YSMM was lower than all other age groups. Bivariate analyses revealed 
that both current and former PrEP use percentages were higher among higher age groups. 
Current PrEP use was highest at 22% for those 35-44 years of age and then began to decline. 
These findings show a curvilinear association, where increased odds of PrEP use were associated 
with increased age, reaching its highest around the late thirties and early forties, then declines. 
For those under 18 years of age, just over 1% reported current PrEP use, and just under 1% 
reported former PrEP use. This provides further evidence that some individuals under 18 years of 
age have been able to access PrEP even before approval by the USFDA for that age group. Due 
to the USFDA restrictions that were in place when this data was collected, it logically makes 
sense that those under 18 years of age would have less experience with PrEP use. However, 
when data was collected, PrEP was already available for those between 18 and 24 years of age, 
and this age group made up the smallest percentage of users (7.4%). This signifies that approval 
of PrEP use alone does not necessarily increase uptake. Further, this is a strong indication that 
PrEP is not being accessed by this highly at-risk population, and that current PrEP promotions 
for this demographic are failing. 
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The full multivariable models told a similar story. For YSMM, older age was associated 
with odds of being both a former and current PrEP user. This could be due to many factors, 
including an increase in sexual risk behaviors, sexual education, knowledge of PrEP, and access 
to PrEP. In my analysis, I adjusted for sexual risk. However, I did not measure sexual education, 
PrEP knowledge, or access to PrEP, all of which have been shown to impact PrEP use (Closson 
et al., 2019; Doblecki-Lewis et al., 2017; Parsons, Rendina, et al., 2017; Strauss et al., 2017).  I 
also found that in the sample consisting of individuals 25 years of age and older, age was not 
associated with odds of current PrEP use compared to never having used PrEP. However, age 
was negatively associated with former PrEP use compared to never, and positively associated 
with current use compared to former use. There may be barriers to initiating PrEP use that are 
more easily overcome for adult SMM, and thereby making the continuation of a regimen easier 
(Doblecki-Lewis et al., 2017). Erikson’s (1959), Levinson’s (1986), and Arnett’s (2000) 
developmental theories suggest that as individuals enter adulthood, they have more stability, 
including steady employment and income, and logically, thereby health insurance. These factors 
likely increase PrEP feasibility and make long term use more appealing as a way of increasing 
stability in sexual health.  
 There were many demographic and behavioral differences shown to be associated with 
higher odds of current PrEP use. For YSMM, fewer demographic variables emerged as 
significantly associated with current PrEP use. However, for adult SMM, there were many more. 
This could be due to the multiple barriers that YSMM face when accessing PrEP, which are 
beyond personal characteristics, and explored further in Study 2. In terms of race, only those who 
identified as something other than the options presented were significantly less likely to be a 
current user compared to White YSMM. Among adult SMM, many race differences were 
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apparent with those who identified themselves as Black, American Indian or Alaskan Native, 
Multiracial, or other, having lower odds of current PrEP use compared to individuals who 
reported being White. Together, these findings suggest that as age increases the disparities 
between PrEP use and race emerge, and if overall uptake of PrEP increased among YSMM, 
those disparities may also emerge. Sexual minority individuals who are White have a lower rate 
of HIV acquisition compared to people of color (CDC, 2018a). However, those who are White 
make up almost 70% of all PrEP users (Ya-lin, Zhu, Smith, Harris, & Hoover, 2018). Disparities 
in use are likely an outcome of both access (e.g., health insurance, cost, provider) and social 
stigma. It is important that PrEP is made available to all racial and ethnic individuals at-risk. 
Potential options for increase uptake among racial populations at-risk is discussed further below.  
 Differences in sexual orientation also appeared. Among YSMM, compared to those that 
had never used PrEP, those who identified as bisexual had lower odds of being a former or 
current PrEP user than those who identified as gay. Oppositely, those who identified as queer 
had higher odds of being a former PrEP user. Trends were similar for adult SMM, however 
among this group, identifying as queer was also associated with higher odds of being a current 
PrEP user. There may be generational differences in sexual orientation identification. For 
example, “queer” was presented as a sexual orientation option in this study, and research on 
sexual identity has suggested that identifications have become more diverse in recent years, 
leading to an increase in identities outside of gay, and bisexual (Watson, Wheldon, & Puhl, 
2019). Having a queer identity is perceived as a spectrum that includes sexual attraction, sexual 
behavior, gender presentation, and gender identity, making the identity far more complex and 
nuanced then identifying as gay. Those who identify as queer may be involved in various aspects 
of LGBTQ life, thereby presenting them with more opportunities to gain knowledge about PrEP. 
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Similarly, due to having a more nuanced sexual/gender identity, identifying as queer may 
broaden their spectrum of information or products that apply directly to them. In the literature 
review for this project, I was unable to find other research that directly addressed PrEP 
difference among those who identify as queer and gay. In this sample, identifying as queer was a 
protective factor and was associated with more PrEP use. Conversely, identifying as bisexual 
was associated with less PrEP use. Some research has shown that knowledge of PrEP and actual 
PrEP use is lower among men who identify as bisexual (Hammack, Meyer, Krueger, Lightfoot, 
& Frost, 2018; Holloway, Dougherty, et al., 2017; Okafor, Gorbach, Ragsdale, Quinn, & 
Shoptaw, 2017). Those who identify as bisexual may view PrEP as something that is only for 
gay men, and therefore not appropriate for them. This is discussed further below in the 
implications for PrEP uptake.  
In terms of geographic location, access to PrEP may not be the same for all adolescents. 
YSMM who lived in the South had significantly lower odds of being a current PrEP user 
compared to all other regions, aside from those in the military or another U.S. territory. 
Similarly, adult SMM who lived in the South and the Midwest had lower odds of being a current 
PrEP user compared to all other regions, again aside from those in the military or another U.S. 
territory. These findings have been mirrored in other studies (aidsvu.org, 2018; Parsons, 
Rendina, et al., 2017; Siegler et al., 2018; Sullivan et al., 2018), and provide further evidence that 
changes need to be implemented in both non-coastal regions and the South to increase PrEP 
uptake among those at risk. There are currently no federal guidelines pertaining to sex education 
in the United States. Having PrEP education mandated into other safer-sex programs could 
increase knowledge about PrEP and thereby uptake among all regions.  
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 Substance use behaviors were differently associated with PrEP use among YSMM and 
adult SMM. For YSMM having recently used a drug was associated with higher odds of both 
current and former PrEP use. However, having a recent day of heavy alcohol use was not 
associated with either former or current PrEP use. These findings were mirrored for adult SMM 
in terms of former PrEP use; however, for current PrEP use, recent drug and alcohol use were 
both associated with higher odds of PrEP use. Some research has shown that PrEP use can be 
associated with the use of party drugs (e.g., ecstasy, methamphetamines, cocaine) (Oldenburg et 
al., 2016; Shrestha, Karki, Huedo-Medina, & Copenhaver, 2017). Further, the use of party drugs 
is associated with more sexual risk behaviors (Folch et al., 2015; Halkitis & Parsons, 2002; 
Rendina, Moody, Ventuneac, Grov, & Parsons, 2015; Sewell et al., 2017). This remains a key 
population for PrEP utilization. It is important that more research is done on how to implement 
more PrEP uptake among this at-risk population. Specifically, how are some YSMM who use 
party drugs, gaining knowledge and access to PrEP while others are not? This particular question 
could be easily answered with the use of survey data assessing PrEP knowledge and access to 
PrEP among party drug users. Findings from that work would likely provide clear points of 
intervention to help provide knowledge and access to those who using party drugs and are at-risk 
for acquisition.  
 Having a recent STI diagnosis and recent CAS with an HIV statue unknown partner were 
also differently associated with PrEP use among YSMM and adult SMM. For YSMM, having 
had a recent STI diagnosis was associated with higher odds of both current and former PrEP use. 
However, recent CAS with an HIV status unknown partner was not associated with PrEP use. 
These findings were mirrored for adult SMM in terms of former PrEP use, however, for current 
PrEP use, a recent STI diagnosis and recent CAS with an HIV status unknown partner were both 
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associated with higher odds of PrEP use. For adult SMM, these findings suggest that their actual 
sexual risk may be more related to actual PrEP uptake, however for YSMM, their actual risk may 
not be as highly associated.  
 Although engagement in CAS with an HIV status unknown partner was not associated 
with PrEP use among YSMM, being diagnosed with an STI was. There are a few different things 
that may be going on which link an STI diagnosis to PrEP use. First, being diagnosed with an 
STI may lead individuals to question their likelihood of acquiring HIV and thereby consider 
PrEP use. This is supported by the HBM (Becker, 1974) that theorizes higher perceived 
susceptibility is associated with a higher likelihood of engaging in health-promoting behavior. 
Second, when an individual is diagnosed with an STI, the medical provider may also provide the 
individual information about PrEP and helping them to navigate care. There are policy changes 
that may be able to be implemented to ensure that knowledge and access to PrEP are provided at 
all health clinics regardless of the population served. These potential policy changes are 
described in more details in the implications section below. Third, for YSMM to access STI 
testing and care, they may be more self-efficacious, have their own health insurance, or be at a 
further stage in their sexual identity development. Those who are at a further stage in their sexual 
identity development may be more open about their sexual orientation (Cass, 1979; Savin-
Williams, 1990) and therefore more able to discuss risk with their provider and use their 
parent/caretakers’ insurance.  
The ELM (Petty & Cacioppo, 2012) would suggest that increased PrEP use associated 
with a recent STI diagnosis could be explained by knowledge of PrEP being processed along the 
central pathway upon diagnosis. The information may have been present before along the 
peripheral pathway, but now perceived as more relevant and therefore lead to a perception of 
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increased susceptibility and ultimately beginning a PrEP regimen. Additionally, being given an 
STI diagnosis could also be interpreted as a cue to action and thereby increase the likelihood of 
engaging in PrEP use.   
 Lastly, I hypothesized that YSMM who were on their parent or guardian’s health 
insurance would have lower odds of being a current PrEP user. This hypothesis was supported. 
YSMM who were on their own health insurance had higher odds of being both a current and 
former PrEP user, than those who were on their parent or guardian’s insurance. Those without 
any health insurance had the fewest odds of being a current and former PrEP user. This suggests 
that having health insurance alone does not necessarily increase access to PrEP for YSMM, 
especially if they are on their parent or guardians’. These findings can be explained by 
examining identity development literature that suggests coming out to family is a pivotal role in 
sexual identity development, however also one that YSMM report being extremely stressful 
(Meyer, 1995; Rosario, Hunter, Maguen, Gwadz, & Smith, 2001; Ryan, 2001). For YSMM, 
going on PrEP may mean having to discuss health insurance access with their parent or guardian, 
discussing their sexual orientation as a reason for wanting access to the insurance, and also 
potentially having to discuss their sexual behavior as reasoning for wanting to go on PrEP. Any 
combination of these could be seen as large barriers to use for YSMM. It is also possible that 
these individuals may not know their confidentiality rights in terms of medication use when they 
are on someone else’s insurance. Future research may wish to assess participant’s ‘out’ness 
about their sexual orientation in association with PrEP use, and additionally, what conversations 
YSMM have had with their caregivers about protection from STIs and HIV. For some, helping 
YSMM to begin these conversations with their caregivers may lead to increased PrEP uptake. 
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There are also public health policies, discussed further below, that could be adapted and 
implemented to help increase uptake among YSMM.   
 Together, this study provides evidence that when examining PrEP uptake among SMM, it 
is imperative that researchers examine YSMM separately from adult SMM. In this research, I 
chose to examine these age group by separating those who are 24 years of age and under from 
those who are 25 years of age and older, then focusing solely on those 24 years of age and under 
to assess what factors differentiate precursors to uptake among them. I believe these age 
groupings would also be supported by some development literature, but not all. For example, the 
literature on emerging adulthood suggests that the ceiling for age groups with this population 
would be 29 years of age and not 24 (aidsvu.org, 2018; CDC, 2018a; Siegler et al., 2018). I 
chose to separate the groups at 25 years of age based on the CDC and AIDSvu literature showing 
that this population is highly at-risk and also least likely to engage in PrEP use, therefore, these 
findings are easily able to be mapped onto their epidemiological and PrEP uptake findings. 
Siegler et al. (2018) estimated that 11% of all PrEP users were 24 years of age and under. The 
full sample of aim 1 showed that 12% of the total numbers of PrEP users were YSMM 24 years 
of age and under.  
In order to understand how PrEP uptake can be increased among YSMM at risk, we need 
to understand how this population concludes that PrEP may be a viable option for them. Past 
research has shown that in order to begin a PrEP regimen, an individual must first view 
themselves as someone who is a PrEP candidate and then have intentions to begin taking PrEP 
(Golub et al., 2013; Holloway, Tan, et al., 2017; Parsons, Rendina, et al., 2017; Rendina et al., 
2017). These variables have been heavily studied in adult populations of SMM, but less so in 
populations of YSMM. Examining how YSMM assess their own HIV risk and intentions to 
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begin taking PrEP, should provide evidence for the development of interventions that can help to 
increase PrEP use among this highly vulnerable group. As such, HIV risk perception, and 
individual and social factors associated with PrEP candidacy and intentions are examined in 
Study 2.    
Study 2: Psychological and Developmental Factors Associated with PrEP Candidacy and 
Intentions. 
The goal of Study 2 was to examine the associations between development factors that 
may impede PrEP uptake among YSMM. I will first discuss the findings from the first part of 
this aim, ‘hot’ and ‘cold’ cognition of HIV risk and age, associated with the perception of PrEP 
candidacy and PrEP intentions. Next, I will discuss findings from the second part of this aim, 
PrEP stigma and perceived benefits of PrEP use associated with PrEP intentions.  
Affective and Cognitive Dimensions of HIV Risk on PrEP Candidacy and Intentions 
 The primary goal for part one of aim two was to examine the association between ‘hot’ 
affective and ‘cold’ cognitive dimensions of HIV risk and both perception PrEP candidacy and 
PrEP intentions among YSMM. The set of hypotheses tested first examined the associations 
between both affective and cognitive dimensions of HIV risk and PrEP candidacy, as moderated 
by age. Specifically, I hypothesized that both affective and cognitive dimensions of HIV risk 
would be significantly associated with the perception of self as a PrEP candidate; however, age 
would moderate these associations. I hypothesized that the association between affective 
dimensions of HIV risk and PrEP candidacy would become weaker with age, while cognitive 
dimensions of HIV risk and PrEP candidacy would become stronger with age. Second, I 
hypothesized, that perception of self as a PrEP candidate would fully mediate the association 
between the risk perception variables and intentions to begin a PrEP regimen. Although there 
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were many significant associations, my predictions were not entirely supported. Next, I briefly 
present the broad findings from both sets of hypotheses and then examine the reasons that I 
believe underlie these findings.   
The second part of this aim was to test the associations between the affective and 
cognitive dimensions of HIV risk and PrEP intentions through PrEP candidacy. In this fully 
adjusted path model, I found that both affective and cognitive dimensions of HIV risk were still 
significantly associated with PrEP intentions, even through the perception of self as a PrEP 
candidate. Affective dimensions of HIV risk were still significantly positively associated with 
PrEP intentions, and cognitive processing was significantly negatively associated.  
The dual processing literature is expansive and contains a multitude of different models. 
Metcalf and Mischel (1999) presented a model that suggests ‘hot’ and ‘cold’ processing run 
parallel to each other, and nodes from within each connects over time, that lead to decision 
making. Erikson’s (1959) theoretical eight stages of development state that adolescence stops 
around 18 years of age, and adulthood begins. At this point, he theorizes decisions are made with 
more focus on the future and long-term goals (i.e., ‘cold’ processing and planning). Levinson 
(1978) theorized similarly, and suggested attention moves towards “me” and “not me,” again, 
eliciting ‘cold’ processing around decisions that pertain to who an individual is, and what they 
want for their future. Taken together, I hypothesized that as individuals age, the pathways 
between affective and cognitive processing become more solidified, and ‘cold’ cognitive 
processing becomes more prominent in goal-oriented behavioral decisions (e.g., staying HIV-
negative). As such, I hypothesized that both affective and cognitive dimensions of HIV risk 
should lead to more perception of oneself as a candidate for PrEP and PrEP intentions, and these 
associations would change with age. This was not the case. 
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First, these findings may be understood as consistent with Arnett (2000) and his theory of 
emerging adulthood. He suggests that, due to the changes in westernized civilizations, the 
transition from childhood to adulthood is not as abrupt, and individuals are able to spend more 
time becoming independent adults. If this is true, then the timelines set forth by such researchers 
as Erickson and Levinson may no longer be entirely applicable to current generations.  
Second, the ELM (2012) theorized there are two pathways to information gathering or 
stimulus intake, the peripheral and central. I incorrectly assumed that those who are YSMM 
would intrinsically know the behaviors they are engaging in are risky for HIV acquisition, thus 
confirmed via the central route of processing. However, their perception of risk may be more 
influenced by the peripheral route, where perhaps they have the knowledge but have not yet 
applied it to themselves. In their work, these authors draw a parallel between ‘hot’ and ‘cold’ 
cognition, and the central and peripheral routes. They suggest that ‘cold’ processing is most 
similar to the central route, as it requires conscious effort, whereas the peripheral route is most 
similar to ‘hot’ processing, and happens without conscious effort. Since these participants seem 
to be making more accurate decisions about their PrEP candidacy via ‘hot’ processing, 
information about PrEP and HIV they are receiving peripherally should be further examined. The 
measurement for affective dimensions of HIV risk used in this study also requires some 
cognitive processing as even asking how someone feels about their risk could trigger self-
reflection of actual behavior and risk. Examining variables that may mediate this association, 
should it exist, may help to increase uptake while simultaneous decreasing stigma.  
Third, and last, affective dimensions of HIV risk were positively associated with PrEP 
intentions, and partially mediated through PrEP candidacy. Cognitive dimensions of HIV risk 
were negatively associated with PrEP intentions and partially mediated through PrEP candidacy. 
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YSMM who utilize more cognitive ‘cold’ processing to make determinations about their sexual 
risk, may be less likely to begin a PrEP regimen, compared to those that respond via more 
affective ‘hot’ processing. Because ‘cold’ cognitive processing requires conscious effort 
(Metcalfe & Mischel, 1999), it is important to investigate what thoughts and information YSMM 
are using to assess their sexual risk. Sexual arousal has been linked to making quicker decisions 
about risk and relying on the intuition of HIV status (Ariely & Loewenstein, 2006; Lowy & 
Ross, 1994; Strong, Bancroft, Carnes, Davis, & Kennedy, 2005). It is possible that decisions 
made when at elevated affect may also influence later perception of the event. For example, if an 
individual utilizes quicker affective processing of the risk, they may be more likely to recall that 
event utilizing the same processing, thus not reflecting on the decision utilizing all the 
information available (i.e., how they knew the other’s status, or if the event was risky). Thus, the 
information they are utilizing may not be accurate to their own behaviors.   
The aim of this study was to examine how affective and cognitive perception of risk may 
impact PrEP intentions among YSMM. Understanding risk perception has been a goal of many 
HIV researchers have been asking since the beginning of the HIV epidemic and the question 
addressed within this study. Although I found support for differences in type of risk perception, 
it is unknown if the difference will lead to actual PrEP uptake. If the discordance between 
objective and subjective risk hasn't changed in the last 30 plus years, there is little chance it will 
now, even with advances in preventative medication.  
One challenge with this study was whether the measures of risk perception adequately 
captured differences in risk perception. It is well documented that fear of HIV is lower among 
YSMM compared to adult SMM (Denison et al., 2015; Giménez-García, Ballester-Arnal, Gil-
Llario, Cárdenas-López, & Duran-Baca, 2013; Prati, Mazzoni, & Zani, 2015; Woollett, Cluver, 
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Hatcher, & Brahmbhatt, 2016), which may make risk perception less relevant for younger 
populations. Covello and Johnson (1987) argued that risk is determined by social constructs, 
such that risk perception can be heightened and lowered based on not only the knowledge of risk, 
but also social, cultural, and moral acceptability of the action. To this degree, the scales used in 
this study were successful in tapping into the participants perceptions of how others view those 
on PrEP.  Somewhat oppositely, others have suggested that risk can be determined based on if 
the action is voluntary or involuntary (M. Finucane, 2000). In terms of sexual risk, those who are 
engaging in sexual risk behavior and view their actions as voluntary are more likely to view the 
behavior as less risky compared to those that view their behaviors as involuntary. The scale used 
for this study did not ask about the individuals' perception of their control over their behavior, 
which may be an important construct to consider with this population. 
Although fear of HIV is largely decreasing among younger populations, fear may still 
play a significant role in information processing (M. L. Finucane, Alhakami, Slovic, & Johnson, 
2000). Fear of negative outcomes may result in implicit biases (Bar-Haim, Lamy, Pergamin, 
Bakermans-Kranenburg, & Van Ijzendoorn, 2007) and impact risk perception (Lerner, Gonzalez, 
Small, & Fischhoff, 2003; Lowenstein & Lerner, 2003), which means those who fear HIV also 
perceive their likelihood of HIV acquisition to be higher. In some cases, this is accurate, a self-
fulfilling prophecy. Butler and Matthews (1987) found that students who feared failing on an 
exam were more likely to fail the exam. As related to PrEP use, those who have increased fear of 
HIV may reject PrEP due to the current stigma associated with use. They may fear being 
associated with the medication and thereby HIV. In this way, their fear may actually put them at 
more risk compared to someone who is not afraid of this association. By decreasing PrEP related 
stigma, fear should decrease, and thus uptake increase.  
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In this study I examined affective and cognitive perception of risk, however all 
behavioral decisions are not determined by either affective or cognitive decision making. 
Individuals also make many decisions or come to conclusions from their baseline state, or default 
mode (Raichle et al., 2001). This is a mode in which thinking is occurring based on past 
behaviors, knowledge, or social expectations that are not consciously calculated. With the use of 
fMRI studies, it's been shown that default mode may be active while an individual considers 
themselves (e.g., autobiographical information), while thinking about others (e.g., others 
thoughts, feelings, moral reasoning, social categories), and while thinking about both the past 
and future (e.g., episodic memory) (Andrews-Hanna, 2012).  
In terms of HIV risk and PrEP uptake, not all participants may come to conclusions about 
their sexual risk behavior via either affective or cognitive processing, some may via their sexual 
risk from a baseline of function, their default mode. At this time, it is unknown what role default 
mode may make in sexual decision making or PrEP uptake. However, the research conducted by 
Andrews-Hanna (2012) included conducting fMRIs on participants while they were instructed to 
consider different topics. Sexual behavior was not covered in their study, but could later be 
examined. If decisions or thoughts around sexual decision making are considered in default 
mode, it may be possible to create an experiment where participants are separated into three 
groups, those with no PrEP knowledge, those with prior PrEP knowledge and no intentions to 
begin taking PrEP, and those with prior PrEP knowledge and intentions to begin taking PrEP. 
Participants would then receive an fMRI after being asked to consider their further sexual health. 
If there are not significant differences among the groups, it's possible that sexual health decisions 
around PrEP may also be considered within default mode. Given the wide variety of topics that 
are able to be considered while staying in default mode, there are many different intervention 
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points (e.g., past behaviors, social expectations) that could be utilized including decreasing 
stigma and increasing benefits to use.      
Although risk perception and fear may be a cue for some individuals to further 
investigate PrEP use, even if they view themselves as being at risk, there are many parental 
factors that may impede individuals from going on PrEP. These factors are described in further 
detail below, as well as potential interventions that could be implemented to mitigate these 
restraints. If there are significant restraints duo to these factors for YSMM, interventions 
targeting risk perception may not be as valuable as interventions aiming to engage parents in 
sexual health promoting behaviors benefiting YSMM. Further, for this population, risk 
perception may not be as important as for those who are older. If Covello and Johnson (1987) are 
correct, one way to increase PrEP uptake regardless of risk perception may be to destigmatize 
PrEP use, making it more morally acceptable, as well as in society and culture.   
PrEP Stigma and Perceived Benefits of PrEP Use on PrEP Intentions 
 The primary goal for the second part, two of aim was to examine how PrEP stigma and 
perceived benefits of PrEP use are associated with intentions to begin a PrEP regimen. I 
hypothesized that more perceived benefits to PrEP use and lower PrEP stigma would be 
associated with higher PrEP intentions. Further, I hypothesized that these associations would be 
moderated by age, such that as age increases, the association between perceived benefits and 
PrEP intentions would strengthen, whereas the association between PrEP stigma and PrEP 
intentions would weaken. These hypotheses are guided by the developmental theories of Erikson 
(1959), Levinson (1978), and Arnett (2000), and Prototype Willingness dual-processing model 
(Gerrard et al., 2008). These developmental theorists all believed that as individuals age, they 
become more focused on positive outcomes for themselves, whereas when they are younger, 
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they are more focused on positive social outcomes. Gerrard’s dual-processing model all stated 
that individuals who are younger likely make more decisions based on social reaction, as 
opposed to reasoned action. In these associations, perceived benefits of PrEP use refer to 
potential positive outcomes for the individual, and PrEP stigma refers to potentially negative 
social outcomes. These hypotheses were supported by my findings.  
 This evidence suggests that as YSMM move towards adulthood, the perceived benefits of 
PrEP use increase and stigma associated with PrEP use decreases. Again, developmental theories 
state that at this period of life individuals begin to set concrete goals for their future and focus 
more on their own individual selves as opposed to how they think others may perceive them 
(Arnett, 2000; Erikson, 1959; Levinson, 1978). These findings support these developmental 
theories. 
 The Prototype Willingness Model of dual processing (Gerrard et al., 2008) states that 
individuals make behavioral decisions based on reasoned action and social reaction. Reasoned 
action and subject norm are closely related to the TRA for health behavior and theorizes that 
when an individual is focused on how a perceived health-promoting behavior positively impacts 
the individual, they are more likely to enact that behavior. Conversely, decisions made due to 
social reaction, are focused on the perception of how others will perceive the individual. This 
explains the results of these findings. Those who perceive more individual benefits to PrEP use 
had more intentions, and those who were more concerned that others might negatively perceive 
their use had lower intentions. The association between benefits and intentions strengthened with 
an increase in age, while PrEP stigma decreased, again both providing evidence for 
developmental theories suggesting that the individual becomes more important from the crowd 
as they age. However, to increase uptake among YSMM, it may be useful to focus on any 
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positive social aspects of PrEP use, like staying HIV-negative. Focusing on individual personal 
benefits of use may not help move those who are younger towards increased intentions.   
There are varying types of stigma examined throughout literature. Stigma is broadly 
defined as a social process characterized by exclusion, rejection, and blame or devaluation about 
a person or group (Earnshaw & Chaudoir, 2009). Stigma operates by influencing an individual's 
thoughts and thereby behaviors based on avoiding negative appraisal from self or others. At the 
person level, stigma can be conceptualized across three areas including experienced, anticipated, 
and perceived, all which can be experienced via self or society (Sheehan, Nieweglowski, & 
Corrigan, 2017). Individuals may feel stigma across any combination of these domains, and each 
combination may influence behavior differently.  
The measure used for this study examines stigma through the lens of both perceived and 
anticipated stigma (i.e., how someone views others and how they expect they will be viewed). 
Specifically, this scale measures responses to questions that ask about how the participant views 
those who use PrEP and thereby how they anticipate others would view them. This measure did 
not examine experienced stigma, which could be also be a factor for this sample. Experienced 
stigma is different from the other two measures, it taps into experiences an individual has already 
have pertaining to the desired behavior (i.e., going on PrEP). Stigma can be experienced in a 
variety of different ways and some participants may have experienced stigma related to potential 
PrEP use via conversations about PrEP with providers, friends, or sexual partners. Similarly, 
PrEP is made up of a medication used to treat HIV, and thereby associated with HIV and HIV 
risk, a health factor that carries its own stigma.  
Future studies that examine stigma and PrEP use would benefit from utilizing a variety of 
stigma questions that tap into all three domains of stigma, as one may be more predictive of PrEP 
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use intentions than others. It may also be beneficial to include measures of HIV related stigma 
and examine associations between HIV and PrEP stigma. This association has been heavily 
studied among adults (Calabrese & Underhill, 2015; Dubov et al., 2018; Eaton et al., 2017; 
Franks et al., 2018; Golub, 2018; Grace et al., 2018; Haire, 2015) and less among younger 
populations. Some studies have shown that HIV is less stigmatized among younger populations 
(Dubov et al., 2018; Harper, Lemos, Hosek, & Interventions, 2014) and as such, PrEP stigma 
may be experienced less by YSMM compared to those who are older. Changes in public policy 
and among health providers could also lead to decreases in stigma and are discussed further in 
the following section.  
 The potential for HIV seroconversion is high among YSMM (CDC, 2018a), before an 
individual may change the focus of their decision making. These findings suggest that perceived 
benefits of PrEP use were lower, and PrEP stigma was higher, for younger YSMM. As such, 
those who are 16 years old are likely experiencing the most PrEP stigma and focusing on the 
benefits for this population as opposed to reducing stigma may lead to increases in PrEP use. 
This finding has clear clinical implications, which are explained more below.           
Clinical, Medical, Public Health and Policy Implications 
The research conducted and findings in this project contribute to current literature by 
providing the first large scale look into potential differences in processing and social factors that 
may directly impact how YSMM make decisions about PrEP use. Simply providing YSMM with 
knowledge about and access to PrEP may not be enough to help them engage in use. For young 
people, there are many developmental factors that play a role in the decision to use PrEP, which 
could be affective, cognitive, or default thought processes, the importance of social acceptance, 
and family factors like 'out'ness. Additionally, there are important policy factors, like having 
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health insurance and confidentiality for minors and those are on their parent's health insurance. 
One of the largest takeaways from this project is that if we, as researchers or clinicians, attempt 
to increase PrEP uptake in the same ways it is attempted among adults, these interventions will 
surely fail. However, we are not starting from zero, there are many sexual health interventions 
that have been developed and implemented, which could easily be adjusted to include sexual 
orientation and other HIV prevention techniques besides abstinence and condom use (i.e., PEP 
and PrEP).  
 I have demonstrated that PrEP uptake is lowest among YSMM and that multiple 
developmental factors may impact their decisions around PrEP use. Specifically, for YSMM, 
their perception of HIV risk, perceived benefits of PrEP use, and PrEP stigma all significantly 
impacted their intentions to begin taking PrEP. Further, compared to those on their parent or 
guardian’s insurance, individuals on their own health insurance had higher odds of being a 
current PrEP user, and more PrEP intentions. These are all areas where clinical mental health, 
medical, and public health interventions may help to guide at-risk YSMM towards PrEP uptake.  
 Mental health clinicians who are working with HIV at-risk YSMM may want to discuss 
the individual’s thoughts about the potential for HIV acquisition. This could include assessing 
how the individual views their own sexual identity and if that identity aligns with who they 
believe PrEP is intended to be used by. This treatment could also include assessing where an 
individual is in terms of their outness. Sexual identity literature suggests that identity 
development is a process (DuBay, 1987; Erikson, 1959; Milton & MacDonald, 1984; Troiden, 
1988) and knowing where a client is in their process may help to guide what aspects of coming 
out are stopping them from engaging in a regimen should they be interested. Going on PrEP 
requires going to regular appointments, discussing sexual risk behaviors with a medical provider, 
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paying for the medication, appointments, and testing (USFDA, 2012), and potentially utilizing a 
parent or guardian’s health insurance. Helping a client become more comfortable with their 
sexual orientation and identity, and disclosing to others when safe, could weaken some barriers 
to uptake.  
Addressing how individuals view their own risk behavior and their beliefs around the 
possibility of seroconversion may address their cognitive dissonance around their risk behaviors. 
My findings suggest that if an individual is at risk for HIV, but focuses entirely on their ‘cold’ 
cognitive processing, they may be less likely to view themselves as a good candidate for PrEP. 
However, if individuals address their risk affectively, they may be more likely to view 
themselves as a candidate. In some ways, this finding suggests that fear of HIV acquisition may 
drive some people towards PrEP use, which is contrary to theories suggesting fear of an outcome 
may lead to higher chances of the undesired outcome (Butler & Mathews, 1987). Increasing fear 
of HIV is unlikely to increase PrEP uptake and more likely to create additional stigmatization of 
HIV-positive people or the LGBTQ community as a whole. Using PrEP during one period also 
does not guarantee continued use during all periods of increased risk, and it’s possible that 
someone who was once on PrEP may become HIV-positive in the future. If HIV fear was used 
previously to get that person on PrEP, as an HIV-positive person, they might have more 
internalized stigma. Additionally, if a client does not perceive many pros to going on PrEP, or 
anticipates experiencing stigma related to PrEP, it may be important to address these beliefs. 
This may include discussing the benefits of PrEP use, while also addressing how they believe 
others may view them for using PrEP (i.e., reasoned action versus social reaction).  
 Cognitive-behavioral therapy (CBT) and motivational interviewing (MI) are two 
behavioral change toolsets that have been utilized in various interventions addressing sexual 
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behaviors among SMM (Hart, Tulloch, & O’Cleirigh, 2014; Melendez-Torres & Bonell, 2014; 
W. R. Miller & Rollnick, 2012; Pachankis, Lelutiu-Weinberger, Golub, & Parsons, 2013; 
Parsons, Lelutiu-Weinberger, Botsko, & Golub, 2014; Rollnick & Miller, 1995; Starks, Dellucci, 
et al., 2019; Starks, Doyle, Shalhav, John, & Parsons, 2019; Starks et al., 2018; Starks & 
Parsons, 2018). CBT is a psycho-social therapeutic intervention that aims to change maladaptive 
thoughts, feelings, and behaviors by addressing how these mechanisms all influence each other. 
Theoretically, by intervening on an individual’s thoughts, feelings, or behaviors, the pattern 
between the three will slowly be broken, and a new pattern emerges.  
In addition to CBT, MI has also been incorporated in health behavior change. MI is a 
behavioral change technique based on the Transtheoretical Model of Change and focuses on 
using an individual’s own intrinsic motivation for change (Rollnick & Miller, 1995). Much of the 
work associated with MI has focused on the pros and cons of behavior changes while providing 
the individual with unconditional support in whatever decision they make. As a technique, MI is 
targeted on overcoming ambivalence about a particular behavior; however, the therapeutic 
approach is that the behavior change is not valued as either positive or negative.  
Both CBT and MI are currently being used in interventions aiming to decrease sexual risk 
among YSMM populations. The Young Men’s Health Project (YMHP) is a 4-session MI 
intervention for YSMM aimed at decreasing sexual risk and substance use, and increasing PrEP 
use (Parsons et al., 2019). This intervention includes a novel approach to treatment as the 
intervention is currently underway in three cities across as the U.S., as well as online via 
telephone and video conference to reach broader participation. The Intervention is currently 
underway and will compare outcomes among the participants who met in person versus those 
that met virtually. If there are no significant differences in the outcomes of this intervention 
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between the two intervention groups, this intervention would provide evidence that mobile 
clinical interventions are possible that reach those who are at risk for HIV in rural areas.   
Project: PARTNER is a 4-session one-to-one intervention utilizing MI aimed to help 
YSMM who are in relationships navigate safer-sex behaviors (Starks, Robles, et al., 2019). 
Along with MI, this intervention also uses videos showing couples engaging in both functional 
and dysfunctional discussions about sex outside of the relationship, condom use, and PrEP use. 
Targets of this intervention include HIV risk reduction, increased PrEP use, and decreased 
substance use. HIV transmissions among men in relationships is high in the U.S., and such an 
intervention could help to decrease this transmission disparity as well as educate YSMM on how 
to have discussions about safer sex practices with future partners. This project is currently being 
tested in NYC among 240 partnered YSMM and is expected to be completed in 2021.   
As a technique, MI around PrEP use may help YSMM overcome ambivalence about 
PrEP use. This conversation may include risk perception and provide the clinician with 
information about how the individual views their behavior without telling them they are 
engaging in risk or providing them with information they are not ready to hear (e.g., “you’re 
engaging in risk and should go on PrEP”). MI would allow the individual to come to their own 
conclusions about their risk by confronting cognitive dissonance. Another benefit to MI is it 
would allow them to explore their concerns about HIV and the benefits and cons of going on 
PrEP. Further, it would allow the participant to engage in a conversation about their specific 
barriers to use that may or may not include being on their parent or caregiver’s insurance and 
coming out.  
MI has been shown to be highly effective in behavioral change when conducted in 
medical settings (Lundahl et al., 2013; Resnicow et al., 2002; Rollnick, Heather, & Bell, 1992). 
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Basic training on MI and PrEP uptake in the medical community could help those who are in 
rural areas gain information and access to PrEP. Basic MI skills training can be conducted at 
both minimal time and cost. Intervention utilizing MI to increase PrEP uptake has been 
conducted in multiple sessions, however future research could easily assess PrEP uptake 
outcomes following participants who engaged in brief conversations with providers. One way to 
test this would be to compare outcomes of PrEP uptake among YSMM who speak with a 
medical provider who utilizes MI around PrEP use versus a provider who does not utilize MI 
around PrEP use. Further providers should come from LGBTQ affiliated practices, general 
community providers, and private providers. Utilizing providers across these domains should 
result in a sample that varies in openness about sexuality and socioeconomic status. If results 
from this study show that short conversations utilizing MI result in increased PrEP uptake, it may 
be easy to implement the intervention across various settings.  
Specific to the variables examined in these studies, utilizing a CBT framework to address 
‘hot’ and ‘cold’ processing in HIV risk perception could lead to changes in PrEP uptake, but 
could also be risky. My findings showed that increasing ‘cold’ cognitive dimensions of HIV risk 
might not lead to PrEP uptake. For example, if an individual does not feel or believe their risk 
behavior is risky, a clinician could help to examine the thoughts and feelings that lead to the 
individual not believing their behavior is risky, but this may move the individual further from 
uptake. Based on the findings from these studies, the chances of increasing PrEP uptake may be 
found in focusing on helping an individual perceive more benefits to their PrEP use, and 
decrease stigma associated with use.  
Education around PrEP use may also be a key point for intervention. A 
HealthMpowerment program was run in Vancouver, Canada and offered participants of the 
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longitudinal study the opportunity to attend two peer-led HIV program classes (Closson et al., 
2019). They found that YSMM who attended at least one of the two classes had statistically 
significant higher knowledge on PEP, PrEP, and TasP compared to those who did not attend any 
of the classes. Additionally, those who attended the classes reported higher HIV treatment 
optimism, suggesting less HIV stigma following the classes. The authors did not report on 
changes in PrEP stigma. However, as HIV stigma decreased it is also possible that PrEP stigma 
decreased. As such, not only might those who attended the class be more likely to use PrEP in 
the future, but they may also be more likely to be supportive of those in their social group who 
decide to use PrEP. Based on the findings of this dissertation project, this may be an effective 
intervention to decrease PrEP use.  
Another HealthMpowerment intervention utilized a strength-based online approach to 
help Black YSMM and adult SMM overcome barriers to HIV prevention and care (Barry et al., 
2018). Participants were encouraged to log onto the intervention website and communicate with 
the other participants via messages boards. The messages posted were then analyzed for content. 
Four primary resilience themes emerged among the messages, including exchanging support, 
engaging in health-promoting cognitive processes, enacting healthy behavioral practices, and 
empowering other YSMM. Engaging YSMM in social networks that support each other and their 
sexual health may lead to a decrease in HIV and PrEP stigma, thus increasing other’s likelihood 
of engaging in use. Further, those who are already able to engage in care may be able to help 
others access care and answer the questions they have.  
 Along with mental health clinicians, medical providers also have the ability to affect 
PrEP uptake. Research literature has shown that medical providers have varying views on 
prescribing PrEP overall (Adams & Balderson, 2016; Blumenthal et al., 2015; Tellalian, 
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Maznavi, Bredeek, & Hardy, 2013). Some have stated concerns about the long-term side effects 
of the medication, while others have stated they do not feel comfortable prescribing the 
medication due to sexual behavior concerns (Adams & Balderson, 2016; Blumenthal et al., 2015; 
Karris et al., 2013; Tellalian et al., 2013). Others are unfamiliar with PrEP (Hart-Cooper et al., 
2018; Petroll et al., 2017; Tellalian et al., 2013; Tiu & Robles, 2019). The latter of these has 
decreased over time (Smith et al., 2016; Turner, Roepke, Wardell, & Teitelman, 2018). 
However, the first two could highly impact someone’s ability to access PrEP, even if there are no 
other barriers.  
 Aside from a medical prescribers opinion of the medication itself, the Purview Paradox 
(Krakower et al., 2014) states that some medical and primary care providers may believe PrEP 
care is outside the scope of their practice, while HIV specialists also view PrEP as outside their 
practice, leaving the potential user with fewer options. Many of these providers do not believe 
they have the time to access risk, complete periodic testing, and quarterly medical appointments 
for refills. Due to the somewhat complexity of maintaining a PrEP prescription, some providers 
have simply said they do not prescribe PrEP. Some medical programs have begun teaching MI as 
part of training to aid in health behavior change (Daeppen et al., 2012; Martino, Haeseler, 
Belitsky, Pantalon, & Fortin IV, 2007; Poirier et al., 2004). Including MI training that pertains 
specifically to sexual health would be beneficial and should include not only how to discuss 
sexual health with YSMM. Specialized training in PrEP care may alleviate some of the above-
mentioned barriers for medical providers.  
 My finding that a recent STI diagnosis is associated with a higher likelihood of being a 
current and former PrEP user highlights the important role for medical providers to be 
knowledgeable about PrEP. Although I am inferring from these findings, it is possible that this 
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association is due to potential PrEP users being offered information about PrEP and potentially a 
prescription when they are diagnosed with an STI and thereby viewed as at-risk. If this is the 
case, it may also be possible to expand PrEP uptake by expanding access to STI testing. STI 
testing providers likely play a particularly influential role in increasing uptake among those at-
risk. Specific guidelines put forward from the CDC or WHO about how to address risk and PrEP 
uptake with YSMM would likely be helpful. Additionally, if it is true that YSMM are making 
decisions about PrEP based on potential stigma, benefits to use, and affective processing, how 
risk is discussed becomes more important.   
Risk perception and appropriateness for use if not solely the responsibility of the 
potential user, but also that of the medical provider. Degrees of risk may be valuable to 
understand further decision making for potential users, any risk (intentional or planned) that 
could lead to HIV acquisition should be interpreted as meeting the threshold for PrEP initiation 
and thus prevention initiated from a provider standpoint. My findings suggest that being at-risk 
does not necessarily mean a potential user will intend to begin taking PrEP, and thereby not 
initiate a conversation with their provider. It is a provider's job to initiate conversations with their 
patients around risk and help the patient to make a change in their prevention technique. One 
way of doing this may be to focus on the benefits of PrEP use for the patient. Providers should 
engage in brief conversations with their patients about the benefits of use versus asking their 
patients why they think they need it. Focusing on the benefits of use could also positively impact 
adherence should the patient decide PrEP use is right for them. If PrEP use is viewed as the 
default for those who are potentially at-risk, the conversation changes from convince why I 
should give you this medication to tell me all the ways PrEP may benefit you. This approach 
 130 
would allow the potential user to briefly reflect on what strategies their using, while also 
considering PrEP.   
Public health interventions have also been utilized to educate individuals about sexual 
health. Safe in the City is a series of short videos totally 23-minutes that was shown in waiting 
rooms or medical centers from 2003-2005. The series showed individuals and couples discussing 
sexual behaviors and sexual risk. Findings from this intervention resulted in a 10% decrease in 
new STI infections for those that were in the waiting rooms with the videos compared to those 
that were in waiting rooms without the videos. Currently, there is another intervention being 
conducted in San Francisco that uses the same format as Safe in the City, but the topic of the 
series revolves around PrEP use, condom use, and continuation of condom use while taking PrEP 
(Cardwell, 2018). Outcomes being tested with this intervention include increased condom use 
and decreased STI. Results from this intervention are expected in 2021. Videos that include 
information about PrEP use and being utilized in public places should be careful to only include 
empowering messaging and avoid language related to “risky behavior” as it may stigmatize the 
use of the medication.    
Public health policies also need to be adjusted to incorporate the unique barriers that 
YSMM may face when attempting to engage in PrEP use. One particularly salient finding from 
this research is the role of health insurance access and the importance of being able to access 
PrEP without a parent’s health insurance. Mental health providers may be able to utilize MI to 
help some YSMM overcome health insurance barriers by increasing their self-efficacy, but 
public health policies that can directly affect a larger population will make a bigger difference. 
Most major metropolitan areas in the U.S. offer PrEP at low-cost or for free through 
LGBTQ organizations or other community resources, but these are generally for the uninsured, 
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so being on a parent’s health insurance could limit this access pathway. Further, some YSMM 
may not feel comfortable accessing care through an LGBTQ organization due to issues around 
outness and sexual identity development. For example, an individual may be engaging in sexual 
risk with other sexual minority men, but not identify as LGBTQ and therefore not want to access 
care through those avenues.  
Public health policies should also target sexual education across the U.S., which there is 
currently no federal guidelines. Although beyond the scope of this project, comprehensive sexual 
education has been shown to be predictive of lower STIs and lower unplanned pregnancy 
compared to other or no sexual education (Kirby, 2008; Kohler, Manhart, & Lafferty, 2008; 
Stanger-Hall & Hall, 2011). Comprehensive sexual education should also include material on 
other HIV prevention methods than only condoms. Providing information on PrEP, PEP, and 
TasP would likely decrease stigma about use if the information is presented in an empowering 
way that focuses on sexual health and not risk.  
The above-mentioned interventions and promotion all focus on the patient directly, 
however targeting the parents of potential users is also important for YSMM. A recent meta-
analysis (Santa Maria, Markham, Bluethmann, & Mullen, 2015) reported that parent-child 
interventions which focused on sexual health have been shown to result in significant increases 
in communications, parent comfort discussing sexual topics, and decreases in sexual risk 
behaviors among adolescents. Interventions varied in terms of modality, length, and involvement 
of youth. At the time of this meta-analysis, no interventions had been tested that examined 
outcomes among parents of known sexual minority youth. However, based on their findings, it is 
possible that many of the following interventions could be adjusted for the needs of parents with 
sexual minority kids.  
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A Miami based intervention, and the most intensive in terms of treatment that I'll be 
discussing in this paper, took place over three-months, included separate group meetings for 
parents and youth, eight sessions, each lasting two hours (Prado & Pantin, 2011). Additionally, 
these participants engaged in at-home family therapy for four one-hour sessions. Sessions 
included sexual education and communication skills for both parents, youth, and peers. 
Specifically, parents received training on being supportive and aiding their youth in decision 
making. Youth received training in how to respond to peer pressure and increase self-efficacy, 
pertaining to substance use and sexual behavior. Compared to the control group, youth in the 
intervention group reported fewer STI's, higher chances of condom use at last sexual intercourse, 
and increased parental-child communication. There were however no differences in terms of 
substance use between the control and intervention group. Youth sexual orientation was not 
reported, and as such, how this intervention may have impacted sexual minority youth or their 
caregivers is unknown. Further, outside of condom use, other forms of protection were not 
included (i.e., PrEP). Although this appears to be a highly effective intervention for decreasing 
sexual risk, the time involved is potentially more than some families may be will to engage. The 
following interventions have similar results, however are less time consuming and more 
accessible.     
One community-based intervention in Atlanta aimed to increase sexual communication 
among fathers and sons, including topics pertaining to HIV, STIs, and condom use (Dilorio, 
McCarty, Resnicow, Lehr, & Denzmore, 2007). This intervention consisted of seven two-hour 
session, six with the fathers alone and the seventh including their sons. Utilizing social cognitive 
theory, sessions included how personal, environmental, and social factors can have an effect on 
decision making among young men. Sessions included videos, discussion, and role-playing as 
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tools to guide communication skills training and provide sexual education.  Fathers and their 
sons completed three follow-ups at three, six, and 12-months following their initial assessment 
before beginning the intervention. Results indicated that compared to the control group, fathers 
who were part of the intervention group reported both increased sexual health discussions and 
increased intentions of discussions with their sons. Sons in the intervention group, compared to 
those in the control group, reported higher rates of abstinence and condom use, and significant 
delays in sexual initiation. From this research, it is unclear what discussions, if any, included 
topics of sexual orientation or sexual health among minority populations. An intervention similar 
to this that includes all fathers of sexual minority young adults could be developed and 
implemented with goals to increase communication about sexual health and other methods for 
maintaining sexual health, including PrEP and PEP use. It is also possible that an intervention 
specific for this population could result in a community of men who may be experiencing similar 
unique barriers to sexual communication due to their child's sexual orientation.   
For parents or children who are not able to engage in-person for sexual education and 
communication training, online or computer assisted sexual education may also be effective. An 
intervention developed and tested among Latino families, a population at increased risk for HIV, 
resulted in increased sexual communication and parental comfort discussing sexual behaviors 
after only two short sessions (Villarruel, Loveland‐Cherry, & Ronis, 2010). The first session 
included educational materials about HIV/AIDS and STI's, as well as skills to overcome barriers 
to sexual communication. Printed out homework was assigned to the participants to discuss with 
their children between sessions. The second session occurred approximately one week after the 
first and included further materials on communication skills. Parents and their children were 
reassessed 3-months following the second session and compared to a control-wait group. Results 
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showed increased sexual communication and comfort from the parents, as well as endorsement 
of sexual communication from their children when compared to the control group. Together, 
both sessions equaled 60-minutes, making the intervention short, effective, and easily accessible.  
With the continued growth in technology, online interventions are becoming more 
popular and may be a necessity for parents of YSMM. Online or technology-based interventions 
will allow parents that are in rural areas, where access to LGBTQ groups or sexual education 
may be less accessible, to acquire communication skills and knowledge pertinent to decreasing 
sexual risk among their offspring. Due to some social stigma that is still prevalent, some parents 
of LGBTQ youth may find sexual education online versus in-person more comfortable. 
Technology based interventions focused on sexual health among parents of LGBTQ youth 
should include information about PrEP and include outcomes measuring parental acceptance of 
PrEP and comfort in communication pertaining to PrEP. 
Interventions that target the parent-child relationship are one way to attempt to increase 
PrEP use, however there are policy barriers as well. There are currently no federal policies in the 
United States that protect the confidentiality of minors (those under 18 years of age) in 
healthcare settings when attempting to access PrEP (Boldt, 2012; Burda, 2015). Laws for minors 
and confidentiality protections vary state-by-state, and can broadly be broken down into three 
categories, those that allow diagnosis and treatment of STIs, those that allow care for and 
prescriptions for STIs, and those that include preventative care (e.g., PrEP) (Burda, 2015). At 
this time, there is no consensus about exactly where PrEP falls, and it could be argued for all 
three categories. Physicians in states that allow diagnosis and treatment for STIs could argue that 
PrEP is not covered because it is preventative care and requires multiple appointments. 
Physicians in states that allow for care and prescriptions could again argue that PrEP is not 
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covered. States that do allow preventative care would protect a minor's confidentiality, however 
only seven states have these laws in effect. For the other 43 states, minors are not guaranteed 
confidentiality when accessing PrEP, which could be a barrier. Further, even in the seven states 
where confidentiality is protected by law, YSMM may not know the laws and other interventions 
may be necessary.  
First, adding preventative medicine to legislature in all U.S. territories would allow 
minors to access PrEP without needing to disclosure their sexual orientation or sexual behaviors 
to their parents. Second, requiring sexual education to include information on preventative 
medicine, including PrEP and PEP use, would provide youth with more information about best 
practices for staying HIV-negative. Third, it should be required that all healthcare professional 
explain the limits of confidentiality to all minors at medical appointments and ask if the minor 
would like the parent to leave the room.  
If the goal of the WHO is to stop all new transmissions of HIV by 2030 (WHO, 2018), 
then public health policies around access to PrEP use and continuation must change. Policies 
need to be put in place that requires all medical care providers to prescribe the medication when 
it is requested by patients who are at-risk. Strict guidelines need to be put in place that includes a 
risk assessment, psychoeducation about PrEP use (including the importance of adherence), and 
also discussions about the limitations of confidentiality for minors and those who are on their 
parent’s or guardian’s insurance. One other way that many of these may be accomplished is with 
the use of medical prescriptions, STI testing, and risk assessments completed via mail. One 
published study has examined preferences for this among SMM and reported the majority would 
be open to access PrEP care that way (John, Rendina, Grov, & Parsons, 2017).  
Implications for PrEP Uptake 
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 There are many implications to these studies that have the potential to increase uptake 
among at-risk YSMM. Only 1% of YSMM in the first study were current PrEP users, and the 
entire sample of study two is made up of individuals who are at risk for HIV, and not taking 
PrEP. Simply put, this is a sample of over 2,000 YSMM who would benefit from PrEP use, but 
are not taking it for a multitude of factors, many of which can be alleviated with changes in 
health care policy.   
 First, it is important that all health care physicians assess HIV risk with their SMM 
clients. CDC guidelines do not provide specific directions on how to assess risk, but rather what 
the criteria for risk would be. As stated in the intro, PrEP is intended for those “at substantial 
risk,” defined as having an HIV-positive sexual partner, a recent bacterial STI, a high number of 
sex partners, a recent history (3-6 months) of inconsistent or no condom use, or be a commercial 
sex worker in an area of high prevalence of HIV. Some criteria are left to the subjective views of 
the provider; for example, “a high number of sex partners” does not specify what qualifies as 
high and what does not. Some research has also shown that physicians are not asking patients 
about recent risk behaviors when returning for follow-ups (Parsons, John, Whitfield, Cienfuegos-
Szalay, & Grov, 2018). Other studies have compared services provided by PCPs versus HIV 
specialists and reported that PCPs are less comfortable with assessing sexual risk (Petroll et al., 
2017). 
Additionally, my findings suggest physicians should pay close attention to the specific 
language their clients use when describing their risk. How a client discusses their perception of 
their risk may not be accurate to their actual risk. When a physician is assessing risk for HIV, 
only focusing on the number of partners, or the amount of risk engaged in, may not increase 
uptake among YSMM. My findings indicate that decisions around PrEP are likely not made 
 137 
based solely on a logical risk assessment. Additionally, if a physician were to engage in dialogue 
that suggests the patient is objectively at-risk when they do not perceive themselves as at-risk; 
the physician may actually push them further from uptake. It may benefit the client for the 
physician to explore the benefits of PrEP use for the client. Another research even suggested that 
instead of asking patients about numbers related to their sexual behavior and labeling them as 
risky or not risky, providers could ask about their sexual concerns when assessing for risk 
(Golub, 2018). This would allow the patient to discuss any fears or anxiety around HIV, along 
with opening the door to other potential conversation related to sexual health. 
 Second, the findings from this research provide more evidence that there is a stigma 
associated with PrEP use, and this stigma may be more influential for those who are younger. 
Both those who are PrEP users and those who may consider PrEP use have reported concerns 
that use of the medication may lead some to think they are HIV-positive or engage in high risk 
sexual behaviors with many people (Dubov et al., 2018; Eaton et al., 2017; Farhat, Greene, 
Paige, Koblin, & Frye, 2017; Golub, Gamarel, & Surace, 2017; Haire, 2015; Knight, Small, 
Carson, & Shoveller, 2016). Experiences with the stigmatization of PrEP has not been limited to 
sexual partners but also reported to have come from providers, friends, and family members 
(Haire, 2015). In this sense, it is ironic that a medication shown to be so highly efficacious in the 
prevention of HIV is associated with negative behaviors. One qualitative study reported that 
YSMM are even told by those who are older than they should be more careful and active in their 
prevention instead of relying on PrEP (Dubov et al., 2018).  
With stigma to PrEP use potentially coming from so many different sources and 
experienced by both users and potential users, public health initiatives to destigmatize use may 
be very effective at reaching PrEP user, potential users, and those who shame users. Some 
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researchers have already begun to make suggestions for what these initiatives may look like 
(Golub, 2018). Due to the commonly held belief that PrEP is used to avoid condom use, 
advertisements and initiatives should focus on how PrEP is intended to be used in association 
with other safe sex practices (i.e., condom use). This messaging could lead to the acceptance of 
PrEP as a backup as opposed to instead of condoms, regardless of actual use.  
Decreasing stigma around use may help some potential users, but may not help those who 
have low PrEP stigma and still low intentions. One way that may impact both is a focus on the 
benefits of PrEP use. For example, ads that support independence and building a stable and 
sexually healthy future could be very effective. By focusing on the future, initiatives may be able 
to reach younger people and show PrEP as a tool that could help them achieve their sexual health 
goals. Positive messaging about the use of PrEP as a sexual health tool without the mention of 
HIV may help both potential users and those who shame users to separate the use of PrEP with 
the potential for HIV. 
Fourth, without health insurance, PrEP can cost upwards of $14,000 per year, including 
prescriptions, quarterly testing, and office appointments (San Francisco AIDS Foundation, 
2015). Public health initiatives need to be implemented that would allow all individuals at-risk 
for HIV to gain access PrEP at little or no cost. Additionally, this cannot be limited to only those 
without health insurance. Our findings indicate that those on their parent or caregiver’s insurance 
have lower odds of former or current PrEP use, and thus have health insurance, but do not feel 
comfortable using it to acquire PrEP. This likely has to do with sexual identity development and 
not wanting to either risk coming out to their parent or not wanting to discuss their sexual 
behaviors with them. 
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 Lastly, there is limited research on how YSMM specifically are learning about PrEP. A 
recent study in Canada showed that YSMM are gaining more knowledge about PrEP via youth 
programs and interventions aimed to increase sexual education (Closson et al., 2019). Another 
study surveyed a large sample of YSMM and asked them to report all the places where they had 
heard about PrEP. More than 50% of the participants had learned about PrEP from their friends 
or acquaintances, 37% from HIV services agencies, 34% from a health care professional, 31% 
from newspapers and magazine, and 13% from TV and radio (Strauss et al., 2017). They also 
reported that although the majority of the sample knew the medication existed, almost 50% did 
not know to obtain it, and over 30% did not know what the effectiveness of the medication is. 
Findings from these two studies show that simple awareness of the medication is not enough for 
YSMM to seek out the medication. Our findings suggest there is an association between testing 
positive for an STI and PrEP uptake, suggesting that YSMM may be learning about PrEP, and 
gaining access to it, from health facilities where they are obtaining STI testing.  
Since the approval of PrEP for individuals under the age of 18, many television networks 
have begun to air ads for PrEP targeted at younger viewers (Marotta, 2019; POZ, 2018). More 
funding should be spent on spreading awareness of PrEP, including who can benefit from it, and 
how to access it. Public health messaging about benefits should include how using PrEP may fit 
into long term health goals. This messaging should not include words like “risk” or “HIV” as 
these terms carry a stigma and may push some away from use or continue to perpetuate the belief 
that PrEP is only for sexually promiscuous individuals. Further, such ads should include diverse 
populations of differing sexual orientations, gender identities, and ages. The inclusion of diverse 
populations will help to destigmatize use among differing groups of people, not just those of 
which the medication may be marketed. As such, it is also important that ads do not only include 
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sexual minority populations as that could lead to further stigmatization of those groups. Taken 
together, these factors and those mentioned above can be used to create and implement 
interventions and advertisements that aim to increase uptake among all populations at risk, 
including YSMM.    
Limitations 
 Although there are many strengths to both of these studies, they are not without their 
limitations. Study 1 aimed to provide evidence of disparities between PrEP use for YSMM and 
adult SMM. These analyses were conducted with screening data for a larger study that recruited 
participants from various dating/sexual networking apps and a popular social media website. 
Other research has reported that individuals who use dating/sexual networking apps to find 
sexual partners may engage in more sexual risk than those who do not use them (Grov et al., 
2016). Although this sample is very large overall, it may not be representative of sexual risk 
behaviors for all SMM, particularly those that do not use dating/sexual networking apps. Second, 
dating/sexual networking apps state they are only to be used for individuals who are 18 years of 
age and older, however in addition to this study, other researchers have reported that YSMM 
under 18 years of age to access these apps (Macapagal et al., 2018). Future studies that aim to 
include SMM who are under 18 years of age, or not engaging in sexual risk behaviors, may want 
to incorporate other recruitment techniques (e.g., youth LGBTQ organizations and college 
campuses), while limiting the use of dating/sexual networking apps.   
In both Studies 1 and 2, I aimed to capture the largest possible portion of individuals 
potentially at-risk for HIV seroconversion. To do this, I assessed for sexual risk as having 
engaged in any recent CAS event with an HIV-status unknown partner, and a recent STI 
diagnosis. Although this casts a wide net, it is possible that participants had engaged in different 
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degrees of risk (i.e., more or less CAS partners or events, locality of STI infection) and the HIV-
status unknown partner definition relies on an individual’s perceived status of the partner, which 
may not match the reality of the partner’s status. It would have been potentially more meaningful 
to have asked participants if they discussed or disclosed HIV statuses with the partners. Future 
studies should investigate risk in a less participant dependent subjectively defined way and 
utilize longitudinal data to investigate how these behaviors predict future PrEP use, or how 
varying degrees of risk effect PrEP intentions.   
Study 2 examined individual developmental factors as they pertain to PrEP uptake, 
among HIV at-risk YSMM across two aims. In terms of recruitment, this cohort of SMM had to 
complete a variety of steps to be enrolled, all outlined above in the methods chapter. Along with 
having access to the social media site or dating/sexual networking apps used for recruitments, 
participants also had to complete a lengthy baseline survey, and complete at-home HIV and STI 
testing. The testing materials were required to be delivered to a permanent home address, albeit 
in a discreet box. For individuals who do not have privacy at home, this could have been a 
barrier to enrollment. Further, not all SMM have a long-term permanent residency and may have 
been deemed ineligible. This could have led to a sample that is not generalizable to those without 
stable housing and a steady income.  
This is the first study completed that examines the association between ‘hot’ and ‘cold’ 
perception of HIV risk, and perception of self as a PrEP candidate and PrEP intentions. Across 
both studies, the findings have various clinical and public health implications, and it is 
imperative that these findings be replicated by other researchers with different samples. 
Similarly, this data is cross-sectional, and therefore, I am unable to make predictions about how 
these associations may change over time.  
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It should be noted that PrEP was unexpectedly approved for individuals 17 years of age 
and younger in May 2018, while these data were being collected. It is unknown how this 
approval may have directly impacted YSMM’s knowledge of and access to PrEP. To date, there 
are no studies that have shown an impact on uptake since this expansion, and I do not believe 
that if this same data were collected today, less than a year later, there would be significantly 
different results for either study. This assertion is backed up by our finding that although PrEP 
was accessible for everyone above 18 years of age, it was still lowest among those 24 years of 
age and younger. As highlighted in this work, there are a multitude of factors that significantly 
contribute to YSMM’s decisions around beginning PrEP that are not simply USFDA approval.  
For study 2, the target age group was 16-24 years of age. This restriction in age range 
may have limited some findings. Age was utilized as the moderating variable, thus splitting the 
sample into high and low age groups. It's possible that due to this limited range, some findings 
may have also been restricted. It may be advantageous for future work aiming to increase uptake 
among those younger to use a wider range where 16-24 years of age are all in the lower age 
group and thus compared to those who are older, and as such without some age-related barriers.   
Lastly, the outcome for Study 2 was PrEP intentions, argued to be the most predictive 
variable associated with actual behavioral change by the TRA and TPB. This study focused on 
barriers that could impede intentions, however these barriers may not matter without intentions. 
For example, if someone meets objective criteria for PrEP use, but has no intentions to initiate 
PrEP use, structural and parental barriers cease to be important. At the current understanding of 
how to increase PrEP use among YSMM, it may be too soon to move away from models with 
more steps (i.e., cascades) to simpler models as presented in Study 2.   
Conclusions 
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These studies provided evidence that not only is PrEP use lower among those who are 
YSMM, but also the first evidence that differences in utilization of ‘hot’ and ‘cold’ processes of 
HIV risk perception exist for YSMM and affect their perception of PrEP candidacy and 
intentions to use PrEP. Affective ‘hot’ perceived risk was strengthened with increased age, 
suggesting that in terms of HIV risk, SMM’s decision making around HIV prevention may be 
more emotionally driven as opposed to more critical and logical ‘cold’ processing. PrEP stigma 
and benefits of PrEP use were also examined. PrEP stigma was associated with lower PrEP 
intentions, which weakened with increased age, and benefits of PrEP use were associated with 
higher PrEP intentions, which strengthened with increased age. The use of CBT and MI 
techniques may be helpful in aiding HIV at-risk YSMM in understanding their risk behavior, 
along with an increasing perception of the benefits of PrEP use and decreasing stigma. 
Physicians that have YSMM patients should keep these findings in mind when they assess for 
HIV risk with their patient’s, and future PrEP implementation strategies should focus on 
increases the perceived benefits of PrEP use while also destigmatizing PrEP use. Future research 
should examine what other mediating and moderating factors may impact the perception of PrEP 
candidacy and PrEP intentions among YSMM.  
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Table 1. History of PrEP use among a U.S. National Sample of Young and Adult SMM 
 
Table 1 
History of PrEP Use among a U.S. National Sample of Young and Adult SMM (N=96,243) 
  
Full Sample 
  PrEP Use 
  
 Never Current Former 
  n % 
 n % n % n % 
Overall 96,243 100.0 
 74,482 77.4 15,922 16.5 5,839 6.1 
Age (m = 33.32) 
   χ2 (10) = 2,981.16, p < 0.001*** 
 13-17 1,291 1.3 
 1,263 97.8a 15 1.2a 13 1.0a 
 18-24 24,599 25.6 
 21,599 88.8b 1,911 7.8b 1,089 4.4b 
 25-34 34,547 35.9 
 25,681 74.3c 6,254 18.1c 2,612 7.6c 
 35-44 17,146 17.8 
 11,978 69.9d 3,937 23.0d 1,231 7.2c 
 45-54 11,765 12.2 
 8,644 73.5c 2,526 21.5e 595 5.1d 
 55+ 6,895 7.2 
 5,317 77.1e 1,279 18.5c 299 4.3b 
Race 
   χ2 (10) = 334.58, p < 0.001*** 
White 60,664 63.0 
 46,269 76.3a 10,858 17.9a 3,537 5.8a 
Black 11,986 12.5 
 9,646 80.5b 1,651 13.8b 689 5.7a 
Asian or other Pacific Islander 5,124 5.3 
 3,904 76.2a,c 888 17.3a 332 6.5a 
American Indian or Alaskan Native 1,645 1.7 
 1,360 82.7d 190 11.6c 95 5.8a 
Multiracial 10,272 10.7 
 7,962 77.5c 1,522 14.8d 788 7.7b 
Other 6,552 6.8 
 5,341 81.5b,d 813 12.4c 398 6.1a 
Hispanic/Latino 
   χ2 (2) = 94.58, p < 0.001*** 
 No 72,484 75.3 
 55,794 77.0a 12,440 17.2a 4,250 5.9a 
 Yes 23,759 24.7 
 18,688 78.7b 3,482 14.7b 1,589 6.7b 
Sexual Orientation 
   χ2 (4) = 1,887.36, p < 0.001*** 
 Gay 
75,888 78.9  56,862 74.9a 14,057 18.5a 4,969 6.5a 
 Bisexual 
18,029 18.7  16,073 89.2b 1,349 7.5b 607 3.4b 
 Queer 
2,326 2.4  1,547 66.5c 516 22.2c 263 11.3c 
Relationship Status 
   χ2 (2) = 215.75, p < 0.001*** 
Single 66,827 69.4 
 52,529 78.6a 10,293 15.4a 4,005 6.0a 
Partnered 29,416 30.6 
 21,953 74.6b 5,629 19.1b 1,834 6.2a 
Geographic Region 
   χ2 (8) = 1,063.77, p < 0.001*** 
Northeast 18,997 19.7 
 13,528 71.2a 4,049 21.3a 1,420 7.5a 
Midwest 17,423 18.1 
 13,870 79.6b 2,667 15.3b 886 5.1b 
South 33,101 34.4 
 26,980 81.5c 4,454 13.5c 1,667 5.0b 
West 25,666 26.7 
 19,126 74.5d 4,710 18.4d 1,830 7.1a 
U.S Territory/Military 1,056 1.1 
 978 92.6e 42 4.0e 36 3.4c 
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 Health Insurance 
   χ2 (6) = 3,492.55, p < 0.001*** 
 None 
21,179 20.8  17,627 88.0a 1,123 5.6a 1,287 6.4a 
 Own 
65,282 64.2  44,843 72.4b 13,172 21.3b 3,897 6.3a 
 Partner's 
2,170 2.3  1,504 69.3c 529 24.4c 137 6.3a 
 Parent/Guardian 
12,124 12.6  10,508 86.7d 1,098 9.1d 518 4.3b 
CAS with HIV status unknown partner 
  χ2 (2) = 176.80, p < 0.001*** 
 No 
18,152 18.9  14,663 80.8a 2,413 13.3a 1,076 5.9a 
 Yes 
78,090 81.1  59,818 76.6b 13,509 17.3b 4,763 6.1a 
STI Diagnosis in the past 6 months 
   χ2 (2) = 4,813.16, p < 0.001*** 
 No 
84,419 87.7  68,227 80.8a 11,549 13.7a 4,643 5.5a 
 Yes 
11,824 12.3  6,255 52.9b 4,373 37.0b 1,196 10.1b 
Any drug use in the past 3 months 
   χ2 (2) = 1,864.12, p < 0.001*** 
 No 
35,946 37.3  30,158 84.9a 3,850 10.7a 1,578 4.4a 
 Yes 
60,297 62.7  43,964 72.9b 12,072 20.0b 4,261 7.1b 
5 or more drinks in the past 3 months 
   χ2 (2) = 94.39, p < 0.001*** 
 No 
36,306 37.7  28,704 79.1a 5,598 15.4a 2,004 5.5a 
 Yes 
59,937 62.3  45,778 76.4b 10,324 17.2b 3,835 6.4b 
Notes: *** p < 0.001; ** p < 0.01; *p < 0.05; PrEP = pre-exposure prophylaxis; SMM = sexual minority men; 
Row percentages are displayed; Percentages within the same column with differing superscripts differ 







 Table 2. Demographic and Behavioral Predictors of PrEP Uptake among YSMM   
  
Table 2  
Demographic and Behavioral Predictors of PrEP Uptake among YSMM  (Ages 13-24, N=25,890) 
 
Former PrEP Use 
vs. Never (ref.) 
  
Current PrEP Use 
vs. Never (ref.) 
  β AOR 95% CI  β AOR 95% CI 
Age 0.21 1.23*** 1.19, 1.27  0.27 1.31*** 1.28, 1.35 
Hispanic/Latino (ref. Yes)        
No 0.09 1.09 0.93, 1.28  0.08 1.08 0.95, 1.23 
Race (ref. White)        
Black 0.10 1.11 0.92, 1.33  -0.01 0.99 0.85, 1.15 
Asian or other Pacific Islander    -0.14 0.87 0.66, 1.16  0.04 1.04 0.84, 1.28 
American Indian or Alaskan Native  -0.19 0.83 0.52, 1.34  -0.19 0.83 0.56, 1.22 
Multiracial 0.12 1.13 0.94, 1.36  0.01 1.01 0.87, 1.18 
Other -0.22 0.81 0.62, 1.05  -0.50 0.61*** 0.48, 0.77 
Sexual Orientation (ref. Gay)        
Bisexual -0.80 0.45*** 0.38, 0.55  -0.95 0.39*** 0.33, 0.45 
Queer 0.37 1.45** 1.10, 1.92  0.16 1.17 0.92, 1.49 
Relationship Status (ref. Partnered)        
Single 0.23 1.26** 1.09, 1.46  0.03 1.03 0.91, 1.17 
Region (ref. South)        
Northeast  0.62 1.85*** 1.56, 2.20  0.70 2.01*** 1.76, 2.30 
Midwest 0.20 1.23* 1.01, 1.49  0.24 1.27** 1.09, 1.48 
West 0.40 1.49*** 1.26, 1.76  0.35 1.42*** 1.24, 1.63 
U.S Territory/Military -1.08 0.34* 0.12, 0.93  -2.29 0.10** 0.03, 0.41 
Medical Insurance (ref. Yes, on parents)        
Own insurance 0.22 1.26*** 1.10, 1.45  0.18 1.20*** 1.08, 1.34 
Partner's insurance 0.15 1.16 0.62, 2.18  0.23 1.26 0.80, 1.99 
No insurance -0.30 0.74** 0.61, 0.89  -1.24 0.29*** 0.24, 0.35 
CAS with HIV status unknown partner (ref. No)       
Yes 0.11 1.12 0.95, 1.31  0.12 1.13 1.00, 1.28 
STI diagnosis in the past 6 months (ref. No)        
Yes 1.22 3.37*** 2.92, 3.89  1.56 4.77*** 4.27, 5.32 
Any drug use in the past 3 months (ref. No)        
Yes 0.44 1.55*** 1.34, 1.78  0.40 1.50*** 1.34, 1.67 
5 or more drinks (ref. No)        
Yes 0.02 1.02 0.88, 1.18   -0.01 0.99 0.88, 1.11 
Note: *** p < 0.001; ** p < 0.01; *p < 0.05; PrEP = pre-exposure prophylaxis; YSMM = young sexual minority men; 
AOR for age represent each one year increase in age.  
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Table 3  
Demographic and Behavioral Predictors of PrEP Uptake among Adult SMM (Ages 25+, N = 70,353) 
 
Former PrEP Use 
vs. Never (ref.) 
  
Current PrEP Use 
vs. Never (ref.) 
  β AOR 95% CI  β AOR 95% CI 
Age -0.02 0.99*** 0.98, 0.99  0.00 1.00 0.99, 1.00 
Hispanic/Latino (ref. Yes)        
No 0.11 1.12** 1.02, 1.22  0.07 1.07* 1.01, 1.14 
Race (ref. White)        
Black -0.02 0.98 0.88, 1.08  -0.09 0.92* 0.86, 0.98 
Asian or other Pacific Islander 0.12 1.12 0.98, 1.29  0.05 1.05 0.96, 1.15 
American Indian or Alaskan Native -0.05 0.86 0.67, 1.09  -0.45 0.64*** 0.53, 0.76 
Multiracial 0.18 1.19*** 1.08, 1.32  -0.11 0.90** 0.83, 0.97 
Other -0.17 0.85* 0.73, 0.98  -0.27 0.77*** 0.69, 0.85 
Sexual Orientation (ref. Gay)        
Bisexual -0.78 0.46*** 0.42, 0.51  -1.02 0.36*** 0.34, 0.38 
Queer 0.62 1.85*** 1.58, 2.17  0.32 1.37*** 1.21, 1.55 
Relationship Status (ref. Partnered)        
Single -0.02 0.98 0.92, 1.05  0.08 1.08*** 1.03, 1.13 
Region (ref. South)        
Northeast  0.39 1.48*** 1.36, 1.61  0.34 1.40*** 1.33, 1.48 
Midwest -0.02 0.98 0.89, 1.08  0.01 1.00 0.94, 1.06 
West 0.29 1.34*** 1.24, 1.45  0.17 1.18*** 1.12, 1.24 
U.S Territory/Military -0.63 0.53*** 0.37, 0.77  -1.50 0.22*** 0.16, 0.31 
Medical Insurance (ref. Yes, on parents)        
Own insurance 0.22 1.24* 1.01, 1.53  0.42 1.52*** 1.32, 1.75 
Partner's insurance 0.29 1.33* 1.01, 1.76  0.49 1.63*** 1.37, 1.95 
No insurance 0.08 1.08 0.87, 1.33  -1.09 0.34*** 0.29, 0.39 
CAS with HIV status unknown partner (ref.  No)       
Yes 0.10 1.11** 1.02, 1.20  0.39 1.48*** 1.40, 1.56 
STI diagnosis in the past 6 months (ref. No)        
Yes 0.86 2.36*** 2.17, 2.56  1.37 3.95*** 3.875, 4.17 
Any drug use in the past 3 months (ref. No)        
Yes 0.58 1.78*** 1.67, 1.91  0.74 2.11*** 2.01, 2.20 
5 or more drinks (ref. No)        
Yes 0.01 1.01 0.94, 1.07   0.08 1.09*** 1.04, 1.13 
Note: *** p < 0.001; ** p < 0.01; *p < 0.05; PrEP = pre-exposure prophylaxis; SMM = sexual minority men; AOR for 













Demographics of YSMM at-risk for HIV and group differences in affective and cognitive dimensions of HIV risk scores 
(N=2,003) 
 Full Sample 
 Affective Risk  Cognitive Risk 
    
Overall n % 
 m SD  m SD 
Age (M = 21.27) 
   t (2001) = 1.70, p = 0.09  t (2001) = 2.43, p = 0.84 
 13-17 79 3.9 
 3.34 0.72  3.65 0.67 
 18-24 1,924 96.1 
 3.20 0.74  3.46 0.69 
Race 
   F (5, 1997) = 1.78, p = 0.11  F (5, 1997) = 1.90, p = 0.09 
Black 253 12.6 
 3.20 0.80  3.36 0.79 
White 1,151 57.5 
 3.17 0.74  3.49 0.68 
Asian or other Pacific Islander 117 5.8 
 3.30 0.69  3.47 0.54 
American Indian or Alaskan Native 42 2.1 
 3.35 0.71  3.34 0.68 
Multiracial 288 14.4 
 3.25 0.75  3.49 0.72 
Other 152 7.6 
 3.29 0.69  3.48 0.66 
Hispanic/Latino 
   t (2001) = -2.33, p = 0.02*  t (2001) = 0.93, p = 0.08 
 Yes 496 24.8 
 3.27 0.75  3.42 0.76 
 No 1,507 75.2 
 3.18 0.74  3.44 0.71 
Sexual Orientation 
   F (2, 2000) = 1.77, p = 0.17  F (2, 2000) = 2.01, p = 0.13 
 Gay 
1,597 79.7  3.21 0.74  3.48 0.69 
 Bisexual 
334 16.7  3.22 0.74  3.40 0.70 
 Queer 
72 3.6  3.04 0.69  3.54 0.72 
Relationship Status 
   t (2001) = -4.05, p < 0.001***  t (2001) = 5.99, p = 0.36 
Single 1,641 81.9 
 3.24 0.72  3.46 0.71 
Partnered 362 18.1 
 3.06 0.80  3.35 0.75 
Education 
   F (2, 2000) = 5.12, p < 0.001***  F (2, 2000) = 1.96, p = 0.14 
 Some High School/GED or less 
462 23.1  3.30a 0.73  3.50 0.72 
 Some College 
1,118 55.8  3.19b 0.77  3.44 0.70 
 4-Year College or more 
423 21.1  3.15b 0.67  3.50 0.62 
Employment  
   F (2, 2000) = 0.55, p = 0.58  F (2, 2000) = 0.55, p = 0.58 
 Unemployed 473 23.6 
 3.22 0.76  3.45 0.72 
 Employed Part-Time 811 40.5 
 3.21 0.72  3.49 0.67 
 Employed Full-Time 719 35.9 
 3.18 0.75  3.46 0.70 
Geographic Region 
   F (4,1998) = 4.18, p < 0.001***  F (4, 1998) = 0.61, p = 0.66 
 150 
Northeast 339 16.9 
 3.07a 0.71  3.44 0.68 
Midwest 363 18.1 
 3.19a,b 0.75  3.48 0.65 
South 763 38.1 
 3.25b 0.75  3.47 0.70 
West 523 26.1 
 3.23b 0.74  3.46 0.71 
U.S Territory/Military 15 0.7 
 3.47a,b 0.60  3.71 0.64 
 Health Insurance 
   F (3, 1999) = 2.40, p = 0.07  F (3, 1999) = 2.77, p = 0.04* 
 None 
394 19.7  3.29 0.76  3.48a 0.65 
 Own 
706 35.2  3.16 0.75  3.42b 0.72 
 Partner's 
17 0.8  3.21 0.72  3.61a,b 0.84 
 Parent/Guardian 
886 44.2  3.20 0.89  3.54a,b 0.72 
STI Diagnosis in the past 6 months   
 t (2001) = -4.14, p < 0.001***  t (2001) = 3.44, p = 0.10 
 No 1698 84.8  3.18 0.73  3.42 0.72 
 Yes 305 15.2  3.37 0.76  3.50 0.75 
Any drug use in the past 3 months    t (2001) = 0.34, p = 0.74 
 t (2001) = 3.70, p = 0.99 
 No 678 33.8  3.20 0.75  3.39 0.73 
 Yes 1325 66.2  3.21 0.73  3.46 0.72 
Note: ***p <0.001; **p <0.01; *p <0.05; YSMM = young sexual minority men.  
Table 5 
Correlations of Variables of Interest 
Measures 1 2 3 4 5 6 7 
1. Age -       
2. Affective Perception of Risk -0.08*** -      
3. Cognitive Perception of Risk -0.04 0.58*** -     
4. PrEP Stigma 0.05* 0.05* -0.03 -    
5. Perceived Benefits of PrEP -0.01 0.19*** 0.08*** -0.24*** -   
6. Perceived PrEP Candidacy 0.09*** 0.11*** 0.04 -0.13*** 0.24*** -  
7. PrEP Intentions 0.01 0.11*** 0.01 -0.12*** 0.28*** 0.37*** - 
M 21.27 3.21 3.47 2.24 3.53 3.91 3.45 
SD 2.11 0.74 0.69 0.55 0.70 0.92 0.97 
Alpha - 0.72 0.71 0.79 0.85 - - 
Note: *** p <0.001; ** p <0.01; * p <0.05; PrEP = Pre-Exposure Prophylaxis. 
Table 5. Correlations of Variables of Interest 
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Table 6. Cognitive and Affective Perceived Risk of HIV, and Age, Associations with Perceived 
PrEP Candidcay and Intentions 
Table 6 
Cognitive and Affective Perceived Risk of HIV, and Age, Associations with Perceived PrEP Candidacy and Intentions (N=2,003) 
 
   Associations with PrEP Candidacy    Associations with PrEP Intentions 
  B S.E. AOR 95% CI   B S.E. AOR   95% CI 
Perceived PrEP Candidacy - - - -  1.27 0.10 3.56*** 2.96, 4.29 
Hispanic/Latino (ref. Yes)          
No 0.18 0.15 1.20 0.90, 1.60  0.10 0.12 1.01 0.80, 1.28 
Race (ref. White)          
Black 0.23 0.16 1.26 0.92, 1.73  0.23 0.15 1.25 0.94, 1.68 
Asian or other Pacific Islander 0.20 0.22 1.22 0.80, 1.87  0.11 0.19 1.12 0.77, 1.61 
American Indian or Alaskan Native 0.66 0.41 1.93 0.86, 4.30  0.27 0.31 1.31 0.71, 2.42 
Multiracial 0.13 0.15 1.14 0.85, 1.53  0.07 0.13 1.08 0.84, 1.38 
Other -0.29 0.22 0.75 0.49, 1.15  0.31 0.20 1.36 0.93, 2.00 
Sexual Orientation (ref. Gay)          
Bisexual -0.29 0.13 0.75* 0.58, 0.97  -0.24 0.12 0.79* 0.63, 1.00 
Queer -0.17 0.26 0.85 0.51, 1.41  -0.15 0.25 0.86 0.53, 1.41 
Relationship Status (ref. Single)          
Partnered -0.16 0.12 1.17 0.92, 1.49  -0.36 0.12 1.43** 1.14, 1.79 
Region (ref. South)          
Northeast  0.03 0.15 1.03 0.78, 1.37  -0.13 0.12 0.88 0.69, 1.12 
Midwest -0.14 0.14 0.87 0.66, 1.14  -0.09 0.12 0.92 0.73, 1.16 
West -0.05 0.13 0.95 0.74, 1.22  0.07 0.11 1.07 0.86, 1.33 
U.S Territory/Military -1.28 0.54 0.28* 0.10, 0.80  0.24 0.47 1.27 0.51, 3.18 
Medical Insurance (ref. Yes, on parents)          
Own insurance -0.32 0.11 0.73*** 0.59, 0.91  0.35 0.09 1.41*** 1.18, 1.70 
Partner's insurance -0.34 0.54 0.71 0.18, 2.05  0.09 0.49 1.09 0.42, 2.86 
No insurance -0.49 0.14 0.61*** 0.43, 0.80  -0.07 0.13 0.94 0.73, 1.20 
STI diagnosis in the past 6 months (ref. No)          
Yes 0.34 0.14 1.40* 0.97, 1.86  0.14 0.13 1.15 0.89, 1.48 
Any drug use in the past 3 months (ref. No)          
Yes 0.11 0.10 1.12 0.87, 1.36  0.11 0.09 1.12 0.94, 1.33 
Perceived Cognitive Risk of HIV -0.09 0.09 0.92 0.77, 1.09  -0.20 0.08 0.82* 0.70, 0.96 
Perceived Affective Risk of HIV 0.37 0.08 1.44*** 1.22, 1.70  0.30 0.08 1.35*** 1.16, 1.57 
Age 0.10 0.02 1.11*** 1.06, 1.16  -0.01 0.02 0.99 0.95, 1.03 
Age and Cognitive Risk of HIV Interaction -0.03 0.04 0.97 0.89, 1.05  - - -       - 
Age and Affective Risk of HIV Interaction 0.09 0.04 1.10* 1.02, 1.18  - - -       - 
Note: *** p <0.001; ** p <0.01; * p <0.05; PrEP = Pre-exposure Prophylaxis; Perceived PrEP Candidacy is dichotomized as an 
outcome variable, as such an increase in AOR represents increased odds of perception as a PrEP candidate; PrEP intentions is 
ordinal as an outcome variable, as such a one-unit increase in AOR represents an increase in odds of a one-unit increase in PrEP 











Demographics of YSMM at-risk for HIV and group differences in perceived PrEP benefits and PrEP stigma (N=2,003) 
 Full Sample Perceived PrEP Benefits  PrEP Stigma    
Overall n % m SD 
 m SD 
Age (M = 21.27) 
  t (2001) = 0.49, p = 0.62  t (2001) = -0.04, p = 0.97 
 13-17 79 3.9 3.57 0.59  2.24 0.55 
 18-24 1,924 96.1 3.53 0.71  2.24 0.55 
Race 
  F (5,1997) = 0.49, p = 0.79  F (5, 1997) = 6.79, p < 0.001*** 
Black 253 12.6 3.55 0.72  2.35
a 0.55 
White 1,151 57.5 3.54 0.69  2.19
b 0.53 
Asian or other Pacific Islander 117 5.8 3.48 0.66  2.31
a,b 0.55 
American Indian or Alaskan Native 42 2.1 3.65 0.65  2.23
a,b 0.50 
Multiracial 288 14.4 3.51 0.74  2.26
a,b 0.57 
Other 152 7.6 3.51 0.70  2.38
a 0.56 
Hispanic/Latino 
  t (2001) = -2.96, p < 0.01**  t (2001) = -2.75, p < 0.01*** 
 Yes 496 24.8 3.61 0.69  2.30 0.55 
 No 1,507 75.2 3.50 0.70  2.22 0.54 
Sexual Orientation 
  F (2, 2000) = 2.41, p = 0.09  F (2, 2000) = 8.14, p < 0.001*** 
 Gay 
1,597 79.7 3.54 0.70  2.22
a 0.54 
 Bisexual 
334 16.7 3.51 0.71  2.34
b 0.55 
 Queer 
72 3.6 3.36 0.71  2.13
a 0.54 
Relationship Status 
  t (2001) = -1.13, p = 0.26  t (2001) = 1.56, p = 0.12 
Single 1,641 81.9 3.54 0.68  2.23 0.54 
Partnered 362 18.1 3.49 0.79  2.28 0.58 
Education 
  F (2, 2000) = 1.28, p = 0.28  F (2, 2000) = 7.13, p < 0.001*** 
 Some High School/GED or less 
462 23.1 3.51 0.69  2.32
a 0.57 
 Some College 
1,118 55.8 3.55 0.69  2.21
b 0.54 
 4-Year College or more 
423 21.1 3.49 0.73  2.22
b 0.53 
Employment  
  F (2, 2000) = 0.65, p = 0.53  F (2, 2000) = 1.38, p = 0.25 
 Unemployed 473 23.6 3.50 0.71  2.23 0.52 
 Employed Part-Time 811 40.5 3.53 0.70  2.22 0.56 
 Employed Full-Time 719 35.9 3.55 0.71  2.26 0.55 
Geographic Region 
  F (4, 1998) = 2.11, p = 0.08  F (4, 1998) = 0.46, p = 0.76 




Midwest 363 18.1 3.49 0.72  2.22 0.53 
South 763 38.1 3.57 0.66  2.22 0.55 
West 523 26.1 3.58 0.71  2.26 0.53 
U.S Territory/Military 15 0.7 3.69 0.54  2.19 0.56 
 Health Insurance 
  F (3, 1999) = 2.68, p = 0.05*  F (3, 1999) = 6.46, p < 0.01*** 
 None 
394 19.7 3.62a 0.67  2.31
a 0.58 
 Own 
706 35.2 3.51a,b 0.70  2.26
a 0.55 
 Partner's 
17 0.8 3.52a,b 0.84  2.41
a,b 0.55 
 Parent/Guardian 
886 44.2 3.50b 0.71  2.18
b 0.52 
STI Diagnosis in the past 6 months   t (2001) = -3.83, p < 0.01*** 
 t (2001) = -0.77, p = 0.44 
 No 1698 84.8 3.51 0.70  2.24 0.55 
 Yes 305 15.2 3.67 0.68  2.26 0.54 
Any drug use in the past 3 months   t (2001) = -0.18, p = 0.86 
 t (2001) = 0.19, p = 0.85 
 No 678 33.8 3.53 0.72  2.24 0.56 
 Yes 1325 66.2 3.53 0.69  2.24 0.54 
Note: ***p <0.001; **p <0.01; *p <0.05; YSMM = young sexual minority men.  
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Table 8. Perceived Benefits of PrEP use, PrEP Stigma, and Age, Associated with PrEP 
Intentions 
Table 8 
Perceived Benefits of PrEP use, PrEP Stigma, and Age, Associated with PrEP Intentions (N=2,003) 
 Associations with PrEP Intentions 
 β S.E. AOR 95% CI 
Hispanic/Latino (ref. Yes)     
No -0.01 0.03 1.00 0.78, 1.27 
Race (ref. White)     
Black 0.06 0.03 1.39* 1.04, 1.85 
Asian or other Pacific Islander 0.03 0.02 1.29 0.92, 1.81 
American Indian or Alaskan Native 0.04 0.03 1.62 0.84, 3.14 
Multiracial 0.02 0.03 1.12 0.87, 1.44 
Other 0.05 0.03 1.44* 0.99, 2.10 
Sexual Orientation (ref. Gay)     
Bisexual -0.05 0.02 0.77* 0.61, 0.97 
Queer -0.02 0.02 0.80 0.49, 1.32 
Relationship Status (ref. Single)     
Partnered -0.08 0.02 1.48*** 1.18, 1.85 
Region (ref. South)     
Northeast  -0.02 0.02 0.90 0.71, 1.14 
Midwest -0.02 0.02 0.90 0.72, 1.14 
West 0.01 0.03 1.06 0.85, 1.33 
U.S Territory/Military -0.01 0.03 0.93 0.31, 2.79 
Medical Insurance (ref. Yes, on parents)     
Own insurance 0.06 0.02 1.28** 1.06, 1.53 
Partner's insurance 0.01 0.02 1.04 0.44, 2.46 
No insurance -0.06 0.03 0.74* 0.58, 0.96 
STI diagnosis in the past 6 months (ref. No)     
Yes 0.03 0.02 1.16 0.90, 1.50 
Any drug use in the past 3 months (ref. No)     
Yes 0.04 0.02 1.16 0.98, 1.39 
PrEP Stigma -0.06 0.02 0.81* 0.68, 0.96 
Benefits of PrEP Use 0.28 0.02 2.15*** 1.87, 2.48 
Age 0.02 0.02 1.02 0.98, 1.06 
Age and PrEP Stigma Interaction -0.05 0.02 0.93* 0.86, 1.00 
Age and Benefits of PrEP Use Interaction 0.05 0.02 1.07* 1.00, 1.13 
Note: *** p <0.001; ** p <0.01; * p <0.05;  PrEP = Pre-exposure Prophylaxis; PrEP intentions is ordinal 
as an outcome variable, as such a one unit increase in AOR represents an increase in odds of a one unit 
increase in PrEP intentions.  
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Figure 1. The Health Belief Model (HBM). The HBM is aimed at understanding significant 
predictors in an individual’s decision to enact a health-promoting behavior. Predictors included 
in the model are perceived benefits, perceived barriers, perceived seriousness, perceived 
susceptibility, self-efficacy, and cues to action. All predictors are presumed to have a directional 
association with the outcome, the likelihood of engaging in the health-promoting behavior.  

























Figure 2. The Theory of Reasoned Action (TRA). This theoretical model is aimed at 
understanding behavior as an outcome of the intentions to enact the behavior. The intentions to 
enact a behavior is directly influenced by the attitudes an individual has about the behavior and 
also the subjective norm, or belief that the behavior will be supported or not supported by 
significant others in the individual's social network.  














Figure 3. The Theory of Planned Behavior (TPB). This theoretical model is an evolution of the 
TRA and has added perceived behavioral control as a predictor of intention and also associated 
with the behavior. The addition of this factor to the TRA allows for the model to be utilized for 
behaviors that may be outside of an individual’s volition to accomplish the behavior efficiently.   



















Figure 4. Hypothesis 2a suggests that higher affective dimensions of HIV risk will lead to higher 
perceived PrEP candidacy. Hypothesis 2b suggests that higher cognitive dimensions of HIV risk 
will lead to higher perceived PrEP candidacy. Hypothesis 2c suggests age will moderate the 
association between affective dimensions of HIV risk and perceived PrEP candidacy such that 
those who are younger will have higher perceived PrEP candidacy. Hypothesis 2d suggests age 
will moderate the association between cognitive dimensions of HIV risk and perceived PrEP 
candidacy such that those who are older will have higher perceived PrEP candidacy. Hypothesis 
2e suggests the affective dimensions of HIV risk will have an indirect effect on PrEP intentions. 
Hypothesis 2f suggests the cognitive dimensions of HIV risk will have an indirect effect on PrEP 
intentions. 
Figure 4. Hypothesized model to test affective and cognitive dimensions of HIV risk on 



























Figure 5. Hypothesis 3a suggests that higher PrEP stigma will lead to lower PrEP intentions. 
Hypothesis 3b suggests that perceiving more benefits to PrEP use will lead to more PrEP 
intentions. Hypothesis 3c suggests age will moderate the association between PrEP stigma and 
PrEP intentions such that those who are younger will have more PrEP intentions. Hypothesis 3d 
suggests age will moderate the association between perceiving more benefits to PrEP use and 
PrEP intentions such that those who are older will have more PrEP intentions.  
Figure 5. Hypothesized model to test PrEP stigma and the benefits of PrEP use on PrEP 






















Figure 6. The figure above displays the results of hypotheses 2a-2f. Hypotheses 2a-2d suggested 
that age would weaken the associations between affective dimensions of HIV risk and perceived 
PrEP candidacy, while age would strengthen moderate the association between cognitive 
dimensions of HIV risk and perceived PrEP candidacy. These hypotheses were not supported. 
Age strengthened the association between affective dimensions of HIV risk and perceived PrEP 
candidacy, while all associations with cognitive dimensions of HIV risk were not significant. 
Hypotheses 2e and 2f suggested that perceived PrEP candidacy would fully mediate the 
associations between affective and cognitive dimensions of HIV risk and PrEP intentions. These 
hypotheses were not supported, as affective and cognitive dimensions of HIV risk were still 
associated with PrEP intentions through perceived PrEP Candidacy. 
Figure 6. Results of the first hypothesized model 








B = 0.05*  
S.E. = 0.03 
B = 0.37***  
S.E. = 0.08 
B = -0.09  
S.E. = 0.09 
B = -0.03 
S.E. = 0.04 
PrEP Intentions 
B = 1.27***  
S.E. = 0.10 
B = 0.30***  
S.E. = 0.08 
B = -0.20*  
S.E. = 0.08 
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Figure 7. This plot shows the interaction of age and affective dimensions of HIV risk on the 
perception of self as a PrEP candidate. For those who were in the high age group, having a 
higher score of affective HIV risk was associated with increased odds of viewing oneself as a 
PrEP candidate.   
 




























Interaction of Affective Dimensions of HIV Risk 
and Age on Perceived PrEP Candidacy













Figure 8. The figure above displays the results of hypothesis 3a-3d. Hypotheses 3a-3d suggested 
that age would weaken the association between PrEP stigma and PrEP intentions, while age 
would strengthen the association between benefits of PrEP use and PrEP intentions. The 
interaction of the benefits of PrEP use and age did results in strengthening the association with 
PrEP intentions. The interaction of PrEP stigma and age also strengthened the association with 
PrEP intentions, thus not supporting the hypotheses.  
Figure 8. Results of the second hypothesized model 
  
Age  PrEP Intentions 
PrEP Stigma 
Benefits of  
PrEP use 
β = -0.05*  
S.E. = 0.02 
β = 0.05*  
S.E. = 0.02 
β = -0.06* 
S.E. = 0.02 
β = 0.28***  
S.E. = 0.02 
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Figure 9. This plot shows the interaction of age and PrEP stigma on intentions to begin taking 
PrEP. Lower levels of stigma were associated with higher PrEP intentions among both groups. 
However, those who were in the high age group had higher PrEP intentions with lower stigma 
than those in the low age group.   























Interaction of PrEP Stigma and Age on PrEP Intentions 
Low Age High Age
* 
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Figure 10. This plot shows the interaction of the benefits of PrEP use and age on PrEP 
intentions. For both groups of low and high age individuals, low perceived benefits of PrEP use 
were associated with low PrEP intentions, and higher perceived benefits of PrEP use were 
associated with higher PrEP intentions. Those who were in the high age group and saw high 
benefits to use had higher intentions to begin taking PrEP than those who were in the low age 
group and perceived high benefits.  























Interaction of Benefits of PrEP Use and Age on 
PrEP Intentions 
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